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EXECUTIVE SUMMARY 
DEVELOPING AN MRC POLICY FOR POPULATION DATA ARCHIVING AND 
ACCESS 
Data archiving is not simply about best practice in storing primary records, although that is 
important.  It is also about making the necessary long-term strategic investments to ensure 
that datasets can be assessed and are interpretable by current and future generations of 
researchers.  
Rationale 
There are several important motivations for preserving research data: scientific, historical, 
economic, and legal. There is also significant demand for the re-use of population-based data 
in the medical research area, as usage of medical/health studies at the UK Data Archive 
(UKDA) show.  
 
The MRC has recognised the importance of developing a policy towards data archiving and 
access, but also understands that it should not do so in a vacuum.  What is required is a better 
understanding of the range and variation of current MRC-funded data creation activities, the 
existing data management infrastructure and practice in MRC-funded contexts, and the views 
and opinions of those likely to be most affected by the establishment of such a policy. 
Data Archiving and Access Project 
To this end, the MRC Data Archiving and Access Project (DAA) was established in 2001 to 
gather information, consult widely, and at the end of the Project, to make recommendations 
to Council concerning data archiving and access policy. Phase I of the Project involved 
conducting a broad but general survey and convening a working group of interested experts.  
Phase II of the Project incorporated both wider and more narrowly focused work. On the one 
hand, a series of site visits were undertaken in order to collect in-depth case study 
information on the conduct of population-based data creation and management; and on the 
other hand, the  “Horizons” workshop was convened to locate the current inquiry in the 
broader context of developments in e-science more generally. 
DAA Phase II 
This paper is a consultants’ report growing out of Phase II.  It presents the results of the case 
studies and lessons drawn from them, and analyzes current DAA provision within MRC-
funded units and projects. It further identifies cultural issues involved, looks to other research 
data organisations, services, and funding bodies internationally for existing policies and 
practices, and presents a number of different possible models for DAA provision.  
 
Case studies 
A small team visited seven study sites and examined eighteen population-based datasets. 
Semi-structured interviews were conducted with principal investigators, project managers, 
laboratory managers, statisticians, geneticists and data managers, attempting to uncover the 
current situation “on the ground” with regard to data management, preservation, and access. 
Researchers views were sought on the philosophical and practical issues involved in 
developing a data archiving and access policy, and what services they themselves might like 
to see supported. 
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One of the findings of the case studies was that even under the rubric “population data” a 
very broad church was represented.  The eighteen studies investigated revealed a lot of 
variation in study types, methods, data types, and formats.  There was also great variation in 
current data management and data sharing provision, ranging from excellent to less than 
ideal.  The attitudes of researchers towards data sharing were also variable, and although 
there was widespread support for data sharing on a conceptual level, in many cases 
researchers were concerned about secondary usage being carried out without appropriate 
control over the legal, intellectual and analytical frameworks. 
 
Additional investigations 
To augment the case studies, additional investigations were undertaken.  An analysis was 
undertaken of current consent arrangements and their impact on data sharing.  Research on 
existing standards for metadata and interoperability in the medical and health-related data 
areas was undertaken.  Data sharing policies from organisations in the UK, the USA, and 
internationally were also examined. 
 
Models for service provision 
Building on the outcome of these investigations, a series of five models for possible 
architectures of service provision have been drawn, ranging on a continuum from fully 
centralised to fully distributed.  Model one is fully centralised, with dataset preservation, 
provision for secondary use, and support of secondary users all located in a single centre.  
Model two has a centralised infrastructure, centralised preservation and dissemination, but 
user support is disseminated among specialist centres.  Model three further distributes the 
service, with data preservation and dissemination as well as user support being devolved to 
distributed subject centres.  Model four is a completely distributed one, with integration 
happening only at a virtual level on the end-user’s desktop, and each individual data creator 
responsible for making their data available via common interoperability standards.  Model 
five suggests a portal service, offering standardised information about, and pointers to, data 
resources, but leaving each researcher to negotiate access individually.  The advantages and 
disadvantages of each model were assessed. 
RECOMMENDATIONS 
It is beyond the scope of this report to present specific recommendations to the MRC 
concerning the particular form and content of its data archiving and access policy and service 
provision.  However, this report offers some general observations and lessons learned from 
the course of the site visits and accompanying research. 
1. Encouraging the Culture of Data Sharing 
It is clear that most researchers support the idea of data sharing. However, in discussion of 
the mechanisms of how access would operate, there is a reluctance to relinquish control.  
There are significant cultural barriers that need to be overcome, and researchers need to be 
encouraged to think in terms of sharing data as a normative activity, as it is in other areas of 
MRC science.  Formalising access control procedures and protocols might serve to make 
researchers more comfortable with data sharing.  It is important that a policy which mandates 
data sharing not be confused with a requirement to open all data to free and uncontrolled 
access.  Researchers will understandably feel far more comfortable if there is a sense that 
secondary users have been in some measure "vetted" before access is allowed to potentially 
sensitive or particularly complex data.  Depending upon the access control procedures 
implemented, such protocols, however, may come to seem unnecessarily onerous to the 
secondary analyst, who may quite reasonably feel that the peer review process already in 
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place for research proposals and resulting publications would obviate such a requirement.  
Enforcing the sharing of data may require both "carrots" and "sticks" in the form of additional 
funds to researchers to prepare their data for secondary analyses, and perhaps making the 
incorporation of data sharing into the research plan a condition of the grant award. 
2. Standards and Guidelines 
It is clear that there is a demand for the re-use of population data in the medical research 
field, as well as a good scientific and economic rationale for its preservation and 
dissemination.  It is also equally clear that in order for data to be reasonably re-usable and 
preservable, certain standards, particularly of dataset documentation, must be met, and that 
researchers would welcome assistance in meeting them, particularly in the form of published 
guidelines and advice. 
3. Rights Management Framework 
A good rights management framework is essential for the establishment of a data archiving 
and access service.  Rights management in its broadest sense covers not only the relationship 
between the data creators and secondary data users, but also protects the rights of institutions, 
funders of research and even research subjects.  A unified rights management framework for 
MRC data would greatly improve a data access service, no matter what the particular model 
of service provision. 
4. Consent 
Consent arrangements need not preclude the use of data for secondary analysis, and it is 
recommended that the MRC draft appropriate guidelines for wordings for consent agreements 
which would allow secondary analysis.  It is important when issuing guidelines on consent 
and data sharing that the MRC educate both researchers and other bodies concerned with the 
ethics of research with human subjects. 
5. Selection of Data for DAA 
All data are not created equal, and in a world of limited resources, priorities for DAA must be 
drawn.  Investigators’ views should be of great value in helping MRC to consider a strategy 
for both assessing and prioritising datasets for archiving. In summary, the following criteria 
may be most appropriate for making these decisions, some of which were previously 
suggested from the MRC DAA Phase I survey:  
 
• the degree of uniqueness or the size/longevity of the study/dataset; 
• the reputability and quality of the study methods and dataset;  
• the potential to answer new important research questions cost-effectively; 
• the likelihood that a dataset can be pooled or combined with other data to provide 
explanatory power that individual datasets cannot provide; 
• the degree to which the study fulfils ethical and legal requirements to enable the re-
use of personal information; 
• the degree of MRC sponsorship; 
• the anticipated cost of preparing a dataset to professional archival standards;  
• the recency of the study; 
• building in prospective data preparation and documentation plans that enable 
secondary access for all new studies . 
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A set of criteria such as these would provide the framework in which to apply independent 
evaluation of MRC datasets for archiving. 
6. Desired Services 
There was nearly unanimous support among researchers for published guidelines for good 
practice in the management of data and their preservation.  Many also supported the idea of a 
data archiving and access advisory service.  A central registry of research instruments also 
received strong support, particularly among younger researchers and project managers.  
Support for a freestanding data archiving and dissemination service was mixed, as many 
researchers feared losing control altogether; support was stronger for a preservation service. 
7. Service Provision 
There are a number of different possible models for the architecture of service provision for 
data archiving and access, ranging along a continuum from completely centralised to 
completely virtual and distributed.  Each model has advantages and disadvantages which 
must be weighed, including cost effectiveness, quality and focus of service and support, and 
ease of use and navigation for both data creators and data users, and support among the 
research community.  Centralised services are often most cost effective because of lack of 
replication of infrastructure and expertise, and may be an easy focal point or “one stop shop” 
for secondary users and data creators, but may also offer the least focused user support, and 
may face the greatest resistance from researchers concerned about access control.  Different 
models also require, and enable, different degrees of data and metadata standardisation. The 
MRC must determine the relative priority of these competing factors in choosing a model for 
service provision. 
8. Policy and Resources 
Regardless of the model of service provision, funding is required for long-term preservation 
and to facilitate data access and user support.  Any data archiving and access policy needs to 
be adequately resourced, and may also require some contractual "teeth" to overcome cultural 
barriers and ensure compliance. 
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DEVELOPING AN MRC POLICY FOR POPULATION DATA ARCHIVING AND 
ACCESS 
1. INTRODUCTION 
This paper is a consultants’ report growing out of the Medical Research Council’s Project on 
Population Data Archiving and Access (DAA).  It presents the results of a series of case 
studies and lessons drawn from them, analyses current DAA provision within MRC-funded 
units and projects, identifies cost drivers and cultural issues involved, looks to other research 
data organisations, services, and funding bodies internationally for existing policies and 
practices, and presents a number of different possible models for DAA provision.  
 
1.1 Rationale  
To quote from the Project’s briefing papers: 
 
“Over the decades the Medical Research Council has funded 
the construction of a large number of population-based studies.  
This includes several longitudinal studies and a significant 
number of cross sectional studies and clinical trials.  Many 
have a unique value for research that runs well beyond their 
use by the Principal Investigators who created the studies. 
This Project aims to develop a policy for the Council that will 
identify its role in archiving population datasets, as well as that 
of investigators and the institutions which the MRC funds.   
Data archiving is not simply about best practice in storing 
primary records, although that is important.  It is also about 
making the necessary long-term strategic investments to ensure 
that datasets can be accessed and are interpretable by current 
and future generations of researchers....  A policy for archiving 
will allow Council to manage its strategic investment in these 
resources more effectively for the benefit of research and for 
the health of the public.” 
 
There are several important motivations for preserving scientific data: scientific, historical 
economic, and legal.  
 
1.1.1. Scientific 
Scientific knowledge creation is a cumulative process, and better access to well documented 
previously collected data can only facilitate this process. New data which are collected to be 
comparable with existing data increase the explanatory power of both. 
 
Data also provide important baselines to track rates of change and capture the frequency of 
rare events. Data collected for one purpose may actually prove relevant to other scientific 
investigations, and the re-analysis of existing data with better tools and techniques may lead 
to new and different conclusions. Thus, access to archived data enables the formulation of 
new hypotheses and may unexpectedly change the relative importance of data previously 
collected. 
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1.1.2. Historical 
Individual data collections are unique entities. They both take place within, and capture 
circumstances that are socially or scientifically fixed in, time.  They can rarely be reproduced 
in exactly the way in which they were first undertaken.  
 
Increased emphasis is being placed on empirical data as a means both of measuring and 
testing the effectiveness of scientific and medical techniques and of measuring the 
effectiveness of political and business decision-making. Thus data collectors have a 
responsibility to ensure that the materials which contribute to these processes are preserved 
for further use and historical record. 
 
1.1.3. Economic 
Data are expensive to collect, and become increasingly so if the collection process is to 
provide high quality, validated data. The costs of preserving and archiving data are relatively 
small in comparison with the costs of acquiring scientific records through observation or 
experimentation.  There is an economic imperative on the funder of data creation to maximise 
their investment, and derive maximal scientific (and at times commercial) value from the data 
sources they help generate. 
 
1.1.4. Legal 
For some data collections, there is a legal imperative to hold and preserve data, and in some 
cases provide an adequate “audit trail” in case of later legal challenges.  This certainly applies 
in the area of clinical trials, and is increasingly the case with Data Protection and Freedom of 
Information legislation. 
 
1.2 Re-use of medical population-based data 
There is clearly scope for the re-use of medical population-based data.  The UK Data Archive 
(UKDA) currently holds a number of such studies and provides them to the academic and 
research community nationally and internationally for purposes of secondary research.   
 
Over 300 studies in the UKDA’s collection (about 7%) contain medical or health-related 
data, largely health and lifestyle data (as one might expect from a social science data 
archive).  These studies jointly accounted for an average of 400 orders for data each year for 
the past 10 years – a small but significant proportion of total data archive usage (see 
Appendix 4). 
 
Different data types and methodologies engender different kinds of re-use.  Some data may 
be most useful when first released and their value may decline fairly steeply thereafter, 
though their preservation may be necessary for legal reasons (e.g. clinical trials data).  Other 
data, for example longitudinal data, increase in richness and value through time. 
 
Clearly any data archiving and access policy must take into considerations the differing uses 
and requirements of different kinds of medical research data. 
 
1.3 The DAA Project 
 
The MRC has recognised the importance of developing a policy towards data archiving and 
access, but also understands that it cannot do so in a vacuum.  What is required is a better 
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understanding of the range and variation of current MRC-funded data creation activities, the 
existing data management infrastructure and practice in MRC-funded contexts, and the views 
and opinions of those likely to be most affected by the establishment of such a policy.   
 
To that end, the MRC Data Archiving and Access Project was established in 2001 under the 
leadership of Peter Dukes to gather information, consult widely, and at the end of the Project, 
to make recommendations to Council concerning data archiving and access policy. 
 
The DAA Project has focused on population-based datasets created as a result of MRC 
resources, but realises that any policy recommendations in this area must join up with other 
areas of MRC science, and should also fit into the broader scientific information landscape 
and be mindful of developments in other disciplines.  To that end, information has been 
gathered not just from population-based research and researchers, but equally the attempt has 
been made to cast a moderately wide net for our investigations.   
 
The project has been a staged one, with Phase I conducting a broad but general survey and 
convening a working group of interested experts.  Phase II on the one hand tightened the 
focus by commissioning a series of site visits to collect in-depth information on the conduct 
of population-based data creation and management; and on the other broadened the focus by 
convening a “Horizons” workshop which attempts to locate the current inquiry in the broader 
context of developments in e-science generally. 
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2. PHASE I: SURVEY, QUESTIONNAIRE AND WORKING GROUP 
Last year, Phase I of the Population-Data Archiving and Access project set out to identify the 
broad principles of a data archiving policy for MRC.  It comprised: (1) a survey of the key 
characteristics of 95 datasets (40 survey respondents); (2) a questionnaire about archiving 
policy (40 respondents); and (3) the first meeting of the Data Archiving Working Group, 
chaired by Professor Sally Macintyre (June 2001).  The conclusions at the end of this Phase 
can be summarised very briefly as follows: 
1. MRC supported datasets vary significantly in their size, methodology, the variables, and 
the format and media used to collect and store data. 
2. There are considerable challenges in putting order into, and making sense of, “old” 
datasets.  Ensuring continuing participation of the original investigators is one solution. 
3. Guidelines to help data creators prepare their datasets to appropriate archiving standards 
as part of routine data management would be helpful.  However, the necessary standards 
may not currently exist. 
4. Archiving will require specific expertise, infrastructure and financial resources. 
5. Principal investigators creating datasets have important concerns about the quality of 
secondary research uses, loss of control over the data and interpretations of them.  Some 
are uncertain about the consent constraints that might apply to new uses. 
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3. PHASE II: FIELD STUDY, FURTHER RESEARCH AND COUNCIL 
RECOMMENDATIONS 
In early 2002 the MRC launched Phase II of the Data Archiving and Access Project.  It 
convened a team consisting of representatives from MRC Head Office, from the UKDA 
(consultants), and from IBM to conduct a series of seven visits to sites where MRC-
sponsored population-based research takes place.  The purpose was to fill out the sketchy 
picture provided by the Phase I questionnaire, and to investigate more fully both the range 
and variability of MRC-sponsored population research, the current provision for DAA “at the 
coalface” and researchers’ attitudes towards the issues raised by the establishment of an 
MRC- DAA policy. 
In essence, the brief for the case study site visits was to: 
• identify and draw on existing good data management and archiving practice;  
• illustrate how data are created and used - and the needs of data creators in sharing and 
preserving datasets; 
• identify technical, cultural and financial challenges.   
3.1. Site selection 
The seven sites were chosen specifically to represent not only a range of population datasets, 
methodologies, and data types; but also a range of institutional settings, from freestanding 
MRC units to MRC-funded research conducted within academic departments.  The Project 
also sought to capture datasets at different points in their “lifecycle” – from projects just 
beginning to collect data to “orphan” datasets whose principal investigators had retired or 
died.  The teams investigated 18 different studies across the seven sites.  Appendix 1 contains 
site report summaries for each of the seven sites visited, and Appendix 2 contains 
standardised dataset descriptions for each of the 18 datasets. 
Table 1: Sites and Studies 
 Host Unit / Programme  Studies 
1 Twins’ Early Development Study (TEDS) 
2 Depression Case Control Study (DeCC) 
I MRC Social, Genetic and Developmental 
Psychiatry Research Centre (SGDP), Institute 
of Psychiatry, London  3 Isle of Wight Studies (IoW) 
4 Southampton Women’s Survey (SWS) 
5 Wessex Fracture Prevention Study (Wessex 
Fracture) 
II MRC Environmental Epidemiology Unit, 
Southampton 
6 Study of the effect of formaldehyde on the 
mortality of workers in the UK chemical 
industry (Formaldehyde) 
7 SHARE: Does Teacher Led Sex Education 
Reduce Sexual Risk Taking? (SHARE) 
8 Masculinity and Health: The Social Factors 
Affecting Men’s Health (Masculinity) 
9 Racist & Sectarian Graffiti in Glasgow – A 
Pilot Study (Graffiti) 
III MRC Social and Public Health Sciences Unit, 
Glasgow 
10 The West of Scotland Twenty-07 Study 
(Twenty-07) 
IV Department of Community Health Sciences, 11 MRC Scottish Colorectal Cancer Study 
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University of Edinburgh Medical School (SOCCS) 
12 Parkinson’s Disease DNA Bank (PDGEN) 
13 Parkinson’s Disease Drugs Assessment  
Randomised Trial (PDMED) 
V University of Birmingham, Clinical Trials 
Unit (BCTU) 
14 Parkinson’s Disease Surgery Assessment 
Randomised Trial (PDSURG) 
VI MRC National Survey of Health and 
Development, University College London 
15 MRC National Survey of Health and 
Development (NSHD or 1946 Birth Cohort) 
16 MRC/INSERM trial of zidovudine in HIV 
infection (CONCORDE) 
17 Evaluation of Subcutaneous Proluekin in a 
Randomised International Trial (ESPRIT) 
VII MRC Clinical Trials Unit (CTU), London  
18 An open randomised trial to evaluate different 
therapeutic strategies of combination therapy 
for HIV-1 infection (INITIO) 
 
3.2 Methods 
The project team's first task was the construction of a case study tool or questionnaire to be 
used to structure the interviews undertaken at the sites.  The tool was then piloted at the first 
site visit, the MRC Centre for Social, Genetic and Developmental Psychiatry (SGDP) at the 
Institute of Psychiatry in London.  The tool underwent subsequent revision based on the 
experience of the pilot visit.  A copy of the final version appears in Appendix 5. 
The method undertaken was semi-structured interview.  The site visit would begin with a 
general introductory session with all staff where the project and its aims were presented and 
discussed.  Then followed parallel sessions where individual principal investigators, project 
managers, statisticians, laboratory managers and data managers were interviewed.  Generally, 
two project team members would interview the site visit participants, with one team member 
asking questions whilst the other took notes.  Whenever practical, interviews were audio 
recorded as an aide mémoire.  The day would end with another group session where any 
other concerns could be raised and discussed. 
Every effort was made to ensure that site visit participants did not feel as if the project team 
were evaluating them or sitting in judgement on their dataset practices.  Every attempt was 
made to engender frank and open discussions of problems and challenges, as well as positive 
achievements. 
Whenever possible, documents associated with the study, such as participant briefing notes, 
consent forms, ethics committee applications, annual reports, etc were collected for 
comparative analysis. 
Site report summaries were created with the following subject headings: 
• Background: description, scientific objectives and funding history.  
• Scientific value and potential for new research: profile and perceived value of 
study, secondary use potential and issues recognised by PI and team.  
• Access: terms of consent, nature of requests and procedures for current access, issues 
concerning future access. 
• Custodianship and ownership: perceived ownership, formal and local contracts 
concerning ownership, IP issues. 
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• Resources: staffing profile, funding, overview of data collection/processing 
operations, storage space, digital storage. 
• Dataset technical details: dataset size, data formats, platforms and software, security, 
metadata, relationships between data types (e.g. human biological samples). 
• Views towards future data sharing/possible MRC DAA service provision: 
research registry, advice centre, best practice guidelines, etc. 
 
These site summaries appear in Appendix 1.  Standardised dataset study descriptions were 
also created for each of the eighteen studies investigated to aid analytical comparisons.  
These study descriptions appear in Appendix 2. 
3.3. Comparative models research 
A second strand of Phase II was to look to other domains, both within and without MRC 
science, for models of data sharing and data preservation. To that end, project members 
visited and corresponded with a number of organisations, including the Economic and Social 
Research Council (ESRC), Natural and Environmental Research Council (NERC), the 
Human Genome Mapping Project (HGMP), the Netherlands Institute for Scientific 
Information Services (NIWI), the Arts and Humanities Research Board (AHRB), and others.  
These visits served as examples not only of data sharing practice, but also policy and 
structures of service provision.   
This comparative research will be furthered by the upcoming Horizons workshop, which will 
situate the current discourse into a wider context of e-science, and provide linkages to other 
areas of MRC investment and policy, and related enterprises in other scientific domains. 
3.4 Council recommendations 
The final strand of Phase II will be the submission to the Medical Research Council of 
specific policy recommendations growing out of the case studies, this consultant's report, and 
the Horizons workshop, for its consideration in December 2002.  
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4. SITE VISIT RESULTS 
The site visits proved to be an extremely rich resource for illustrating the range and 
complexity of MRC investments in population-based research.  They were also extremely 
illustrative of the variation in awareness of, and views about, issues central to the theme of 
data archiving and access. 
4.1. Varied study types 
One of the lessons of the case studies was that even under the rubric “population data” a very 
broad church was represented.  Of the eighteen studies investigated, there was a lot of 
variation in study types and methods. 
 
Eight of the studies could be called trials, six of the studies were longitudinal in nature, two 
were focused primarily on the collection of DNA for banking (although many more of the 
studies had a DNA element to them) and two fell under the slightly vague rubric of “medical 
sociology”, owing more of their methodology to that social science, although their subject 
matter was medical or health related.   
 
Most of the studies had survey elements, many also had clinical measurements and 
assessments, some also had associated physical or genetic samples.  Many used standard 
clinical scales, for example the Rutter scales, DSM-IV, SADS, etc. Some had qualitative 
elements, such as focus groups, or participant-produced art.  A number had audio- or video-
taped interviews. 
4.2. Varied data types 
The types and forms of data collected and produced by these studies also varied 
tremendously.   
 
4.2.1. Paper 
All of the studies involved a certain amount of paper, if only in the form of consent forms.  
Paper-based data also included original questionnaires, interviewer notes, clinical 
measurements, drawings, photographs and maps.   
 
4.2.2. Digital data 
Electronic data included coded questionnaire responses, interview transcripts, clinical 
measurements, and digital images.  Survey data in some studies were “born digital”, whilst 
the majority were coded from paper originals.  The software formats for these digital data 
were many and varied, including text or word-processed files, various databases, statistical 
software, and a variety of proprietary image formats (in the case of DNA, gels linked largely 
to the laboratory machines producing them). 
 
4.2.3. Physical samples and DNA 
Physical samples were another data type collected by a number of the studies, including 
epithelial cells, blood and plasma, and tissue samples (tumours, for example). A number of 
the studies included extraction of DNA from these samples, and went on to produce genetic 
sequence data. 
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4.3. Current data management provision 
Among the different sites visited, data management provision varied fairly widely.  
Interestingly, research lifecycle seemed to be correlated with the effectiveness of the data 
management for the study.  Studies which had just begun and studies which had been in 
operation for a very long time seemed to have the most difficulties with data management 
protocols – the former due to lack of experience, and the latter due to being “locked in” to 
systems and protocols established in a much earlier era, which might be bordering on 
obsolete.  Studies in “mid-life” often seemed to have the most effective data management 
structures. 
 
Effectiveness also varied by study type.  The clinical trials unit, for whom data preservation 
is required for legal, audit trail reasons, had well-established, effective data management 
protocols.  Studies under the rubric “medical sociology” were probably the least concerned 
with long-term data management, as they tended to be smaller, one-of-a-kind studies.  
Longitudinal studies faced particular challenges (alluded to under lifecycle above) since data 
collection, storage, and retrieval methods may have changed dramatically during the lifetime 
of the study. 
 
It was also interesting to note that different studies conducted within the same unit could have 
differing levels of expertise and effectiveness of data management.  Some of the effect of 
“lifecycle” noted above could be mitigated by more data management expertise sharing 
within units.  This may be another reason why the clinical trials unit was so effective; 
because the senior statistician was involved in all the studies from the earliest stage and can 
ensure adherence to standards in data collection protocols, etc.  Sharing of data management 
expertise, and the establishment of published guidelines for good practice in data 
management, would be extremely helpful. 
 
Indeed, the units which had a central data person supporting more than one project often had 
superior data management. This was probably because the person was forced to think more 
generically and in a standards-based way about data management, rather than being free to 
tailor procedures to the needs of one particular data creation activity.  This may be part of the 
reason why the labs that handled physical materials also had superior data management 
systems on the whole, since ordinarily these labs were serving multiple studies 
simultaneously.  This finding would tend to support the notion that centralisation of service 
and expertise can promote quality in data handling. 
 
4.3.1. Physical infrastructure 
The physical infrastructure (facilities, computers and networks, paper storage) ranged from 
excellent to less than optimal.  Paper storage was mentioned most often as the most pressing 
and most expensive problem, and many sites had recourse to an external contractor for paper 
storage (largely Iron Mountain).  This was not, however, seen as the optimal solution, as 
referral back to stored paper was costly and difficult.  Nearly all sites did require local storage 
of some paper materials which were referred to regularly.  Many felt that their facilities were 
inadequate in terms of archival issues like fire safe and environmental control, although 
physical security and theft prevention were of primary concern.  Preservation of audio and 
videotapes was particularly poor, with little understanding of (or where there was 
understanding, insufficient resources for) archival practice for such media. 
 
Most sites were content with their hardware and software provision for operational purposes, 
but for many, issues such as media backup and network security were left to the host 
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institution (university or hospital).  Those studies dealing with genetic materials were 
generally most aware of electronic security issues. 
 
4.3.2. Awareness and training in data management 
Whilst many data managers were aware of some of the principals of archiving and records 
management, not one of the sites visited had any staff formally trained in these areas.  Data 
managers were nearly unanimous in their desire for published guidelines to good practice, 
and there was a high level of good will and desire to conform to good practice expressed.  
However, it is also clear that preservation and documentation for secondary analysis was not 
in the forefront of data managers’ minds on a daily basis, as most of them were busy serving 
immediate operational and research needs.   
 
Whilst most data managers had significant hands-on experience in managing digital data, 
there was particular concern around paper-based data and what could and should be done in 
terms of its preservation.  Almost none of the sites had considered scanning or digitisation of 
documents such as consent forms, and there were questions about the admissibility and 
authenticity of such electronic versions for which guidance is sought.  Many sites wished to 
maintain paper questionnaires because of verbatim responses and interviewers notes which 
might not have been coded, but again scanning as image files or documents was not widely 
considered as a viable alternative to storing paper.  Exceptionally, the NSHD had invested, in 
an earlier era, in microfilm/fiche, and was now faced with the question of whether to continue 
subsequent waves in this analogue format or invest anew in digital imagery, which is a lesson 
in the costs of shifting technology.   
 
4.3.3. Standards awareness and use 
With the exception of clinical trials where the standards are fairly well established and 
motivated by audit trail concerns, there was little awareness of archiving and metadata 
standards among the sites visited.  Metadata is a particular area of concern.  Whilst the 
content of digital databases tended to be fairly well documented, there was a distinct 
insufficiency of internal documentation of other kinds of data: registers of the content of 
paper files, audiotapes, etc.  The genetic and human samples labs were a noticeable exception 
to this generalisation. 
 
Nonetheless, those data managers with multiple responsibilities for multiple studies, and 
those who were responsible for making orphan datasets usable again, often had the best 
awareness of what kinds of documentation standards are useful.  Those serving solely the 
operational needs of a particular study were the least likely to think in terms of 
standardisation and documentation.   
 
4.3.4. Summary 
Current data management provision varies across the sites investigated.  Based on the 
experience of the site visits, we would offer the following observations: 
 
• There was a desire to conform to good practice in data management, and a keen need 
felt for published guidelines on this topic. 
• Concern was voiced, however, that if guidelines are produced, adequate resources are 
provided to meet them. 
• Units with a central core of expertise which serviced many studies seemed to have 
superior data management procedures and protocols, as did studies in “mid-life”. 
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• Expertise was often not well shared across studies within the same unit which were 
not centrally serviced. 
• Whilst metadata surrounding digital data files was often fairly good, metadata about, 
and internal tracking of, ancillary non-digital data was patchy (with the exception of 
physical samples). 
• Management of paper was viewed as a particular problem, and digital solutions were 
not well investigated or used. 
• There were very few complaints regarding computer software and hardware; the 
largest complaint regarding physical infrastructure had to do with paper storage. 
 
 
4.4. Researcher Opinions 1: long term value of data 
During the interviews, principal investigators were asked about the scientific value and 
potential for new research of their study data.  Issues covered were: 
 
• the extent of evidence of external knowledge or value of the study/dataset; 
• the unique features of the study or dataset; 
• whether the study could be compared or pooled with other similar studies; 
• what they considered to be the expected ‘lifetime’ of research for the dataset. 
 
4.4.1. Evidence of value or external knowledge of the study/dataset 
As expected, the studies that were judged to be the most renowned or with a perceived high 
profile were those that were unique, pioneering, expensive, with large samples, followed over 
time (e.g. cohort studies) or addressed significant public health issues.   Such pioneering or 
significant funding investments such as the NSHD, the SWS, the ESPRIT trial and the 
PDGEN DNA bank naturally attract media and policy attention because of the hopes they 
offer in helping to understand the aetiology of certain diseases and to develop new 
treatments. In addition to web publicity, publications and the conference circuit, knowledge is 
transferred rapidly across the academic community as many of the experts in the same fields 
sit on various committees to advise on study funding; study design and analytic questions. 
 
The NSHD, having been established for over half a century, is obviously truly unique, as is 
the team’s expertise in formulating and running the study.  The SWS is unique in the western 
world primarily as its approach, which is reliant on recruiting using the UK GP network, 
would be very difficult, if not impossible, to emulate in other countries such as the USA. 
 
The Formaldehyde study is the biggest study of its kind with 13,500 participants and within 
the field, is considered to be the most informative of all studies on formaldehyde.   
 
The Isle of Wight Study conducted by Rutter in the 1960s was unique at the time due to both 
the richness of data collected, that was far greater than for comparable studies, and its 
methods. It was the first study to involve direct assessment of children and depended on a 
partnership with social and medical services, which could not take place today, for example 
gaining direct access to their record systems.    
 
In the area of clinical trials, the CTU has a history of co-ordinating groundbreaking 
HIV/AIDS trials that have both influenced therapy and contributed to understanding of the 
disease mechanisms.  Its HIV study, ESPRIT is the largest cross-national study of its kind, 
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funded in the region of 3 million dollars, and as a consequence, its results are much awaited.  
PDGEN is also very well known because of its size, rigour and large case-control design, 
considered to be the key factor looking at genetic factors in complex disease.  Finally the 
Wessex Fracture Study, a big public health interest of the international osteoporosis research 
community, is unique as no one else is undertaking this kind of intervention. 
 
For some of the older groundbreaking studies, where new methods of measurement had been 
developed (e.g. Michael Rutter, Mike Wadsworth, George Brown) the tools themselves are 
seen as being equally valuable future assets for the scientific community.  The Dietary 
Assessment Tool from the SWS has also been published as a validation tool, and is tied to 
well known questions.  To promote institutional expertise, some units also run training 
programmes in study design, and data collection and coding, thereby promoting their studies 
further. 
 
However, research can also become well known when studies give unexpected results.  One 
such case amongst the studies we examined, was the clinical trial, CONCORDE, referred to 
as the prototype HIV study in the field and known to policy makers and practitioners across 
the world.  This was a big HIV trial investigating early or deferred treatment with a single 
drug with a clinical end point, measured at the time (late 1980s) by the number that died and 
the number that got AIDS.   The trial results, which were contrary to other findings, showed 
that there were significantly higher differences in mortality for the early treatment group - a 
shock to the company, the research and clinical community.  This trial sparked an 
international controversy that affected future clinical practice.  
 
Finally, many investigators stressed that studies were of greatest value when they had a long-
term follow-up design, for example, trials that were supported by a core funded unit with 
continuity.   
 
4.4.2. Studies with which own data could be pooled or compared 
Investigators were asked to consider how their data related to other studies, and to what 
extent it would be possible to compare or pool data.  Comparison or pooling offers greater 
power to answer scientific questions and as a consequence can be seen as adding value to the 
original study. 
 
For the pioneering or unique studies, as discussed above, the theories and methods of the 
study have often driven other research agendas and study designs across the world, thus 
making realistic comparison a reality. The NSHD, the Twenty –07 are examples of this.  
Other purposive cross-national data collection strategies to which the teams were contributing 
members, offered further comparative data sources.  An example is the multi-national INITIO 
clinical trial. Some of the newer trials, such as PDmed and PDsurg were expected to 
encourage new large-scale data trials to follow in other countries to provide comparative data.   
 
Finally, some teams recounted smaller more focused studies, from within their own units, 
funded by MRC, or from individual European countries, with which their data could be 
pooled.  Additionally, new value and power could be added if a dataset could be combined 
with data beyond its own geographical limitations. 
 
The idea of ‘pooling’ data was felt by others to be untenable, as the methodology and 
instrumentation between studies is often so different.  Data were more likely to be compared 
with other studies with similar styles of data collection.  In this respect The NSHD was 
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comparable with other UK based birth cohort studies, the NCDS, 1970 Birth Cohort and 
ALSPAC, and may have similar psychiatric data to some of Rutter’s studies, e.g. the Isle of 
Wight.  
 
In the field of clinical trials, comparison appeared to be more evident, for example with the 
existence of trialist collaborative groups set up by the CTU.  The ESPRIT study could be 
compared with MRC commercial studies, e.g. SILCAAT which, while addressing a different 
population, could provide good comparison.  Equally, CONCORDE data had been pooled 
with a Wellcome company sponsored study that investigated early HIV treatment.  
 
Trials investigators use meta-analysis as a key methodology in their work, and as such the 
CTU has its own dedicated meta-analysis team.   As the results from trials are published to 
high standards, so these published data can be utilised for meta-analysis.   However 
investigators emphasised how expensive meta-analysis was to undertake, and as such the 
relative value of such an exercise always had to be weighed up.   Some of the trialists further 
insisted that in order to undertake a reliable and robust integration of data across trials, it was 
essential to return to the source data (the individual patient data), as tables were generally not 
published in the same format (e.g. tabulated in different ways or different outcome measures). 
 
The other primary use of data within the sphere of comparative use was the contribution to 
systematic reviews.   
 
4.4.3. Lifetime of research on datasets  
Leading on from the comparative potential of data, investigators were invited to consider the 
expected ‘lifetime of active research’ on their unit’s dataset, both by their own team and in 
terms of the utility for secondary research. 
 
Opinions were divided as to the potential research longevity of study data, which were driven 
primarily by the kind of data.   
 
Cohort studies have obvious longevity and the degree of prior investment by MRC in its 
largest longitudinal studies might suggest that continued investment would also be a sensible 
strategy.   The longitudinal studies, such as NSHD, Twenty-07 and SWS already had secure 
funding for set periods, but it was expected that the investment would be likely to continue.   
Even after data collection ceased, a lengthy period of analyses within units was anticipated.  
Furthermore, cohort studies’ tendency to address broader sets of questions and variables 
provided good opportunities to ask new questions.   
 
Studies that were unique were also viewed as having a lot of lifetime, where the longer view 
of use should be taken at the outset.  The potential existed to go back to original schedules to 
reformulate new analyses.  However, the complexity of some data, for example in the way in 
which questionnaire responses may have been rated for psychiatric measures, may be a 
barrier to longer term use by new research teams (discussed later on).   
 
Studies that would be generating genetic data were felt to be of the greatest long-term value 
for new analyses.  They offered the opportunity for a dataset to have utility long after the 
study has finished, and, in the case of some clinical trials, had long-term commercial value.  
The PDGEN study and its two associated trials were thought of as long-term sources of data 
which presented long ranging scope for analysis.  Investigators were optimistic that they 
could utilise the data until retirement, but the utility of the data was regarded as stretching 
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further than this - possibly fifty years or more, when new genetic tools could be applied to the 
data.   Indeed, DNA banks could enable prevalence studies to be performed on genes not yet 
identified. 
 
Future follow-up studies also had the potential to yield sufficiently rich data to answer 
tomorrow’s research questions.  In the case of the retrospective panel study, Formaldehyde, 
data would be accrued until all the sample are dead, suggesting the potential to keep going for 
some years.  Equally, for the clinical trials there may be several years’ worth of analysis 
looking at survival rates.   
 
For ongoing studies, such as clinical trials, the chance to add on various components to the 
study, for example, specific measurements, tests or questions, was viewed as extending the 
lifetime of the data.  Outputs of the SWS were considered to be likely to contribute to 
development of further, independent, studies such as systematic reviews and intervention 
studies.  Also, studies that had already opened up to external collaborators were positive 
about an extended lifetime.  
 
For narrowly focused or smaller studies on the other hand, there may not be much scope to 
answer new questions.  Clinical trials are often very focused, both in the questions they ask 
and the breadth and number of variables.  While the published data are used for meta-
analyses, there is relatively limited value in mining the data or attempting new analyses.   
 
For other types of studies, investigators considered that medical measures were likely to 
become outdated and that those with social science data were likely to be superseded in a 
relatively short time.  
 
Finally, the expected future utility of a dataset was also seen to depend on a number of more 
practical criteria.  First was the state of the data, for example whether a team’s data 
management could enable a reliable and usable dataset, and whether all essential documents, 
which might be necessary to undertake future work, still existed. Second was whether active 
collaboration of the research team would be required to make long-term use a reality – in 
cases where investigators wish to move on to undertake new science, the future utility of a 
dataset might be restricted.  Third was the question of investment in the purposive 
construction a long-life dataset – how much value should be attached to prospective archiving 
versus the pursuit of the planned and immediate scientific research agenda, where funds may 
be in competition?   These data sharing issues are addressed in the following section. 
 
4.4.4. Conclusion 
The varying views expressed by investigators regarding the future value of their datasets 
highlighted the belief that only some datasets have comparative potential or longevity.  
Datasets that could be used in comparative analyses included those that were: cross-national 
in scope; had influenced the design of other studies; could be used for meta-analyses; could 
be combined with data beyond the study’s own geographical focus.  Datasets with longevity 
were identified as those that: are longitudinal or unique in nature; have the potential for long-
term funded follow-up of subjects; are large-scale unique clinical trials; are linked to large 
sample DNA banks; are of high quality and well documented.   For other, smaller or more 
narrowly focused, studies there appeared to be little value in going back to old data, when 
compared with the opportunity to address new science.  Finally additional secondary analytic 
value was viewed to require: focus and breadth of investigation; complexity; and high data 
quality.   
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4.5. Researcher Opinions 2: attitudes towards sharing data and accessing others’ 
data 
 
Investigators were asked a number of questions about sharing their ‘own’ data and re-using 
other data not under their control.  They were asked about: 
 
• ownership of data and whether they considered that they had responsibilities to ensure 
wider scientific use; 
• barriers that might exist to further exploitation of their dataset by a secondary analyst; 
• motivations to accept or decline access to their own data; 
• whether they required access to datasets not under their control. 
 
4.5.1. Ownership of data and the perceived responsibilities to ensure wide use 
All the investigators held clear views on ownership of their datasets.  MRC funded study data 
were considered to be owned by and copyright of the MRC unit and/or the university, 
depending on primary sponsorship.  Often universities had provided senior staff costs, space 
and other costs (e.g. underwriting a study).  In the case of cross-national clinical trials, the 
steering committee, seen to represent the national centres, was also mentioned as have a 
claim to ownership.  For trials sponsored by pharmaceutical companies there may be valid 
questions concerning their potential interest in ownership of data. Finally, two researchers 
interviewed pointed to the patients (in trials) as having some claim to ownership of data.    
 
Various rights of the investigators and sometimes the unit as whole were asserted pointing to:  
 
• collectively having the right to allow others to use data for research in a manner 
consistent with the original ethics approval; 
• exploiting the data first because of the intellectual investment made by the original 
team; 
• making the final decision on access to primary data or DNA samples.  
 
and having responsibilities for: 
 
• protecting the interests of the research subjects from unnecessary harm or contact; 
• optimising the research potential of the dataset so that it could be shared with 
collaborators/used in the future;  
• publishing study protocols to avoid unnecessary duplication and to encourage 
collaboration; 
• ensuring that data could be used maximally, but only in proper, responsible, high-
quality new use, interpretation and publication;   
• being receptive to sharing data; 
• ensuring that the dataset is properly stored and does not become an orphan; 
• formally archiving the data. 
 
The question of how teams viewed their responsibilities towards data sharing revealed 
divergent views.  While some teams were keen to take a role in actively encouraging and 
supporting secondary use, others were adamant that soliciting requests for re-use was beyond 
their current duty.  Principal investigators generally tended to take a more active approach in 
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promoting data sharing - via their roles as chairs of national working parties and of trials’ 
management committees.  Many studies had not considered archiving data at the time the 
study was set up, and as such believed that their responsibilities did not stretch beyond in-
house storage and data management.  Creating a fully documented archivable dataset in their 
opinion required recourse to dedicated funding. 
 
When asked further about who should take prime responsibility for preserving and facilitating 
secondary use of the dataset, investigators pointed to the MRC, who should develop the 
provision of systematic approaches and enable appropriate resourcing.    For high profile 
clinical trials, researchers felt that the steering committee should take responsibility to 
promote the study and its use. 
 
On the question of intellectual property rights, in an era where research excellence is judged 
on publications output, some investigators were concerned that they may lose out on 
recognition for the original creation and management of data in publications arising from data 
obtained through an independent archive.  In the case of sample banks and clinical trials, 
where provision for long-term access or international collaboration was the principal aim, 
these kinds of IP issues were typically addressed up front, so were less of a worry to 
researchers.  However, two researchers expressed the need for the academic/funding world to 
better recognise the value of the work of trialists, including the statisticians and co-ordinators, 
in publications. 
 
Regarding the question of rights and responsibilities to make decisions about secondary 
access to primary data or samples, the following section addresses investigators’ perceived 
barriers to secondary use of, and motivations to accept or decline access to, data.  
 
4.5.2. Barriers to secondary analysis of dataset 
The question of what, if any, barriers existed to further exploitation of data by a secondary 
analyst revealed in some cases a number of key concerns, and in contrast, in others a more 
nonchalant response. 
 
The following issues were cited as being distinct barriers: 
 
• the lesser value of data without the active collaboration of the primary investigating 
team; 
• for complex data, the degree of investigator involvement that would be required to 
support users; 
• loss of control over data and intellectual property rights; 
• the potential to misinterpret or misuse data; 
• the huge task required to document data to high standards to render it usable;  
• ethical and consent issues; 
• concerns that data would not be used to the extent that justified investment in 
archiving; 
• the mechanism or infrastructure in place to enable data sharing. 
 
4.5.3. Complexity and intensive user support 
The complexity, quirks, or lack of adequate documentation of data were seen, in particular by 
researchers in the older and larger established studies, to be a major barrier to re-using data 
properly, and particularly without the input of the investigating team.  A high level of 
investigator involvement that was viewed to be essential by many teams in supporting new 
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users.   For those with experience of providing guidance on complex data, the time expended 
on such exercises had proved to be significant.  For some study teams, the lack of staff 
available to support every potential collaborative study meant that data sharing was highly 
selective.  For some studies, only the part of the dataset which was of particular interest was 
even cleaned, making the dataset as a whole currently unusable, even by the in-house team.   
In contrast, for clinical trials, this was never the case, primarily as established practice, 
dictated by the SOP and Clinical Trial Protocol, sought to ensure that data were frequently 
monitored, reliable and well documented.  
 
4.5.4. Control and threat to intellectual property rights 
Concerns were voiced about the loss of control over data or intellectual property rights when 
data were publicly archived. There was a perception that investigators would not get their 
names on secondary research papers as collaborators if the datasets were accessed through an 
independent archive.   Moreover some teams expressed the need for ensuring that the study 
team could work on the data first.  The Phase I DAA survey further revealed a view that 
secondary users could be likened to ‘scavengers’.   Keeping data in-house and restricting 
access was seen to be one way of preserving intellectual capital.   
 
4.5.5. Misinterpretation 
Worries about misinterpretation of the data arose from previous experiences of selective and 
opportunistic interpretation by new analysts.  Interpreting complex data requires considerable 
expertise and an understanding of the limits of the data and how they were collected, which 
in turn requires considerable documentation.  Genetic data was considered to be most 
problematic, where the huge analytic potential in linking it with phenotypic data or outcome 
measures data, made it a target for scientists not versed in the art of population data analysis.   
For one trial, the statistician considered that only geneticists with the right clinical, medical 
expertise would be able to analyse the data in conjunction with a team with a broad base of 
skills.  One team noted the possibility of the negative impact of misuse on sample attrition for 
longitudinal studies, and another expressed concern regarding the misuse of politically-
sensitive occupational or environmental data by pressure groups or industry. 
 
Changes in current practice towards more transparent research, have seen scientific journals 
requesting contributors to send (or supply via the web) copies of data for verification/ 
auditing purposes, especially where findings may be controversial.  In this respect some 
investigators considered that the scientific community ought to bear the consequences of mis-
interpretation and expose it through academic debate, rather than prevent it from occurring in 
the first place. 
 
4.5.6. Documentation of data 
Study teams running ongoing studies were daunted by the prospect of transforming their data 
into a widely usable resource.  Documenting data to the high standard required to render it 
usable was seen as a huge task, and one that they considered they were not explicitly funded 
to undertake.  In the case of some studies, documents such as contact information for the 
sample were not kept, suggesting that there would be difficulties in conducting a future 
follow-up study.  
 
4.5.7. Ethical considerations 
For some studies, researchers expressed concern that ethical considerations with respect to 
the nature of the original informed consent agreement might impose restrictions on re-use.  
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These are discussed in the section in this report on Informed Consent and Implications for 
Sharing Population Data. 
 
4.5.8. Re-use not justifying investment in archiving 
The question of public investment in archiving was viewed by some to be approached with 
caution.  Examples of publicly-available datasets that were not well used were cited, such as 
the NHANES data and the Framlington Heart Study.   A significant tension between the a 
priori level of investment in data preparation versus new data collection and primary 
research, in a world in which scientific budgets are limited, should be recognised.  Indeed 
where a data policy exists, resources for archiving are liable to compete with those for the 
‘science’.  
 
Investigators saw the need for a policy to determine relative levels of investment in data 
preparation and documentation according to different types of datasets and for different end 
uses.  For example, for cohort studies, or studies that have the potential for follow-up, the 
costs of good project housekeeping, high-quality data documentation, anonymisation, sample 
maintenance and sufficient document retention facilities (including paper storage, or 
digitisation costs) would need to be budgeted.   
 
4.5.9. Mechanism for data sharing - access control 
Finally, when discussing mechanisms or infrastructure that could support and enable data 
sharing, the issue of access control proved to the top priority.   For those who did allow 
access, the efforts and personnel required to establish a mechanism for access, to appraise 
new proposals or check secondary reports prior to publication, should not be under-estimated.  
Models of access control are discussed further in the section on Researcher Opinions 3: 
Access Control.  
 
4.5.10. Motivations for accepting or declining collaboration/access 
In addition to the general perceived barriers to secondary use, investigators were asked to 
consider specific motivations for accepting or declining collaboration or access to their 
team’s data or samples. 
 
Criteria mentioned in support of accepting collaboration or access were:  
 
1. For proposals: 
• having a research interest in common with the Unit; 
• asking relevant and useful questions - not easily answerable from the research 
literature;  
• taking the field forward not just replicating existing findings; 
• usefulness to the progress of the study; 
• asking questions that only the dataset could address – not as just a resource of 
samples/DNA; 
• having appropriate ethical approval where necessary; 
• having the infrastructure in place – funding, staffing and laboratory facilities;  
• multidisciplinary in nature and having scientific opportunity. 
 
2. For researchers:  
• experience/standing/evidence of research quality of the secondary analyst; 
• those already known to and trusted by the Unit; 
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• competent, substantive expertise which the Unit does not have in-house; 
• willingness to work with in-house statisticians. 
 
For declining collaborations or access points the key factors were: 
 
1. For proposals: 
• loss of focus on the study aims and the primary hypotheses;  
• not overloading the study participants – danger of attrition; 
• a directly competing project; 
• not of scientific judgement or value; 
• where the data cannot answer the question or are obviously frivolous; 
• which had no respect for longitudinal nature of the data;  
• where purely for cross-sectional analysis (for cohort studies). 
 
2. For researchers:  
• insufficient skills to analyse particular kinds of data; 
• insufficient technical competence to handle/interpret data due to their complexity. 
 
As expected there were different levels of motivations depending on the nature of the request 
and the sensitivity of the data.  Those asking for access to anonymised data and samples were 
more easily accommodated than those investigators wishing to utilise primary data or 
personal information, for example to conduct follow-up studies.  Finally, all investigators 
expressed the need to have a suitable infrastructure in place to be able to manage request to 
access data or collaborate.  Models of service provision for archiving and data access are 
discussed later on, while options for controlling access to data, as suggested by investigators, 
are described in the section Researcher Opinions 3: Access Control. 
  
4.5.11. Gaining access to other datasets not under own control  
On the whole, investigators did not convey any major barriers to obtaining access to other 
data sources.   For those who said they did use data other than their own team’s, current 
access to other research team’s study data tended to be straightforward and on a collaborative 
basis with the study investigators.  This was felt by most to be an important and preferable 
model, rather than just gaining access to the data per se.  Datasets mentioned were EPIC, 
NSHD and NATSAL.    
 
However, it is evident that access via the collaborative model depends to a large extent on 
established networks, and that the views of the principal investigators, who are all at the 
forefront of their disciplines, may not reflect the desire of other younger researcher’s to use 
existing unarchived data.   One trials investigator felt that ‘inner circles’ often had 
advantageous access to information about the study and funding calls to re-use data, and the 
MRC should attempt to make this process more transparent. 
 
Other researchers mentioned using datasets like the BHPS and the other birth cohort studies, 
via the UK Data Archive.  Investigators also purchased data, for example, the Southampton 
and UCL teams bought the ALSPAC, in order to conduct comparative analyses.   
 
The clinical trials teams were more likely to want to get hold of other primary data that were 
not accessible, particularly for cases of meta-analyses which were concerned with looking at 
long term outcomes (or adverse effects), and where locating and flagging the patients was 
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essential.   These data were often in the commercial domain, deriving from considerable 
financial investment from pharmaceutical companies.  
 
For others there appeared to be little interest in accessing other MRC datasets, partly due to 
the perceived difficulties in interpreting other people’s data. 
 
4.5.12. Conclusion 
On balance, study teams were mostly happy for their unit’s data to be widely re-used but with 
caveats.   Access to almost all of the studies would require some degree of vetting and many 
saw the need to conduct new analyses and publish on a collaborative basis.   Vetting was 
proposed for reasons of safeguarding data, preventing misuse or mis-interpretation and 
helping users navigate complex data, rather than through selfish reasons. 
 
Other points raised concerned loss of intellectual property rights or a threat to one’s own 
research career.  A further concern was the amount of work to make a dataset widely usable, 
and connected to this was the uncertainty of the value of MRC investing in an a priori 
archiving strategy in comparison to supporting new data collection efforts.  
 
There were few problems encountered in gaining access to other researchers’ data, although 
this did rely heavily on “who one knew” and being part of established formal and informal 
networks.   Clinical trials units expressed a desire to utilise pharmaceutical data, but thought 
this possibility to be unlikely. 
 
In quoting from the MRC Phase I DAA report, investigators tended to favour a ‘ system that 
promotes and supports responsible secondary research while rewarding primary researchers 
for their intellectual investment in the original study objectives and design and in managing 
primary data collection and analysis.  There is a fear amongst investigators of loss of control 
over their data and of increased bureaucracy’.  
 
 
4.6. Researcher Opinions 3: access control 
 
The preceding section discussed the perceived barriers to both sharing and re-using data.  
This section sets out some of the solutions raised by investigators for dealing with some of 
the concerns raised – namely:  data confidentiality;  intellectual property rights; fear of mis-
use; and the complexity of data.  
 
In order to elicit more precise responses study teams were asked to explain or consider the 
following questions regarding access to data and biological samples: 
 
• current (or likely) scale and type of requests for secondary access; 
• current formal or informal access criteria or processes for collaboration/secondary 
use; 
• nature of agreement/policy with collaborators/secondary users on ownership of data 
or publications from secondary analyses; 
• methods of access control advocated for the future. 
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4.6.1. Secondary access: scale and type of request 
The scale of requests varied a great deal between studies, from more than twenty per annum 
to none.  For the well-established longitudinal studies, there existed a definite community of 
users, whereas for studies in progress, or completed more focused studies, no access as yet 
had been requested.  
 
NSHD reported in the region of twenty requests per annum, of which ninety percent were 
fulfilled.  Requests are only refused when the data can’t answer the question or the request is 
obviously frivolous.  Currently twenty researchers were using NSHD data and for some areas 
of the study, like mental health, the collaborators were responsible for driving the design and 
analysis.   
 
While it was too early for requests for many of the ongoing clinical trials, many requests 
were expected once a reasonable amount of data/samples had been collected  
 
In general, units’ policies on secondary access to the sample population (primary research) 
tended to be highly restrictive, although NSHD would, in certain cases, allow access to more 
sensitive data on site only.    For recent studies, requests for access to the sample population 
or biological samples, rather than to the data per se (secondary research), were certainly more 
common, and typically were for the purpose of undertaking new data collection.   For at least 
two of these studies, collaborations had already been set up, for example in adding new 
questions on self-reported outcomes or physical measurements to the data collection.  These 
collaborations on data collection were only considered if the proposed additions were seen to 
add value to the study and, crucially, were not overly intrusive to the study instrument. Other 
requests mentioned had been for permission to use the questionnaire or, in one instance, 
syntax file for derived variables.  Finally, publications always tended to generate a large 
number of requests for information.   
 
In addition to the unique value or size of studies, the scale of requests to access data 
depended to a large extent on the degree of publicity and proactivity in seeking users. The 
majority of units visited did not operate a policy of soliciting collaboration or secondary 
access. 
 
Managing requests, or anticipating how to manage future requests, from collaborators/ new 
users can become a considerable operation as the volume increases. For every request 
judgements must be made on the suitability of the proposal and the proposers, and the study 
team’s capacity to handle the collaboration/secondary use.   
 
4.6.2. Current formal or informal access criteria/processes and nature of agreements 
with collaborators/secondary users, including IPR 
Investigators were asked to describe any current formal or informal criteria or processes they 
used to decide whether or not to collaborate/give access to data or samples.  They were also 
asked about the nature of agreements with collaborators or secondary users. 
 
Only two of the units conducting population studies had formalised access criteria.   For one, 
decisions on who to allow access were judged in-house on an ad-hoc basis by the team of 
senior scientists.  For the other, the study steering group would consider a one-page proposal 
to determine access, and on acceptance would identify a liaison person to be collaborator and 
co-author.  The preference in both cases was for ‘guided access’ due to the complexity of the 
longitudinal data.  In contrast, trials teams, who were more likely to collaborate, had 
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formalised mechanisms for sharing data built into protocols and via steering/management  or 
data monitoring and ethics committees, but still relied on a subjective assessment of the 
quality of the request.   The criteria used to determine access for all studies reflect those 
highlighted in the previous section, on motivations for accepting or declining 
collaboration/access.   The main factors for acceptance are described in the section 
Researcher Opinions 2: Attitudes Towards Sharing Data and Accessing Others’ Data.  
 
Three of the units who had re-use facilities set up, or who were involved in multi-country 
studies, had established pro forma written agreements.   The NSHD’s end-user licence 
requires a number of undertakings, some of which are similar to those set out in the UK Data 
Archive Individual Access Agreement: promising confidentiality of data; not passing on 
personal information, the study team checking drafts of papers for publication; 
acknowledgement of the NHSD team; not keeping data and data descriptions on same 
computer; destroying data after use; and using sensitive data on-site only.  The Glasgow 
Twenty-07 team further ask for any derived variables to be given back to the team, which is a 
valuable method of adding value to datasets. All of the clinical trials had established written 
procedures, or were in the process of drafting them. 
 
Others were currently using informal procedures.  For known and trusted researchers, 
agreements were likely to be contained in correspondence, whereas for ‘unknown’ 
researchers some saw the need for a tighter, signed agreement.  Newer study teams were 
working on putting collaborative agreements in place where future requests for re-use were 
anticipated.    
 
In the case of genetic information, strict procedures were often in place – for example the 
local genetic advisory committees would consider issues of collaboration and access. 
 
Regardless of the formality of access procedure, users were always asked to sign a 
confidentiality agreement before accessing data.   It was very rare that identifiable data were 
ever released, but for the unit that did allow access to sensitive data, those data had to be 
accessed on site only.  One unit’s collaborative access policy required data to be used only on 
site.   
 
Most teams agreed, for collaboration, the need to establish an agreed approach to authorship, 
whereby principal investigators are given a share in authorship.  One of the units had a User 
Manual that covered publication policy. For clinical trials, IPR procedures are typically 
formalised and described up front in the protocols, and the management/steering committee 
take responsibility for appointing and approving writing groups for trial publications.   One 
team mentioned that sponsoring companies would always be informed of the release of data.  
 
4.6.3. Methods of access control: future 
While some units already operated formalised access control procedures, all welcomed future 
plans for this.  Many had not considered plans for enabling access down the track, although 
clinical trials units traditionally did have mechanisms in place whereby a virtual committee 
was kept in place, made up of ex-trial investigators or committee members, who would 
continue to be involved in decision making some 8-10 years after the closure of the trial. 
 
On the whole investigators advocated some degree of vetting by either the study team or by 
an appropriate independent body/committee, to apply criteria systematically and consistently.   
Equally some teams mentioned the MRC or a centralised archive resource centre to help 
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evaluate and facilitate requests for collaboration.   The Phase I DAA Working Group report 
found that “45% of the 40 studies analysed would want independent input into decisions on 
providing access".   Written agreements were thought to be good practice 
 
Some investigators argued further that they would only allow secondary usage if their own 
unit’s investigators and statisticians are involved, while others advocated access via invitation 
only.  Particularly for complex data, and without recourse to full documentation, ‘guided 
access’ for new users with the help of the research team was advocated.  In the majority of 
cases, new proposals would also require ethics committee approval.   Many investigators 
agreed that re-deposit of new data (e.g. derived data) should be a condition of re-use.    
 
In addition, while many investigators saw the need to conduct new analyses and publish on a 
collaborative basis, they also welcomed the idea of an agreed rights management framework 
and commercial exploitation plans for MRC studies.  
 
4.7. Researcher Opinions 4: services desired 
Opinions were sought on the utility of a range of possible services which could be provided 
in the Data Archiving and Access realm. 
 
4.7.1. Research instruments’ registry 
In general, there was positive support for the idea of a central repository of research 
instruments.  This support was strongest among the project managers and data managers, and 
weakest among principal investigators.  Some PIs asserted that they were already familiar 
with the study instruments relevant to their particular area of interest, so that they would be 
unlikely to use such a resource, but could see how it might be useful as a training tool for 
young researchers.  Support for the registry tended to be higher within those projects which 
were in the early stages of research (probably because they had just been through the arduous 
process of constructing study tools for their own projects). 
 
4.7.2. Published standards and guidelines for data preservation and documentation 
This proposed service received widespread support from nearly all personnel at all sites, 
particularly those with direct responsibility for data management.  There is quite clearly a 
desire to “do the right thing,” but also quite clearly a lack of training in these areas.  There is 
a concern that if new standards and guidelines are produced, that adequate resources be 
provided to meet them.  For studies which have been in existence for some time, this might 
require considerable extra resources, to bring data and documentation produced in a different 
era up to modern preservation and documentation standards.   
 
4.7.3. Advisory service for preservation/dissemination issues 
This likewise received fairly widespread support, although less than for published guidelines.  
In order to ask for help one needs to know what questions to ask, therefore an advisory 
service would be most useful in the context of accompanying guidelines and expectations.  A 
number of those interviewed remarked that simply seeing the case study tool and the kinds of 
questions the DAA project team was asking had already raised their awareness of particular 
issues to do with data archiving. 
 
4.7.4. Data preservation/dissemination service 
Some could see the usefulness of a “data warehouse” kind of facility, analogous to Iron 
Mountain (but for safekeeping digital data), but many were hesitant about the implications of 
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depositing data with a third party.  PIs clearly still wanted a role in determining criteria by 
which other researchers received their data, but some (particularly those for whom there were 
already significant requests for access) could see the value of having help in the mechanics of 
data dissemination.   
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5. INFORMED CONSENT AND IMPLICATIONS FOR SHARING POPULATION DATA 
5.1. Introduction 
 
This section focuses on the use of patient information sheet and consent forms by the projects 
examined in the case studies and how these relate to secondary or follow-up uses of data 
(phenotypic and genetic), samples or subjects themselves.  Further, the case study 
organisations’ ability to comply with guidelines or regulations for retaining essential 
documents relating to consent is discussed.  
 
The historical origin of current ethical principles for conducting research with human subjects 
arises from the Nuremberg Code which sets out statements of the moral, ethical and legal 
principles. In 1964 the World Medical Assembly adopted the Declaration of Helsinki to 
provide guidance for physicians in biomedical research with human subjects.  This was most 
recently amended in 1996.  The principles for conducting research contained in the 
Declaration of Helsinki require that adequate information must be provided to the research 
participants, participation in the research must be freely volunteered, with the understanding 
that the research subject can withdraw at any time and, in addition, informed consent should 
be obtained, preferably in writing.  
 
In the UK, responsibility for ensuring the dignity, rights, safety and well-being of all actual or 
potential research participants in the fields of health and social care is set out in the Central 
Government’s Health and Social Care Act 2001 and the Department of Health’s Research 
Governance Framework for Health and Social Care.  The Research Governance Framework 
defines the broad principles of good research governance and is key to ensuring that health 
and social care research is conducted to high scientific and ethical standards.  As a general 
principle, all research proposals that involve recent or past NHS patients, records, premises or 
facilities must seek approval from a national Research Ethics Committee (REC).  These 
committees are convened to provide the independent advice to participants, researchers, 
funders, sponsors, employers, care organisations and professionals on the extent to which 
proposals for research studies comply with recognised ethical standards.   
 
5.2. Guidelines for good ethical conduct  
 
The MRC and the Wellcome Trust require approval from the appropriate Research Ethics 
Committees, for all funded research involving human participants or biological samples.  
Approval from other regulatory bodies such as the Human Fertilisation and Embryology 
Authority or the Gene Therapy Advisory Committee in the UK should also be sought where 
necessary.  Researchers are advised to ensure the confidentiality of personal information 
relating to the participants in research, and that the research fulfils any legal requirements 
such as those of the Data Protection Act of 1998 and the Human Rights Act of 1998.  
 
Over the past five years a number of funding bodies have published excellent and very 
detailed sets of guidelines for scientific researchers on the conduct of ethical research, 
particularly in setting out the moral and legal responsibilities that researchers have towards 
research subjects.  Examples in the UK include Central Office of Research Ethics 
Committee’s (COREC) Guidelines for Researchers applying to RECs or MRECS, the MRC 
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Good Research Practice (2000), the MRC Personal Information in Medical Research (2000), 
the MRC Operational and Ethical Guidelines on Human Tissue and Biological Sample Use 
for Research (2001), the MRC Guidelines for Good Clinical Practice in Clinical Trials 
((1998), the Wellcome Trust Guidelines on Good Research Practice (2002), the BBSRC 
Statement on Safeguarding Good Scientific Practice (2000), the General Medical Council, 
Role and Responsibilities of Doctors: Good Practice in Medical Research (2002), the Royal 
College of Physicians, Research Involving Patients (1990) and the EU ICH Guidance on 
Good Clinical Practice (1997).  The ethical guidelines of many other professional 
organisations also endorse the Declaration of Helsinki principles.  
 
Guidance provided in these documents covers the requirements for obtaining consent for 
projects as specified by sponsors, research ethics committees and Clinical Trials Institutional 
Review Board or Independent Ethics Committee.  The principles and content are of great 
help to researchers designing Information Sheets, for trials involving patients, patient 
volunteers and healthy volunteers.  Essential pieces of information that should form part of 
the consent agreement are the Information Sheets and Informed Consent Forms. 
Information Sheets should contain information under particular headings and in the order 
specified and should be written in simple, non-technical terms and be easily understood by a 
lay person.  The headings should cover information about: the invitation to participate and 
selection procedures; who is organising and funding the research; the purpose, the length and 
aims of the study; voluntary participation and right to withdraw; expected degree of 
involvement in the research, including treatment and test procedures; the benefits and 
possible disadvantages or risks of taking part; access to medical records; storage of personal 
information gathered; what will happen to the results 
 
5.3. Information Sheets and Informed Consent Forms from Case Studies  
 
As part of the site visits, the nature and content of the documentation relating to the studies’ 
Information Sheets and Informed Consent Forms for each study were examined.  The 
principal focus was to establish the degree of restriction for future access to data, subjects and 
biological samples, and secondly to examine the compliance with the guidelines or 
regulations for storage and retention of these documents.  
 
Regarding the procedures used for obtaining consent, the case studies fell into four 
categories: 
 
• First, the clinical trials (ESPRIT, INITIO, CONCORDE, PDMED and PDSURG, Wessex 
Fracture Prevention Study) which have their own guidelines for running studies, set out 
in standardised formal documents.   
 
• Second, the sample bank collection projects (Parkinson’s Disease DNA Bank, the 
Depression Case Control DNA Collection and the MRC Scottish Colorectal Cancer 
Study) which are gaining consent specifically for generalised re-use of the information 
collection.   
 
• Third, the survey-based and cohort studies (Southampton Women’s Survey, 1946 National 
Survey of Health and Development, The West of Scotland Twenty-07 Study, Twins’ Early 
Development Study and Isle of Wight Studies) and qualitative methods studies 
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(Masculinity and Health) which use a variety of informed consent forms and differing 
promises about data access.   
 
• Finally, older studies for which follow-up were underway, (such as the retrospective 
cohort study Formaldehyde and the Isle of Wight Studies) had less straightforward 
positions on consent.   
 
5.3.1. Clinical trials 
In Europe the running of medicinal drug-based clinical trials is guided by the EU 
International Conference on Harmonisation Guidelines for Good Clinical Practice (ICH 
GCP).   MRC's own Guidelines for Good Clinical Practice in Clinical Trials also sets out 
ethical and scientific standards for designing, conducting and reporting trials that involve the 
participation of human subjects.   These documents set out to ensure that the rights, safety 
and well being of the trial subjects are protected, consistent with the principles that have their 
origin in the Declaration of Helsinki, and that the clinical trials data are credible.  
 
Institutional Review Boards and independent ethics committees are established for every trial 
to review all proposed clinical trials, and demand a standard set of documents: a Clinical 
Trial Protocol; a set of Standards Operations Procedures (SOP); written informed consent 
forms (and updates); subject recruitment procedures; written information for subject and an 
Investigator’s Brochure.   
 
In all cases examined, the trials had detailed Protocols and SOPs, had complied fully with the 
applicable regulatory requirements for obtaining and documenting informed consent.  Prior to 
the beginning of a trial, investigators had all gained IRB/IEC written approval of the 
proposed informed consent form and any additional written information to be provided to 
subjects.  These documents provide information about the trial and clarification regarding the 
subject’s involvement and rights, and whilst promising confidentiality, also clarified that 
information would be used for medical (or in other cases, research) purposes only.  Wording 
of this kind implies the will to enable a more liberal use of data within the community, yet is 
placed alongside the reassurance of a promise of anonymity.  
 
5.3.2. Sample banks  
The MRC is increasingly supporting major collections of blood, tissue and DNA samples 
from groups of individuals, for example those with specific disease types.  These studies 
typically collect both samples and phenotypic data from the subjects, which together provide 
important and powerful resources for research into the aetiology of specific diseases.  
 
The consent forms from the studies of this type followed REC recommendations for gaining 
informed consent, and all asked for consent for the samples to be made available for future 
research relating to health that were ethically approved (including the DNA collection from 
the recent wave of the NHSD).   Some studies specified that other research teams would have 
controlled access to the sample collection, as prescribed in the MRC Operational and Ethical 
Guidelines on Human Tissue and Biological Sample Use for Research.  Controlled access to 
the collection was taken to mean vetting by: the project’s steering or management committee, 
or MRC where appropriate; approval though a new Research Ethics Committee submission; 
and often external peer review of the proposal.  
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5.3.3. Surveys and cohort studies 
Cohort studies require a form of consent that will allow for prospective follow-up of the 
sample.  As the usefulness of the data relies upon high response rates at each wave, 
investigators have traditionally been concerned to protect their research subjects.  
 
A variety of terminology was used by the survey investigators to provide reassurance to 
subjects about the confidentiality of the personal information they provided.  The 1946 cohort 
study (the NSHD) and the Southampton Women’s Survey (SWS) ask for explicit consent for 
each aspect of data collection, and permission for the team to return in the future.  In these 
two cases, consent to view medical records or sample information was limited to members of 
the research team only, rendering longer-term follow-up by other researchers problematic.   
 
Other studies use phrasing to reassure subjects such as 'information given is kept and used 
only in the form of numbers, so that it is entirely confidential' or 'information will be kept 
strictly confidential’.  In the former case, the wording precludes any alternative use of any 
qualitative information collected.   Similarly the terms of the REC review for the Isle of 
Wight study specified that access should be restricted to the principal investigator only.    
 
A further concern, reported by at least one of the investigators, was that the workings of the 
Data Protection Act at the local level had provided serious impediments to the conduct of the 
project. Additionally, the only qualitative study we visited had severely restricting terms of 
consent for future access, whereby the team had promised to destroy the tape and transcripts 
after the project had been written up.  In our view this practice is not necessary and is not 
something that is required under the law or recommended in guidelines, but nevertheless is 
sometimes demanded by local ethics committees. These same questions have also arisen 
through the ESRC’s Qualitative Data Service's work, whereby some RECs or local Data 
Protection Officers have taken unnecessarily over-restrictive views towards consent for 
research projects, particularly those collecting longitudinal or qualitative data.  
 
5.3.4. Follow-up of early studies 
For studies conducted decades ago, the position on consent to re-use material or follow-up 
subjects is often a little hazy.  For example, for the Isle of Wight Studies and the earlier waves 
of the NHSD, consent to participate was not governed by any legal principles and, 
consequently, was assumed by virtue of the questionnaire having been returned.   In this 
instance follow-up or re-use of data may be problematic, but the teams we interviewed saw 
this as the responsibility of RECs to determine the ethical position.   Similarly, the 
Formaldehyde study, a retrospective cohort that is following up cancer or death registration 
of employees from companies’ records, could not gain individual’s consent, but instead relied 
on approval from local safety committees who represented the welfare of the employees.   
The same issue arises with orphan studies where consent forms have gone missing.   
Investigators appeared to be unsure about the precise legal framework operating in these 
cases, and we would recommend that the MRC provide some guidelines in this area. 
 
5.4. Storage and retention of study documents: legal and consent considerations 
 
There are a number of legal conventions that require personal information to be kept safely.   
First, the Data Protection Act 1998 contains enforceable eight principles of good practice 
applying to anyone processing or using personal data.  Regarding the storage and retention of 
documents, data must be: processed for limited purposes, in accordance with the data 
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subject's rights and within the terms of consent given; and kept securely and for only as long 
as necessary.  The length of time for which documents must be kept for human-subject-
focused research depends on the regulatory body, but as far we are aware there are no legal 
requirements on the length of time that consent forms per se must be kept.  Nevertheless, 
there is a range of relevant guidelines or documents on good practice for study document 
retention.   
 
Guidance to the NHS is provided in the 1999 ‘For the Record’ HSc1999/053, which sets out 
minimum retention times for records.  For patients involved in clinical trials this period is 
fifteen years after the conclusion of the treatment, including consent forms.  For therapeutic 
research, the ICH GCP recommend retaining “Essential Documents” for the conduct of a 
clinical trial until at least two years after the last approval of a marketing application or the 
formal discontinuation of clinical development of the investigational product, unless 
specified otherwise by sponsor or appropriate regulation. 
  
Sponsors of medical research, the Wellcome Trust and the MRC further set out guidelines for 
data security and storage.  For MRC studies, identifying information (e.g. consent forms) 
must be stored in a separate place from data and research teams must maintain written 
procedures for keeping electronic and written information secure (whether being processed or 
archived), that must be enforced and reviewed at regular intervals.  The MRC also expects 
research records relating to clinical or public health studies to be maintained for twenty years, 
to ‘allow adequate time for review, reappraisal, or further research, and to allow any concerns 
about the conduct or consequences of the work to be resolved’.  For all studies for which 
consent was obtained, the protocol, a sample of records and the consent procedures should be 
retained for thirty years.   Further, it is recommended that the full records for historically 
important studies, novel clinical interventions or controversial studies are kept for longer 
periods. 
 
The Wellcome Trust considers a minimum of ten years to be an appropriate retention period, 
however, research based on clinical samples or relating to public health might require longer 
storage to allow for long-term follow-up to occur. 
 
The majority of the research teams we visited were aware of, and compliant with, the 
recommendations on secure storage of personal information and on document retention.  
Some units were extremely diligent in their operational procedures for compliance with the 
Data Protection Act requirements and MRC guidelines.   
 
The majority of teams stored personal information separately from data, although two of the 
studies we visited were found to be filing signed consent forms together with paper data 
during the data processing stages.  All of the teams used locked filing cabinets to hold paper 
documents, with controlled access to these, but very few had fireproof safes or proper 
archival storage facilities.   Teams reported that cost was the main reason these facilities were 
not available to them, and that previous requests to MRC for professional storage equipment 
had usually been turned down.   Another study had had the misfortune to have most of its key 
unique documents destroyed in a storeroom fire.   Across the board, teams stored blood and 
tissue samples without identifying information other than ID. Information relating to consent 
and data were also stored securely.   
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Many of the project managers told us that they would be grateful for advice or guidelines on 
the storage of study materials.  For those without good on-site paper storage facilities, 
professional storage equipment would enable more efficient document retrieval.   
 
We identified a number of circumstances that worked against the practicality of complying 
with longer-term retention conventions.  First, the lack of long-term adequate storage space 
for paper, and the high cost of professional off-site storage, meant that for about half of the 
centres the future retention of consent forms might be problematic.  Indeed, as we point out 
above, adequate paper storage is a real issue for the larger studies.  Many longitudinal studies 
were using companies such as Iron Mountain for retention of older data and associated key 
documents.  In a couple of cases, study documents were reported to be housed in any spare 
place found to be available on site (basements, attics, cupboards etc) and, without an 
inventory.   
 
For clinical trials, independent data-monitoring committees are responsible for assessing the 
progress of the trial, including the safety of data, and critical efficacy endpoints.  Electronic 
data processing systems for trial are required to comply with established requirements for 
completeness, accuracy, reliability and consistent validation.  Great emphasis is therefore 
placed on the investigators maintaining an audit trail, data trail and edit trail.   All three of the 
trials units examined had established data monitoring procedures and audit trails and the 
clinical trials managers were far more likely to be fully briefed about legal requirements, 
namely because they had the advantage of local guidelines (SOPs) to consult.  For trials, the 
consent forms were always stored separately from Case Report Forms at the local clinical 
site, rather than at the central trial units, with a further copy retained with patients’ records. 
  
Those teams who needed to consult personal information on a regular basis, such as consent 
forms, were keen to explore the idea of scanning these documents to enable quick and easy 
access.  Clinical trials teams, however, were not convinced as to the utility of digitising these 
kinds of study materials. 
 
5.4.1. Document format 
The format in which key primary documents should be stored is less prescriptive than 
retention times across various guidelines, although there is separate guidance on storing paper 
and electronic data or document files.  In the course of our research, we did not find any clear 
guidance on whether informed consent documents could be image-scanned and retained as 
legal electronic documents.   
 
Neither the MRC nor the DoH provide any guidance on the legality of conversion, but the 
1999 BSI standard (PD 0008:1999): A Code of Practice for Legal Admissibility and 
Evidential Weight of Information Stored on Document Management Systems (EDM) does 
offer current interpretation of best practice on legal admissibility of documents stored on 
EDM systems, although is not intended to guarantee legal admissibility.  The Code advises 
on scanned images, documents created by a computer system and documents generated by 
third parties.  The Code requires a documented procedure for scanning operations, where 
each document should have a unique identity number, which cannot be altered, and the date 
and time of scanning and the identity of the scanner operator must be recorded.  The Code 
also allows for the scanning of photocopies of originals, which should be indicated on the 
electronic copy.  The usual precautions regarding security of electronic data also apply.    
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A new European Directive on Clinical Trials currently under consultation is proposing 
‘Detailed Guidelines on the Trial Master File and Archiving’.  This directive will provide 
advice on what essential documents must be retained (archived) for sufficient periods to 
allow for audit and inspection and the guidelines aim to give details on: the minimum set of 
documents to be retained; the quality of documents to be archived; minimum standards for 
storage conditions; media transfer and certified copies; and retention times.   Much of the 
information is drawn from the ICH GCP, and does not propose any new standards. 
 
MRC should follow the current debate in this area and, in particular for studies other than 
clinical trials, raise the issue of document retention of NHS-related documents (e.g. patient 
consent forms) with bodies like COREC so that advice can be incorporated into their own 
guidelines. 
 
5.5. Summary 
 
Our investigation into terms of consent for the range of MRC studies selected has concluded 
that, in general, most of the recommendations proposed by the regulatory bodies for the 
ethical conduct of research are followed.  Indeed many of the teams’ procedures 
demonstrated that they were acutely aware of the Data Protection regulations on the security 
of personal information, although less so on document retention procedures.  
 
Regarding terms of consent, there are significant differences in the explanation and form of 
wording on how data will be used in the studies’ information sheets and consent forms.   The 
content is driven by a number of factors: 
 
• the legal requirements or recommendations of regulatory bodies (e.g. Data Protection, 
DoH, NHS, COREC, RCP, GMC); 
• the requirements of the sponsors (MRC, Wellcome Trust, etc.);  
• the demands of local ethics committees; 
• the concerns of the principal investigating team to keep data ‘safe’ in their hands.  
 
We recommend that if MRC do adopt a data sharing policy that they recommend approved 
forms of wordings for consent forms and information sheets for the studies they fund (as they 
advise for research collecting biological samples in the Operational and Ethics Guidelines 
booklet).  This could be achieved by enhancing the information in section 7 of the Guidelines 
on Personal Information in Medical Research, but also needs to be done in conjunction with 
a programme of education of the scientific community towards the benefits of data sharing, to 
prevent overly restrictive consent clauses being built in by investigators. At the same time the 
MRC need to inform the governing and regulating bodies that often drive the procedures for 
the conduct of population studies (especially local Research Ethics Committees and local 
Data Protection Officers) to make them fully aware of the motivations of MRC, and the 
implications of terms of consent in studies for operating a fruitful data sharing policy.   
Recommendations from COREC to researchers on less restrictive wording for consent 
clauses would be particularly beneficial. 
 
The clinical trials community is perhaps the most advanced in terms of consideration for data 
sharing.  In the interests of auditing and enabling greater access to data, the MRC might wish 
to follow this direction in recommending formalised basic protocols and SOPs, and data 
monitoring committees to be established for all projects, or clusters of projects, they support.   
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Finally, in order to ensure that teams comply with the relevant legal requirements on how 
study documents and data should be stored for MRC studies, we would advise MRC to 
provide clearer practical guidance, to undertake periodic checks, and to follow closely current 
debates on these matters.   
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6. EXISTING METADATA AND INTEROPERABILITY STANDARDS 
 
Any attempt to develop a data archiving and access policy must be mindful of potentially 
relevant standards.  Many models for the architecture of data sharing and service provision 
rely heavily on adherence to standards.   
6.1. Introduction 
 
6.1.1. Metadata  
Metadata are data that describe other data.  Most commonly, the term “metadata” is used to 
mean information about data which can be used for searching or cataloguing data holdings.  
For example, if the metadata are being used to describe an online journal article then they 
could include the author, title, publisher, date and URL.   
 
6.1.2. Metadata standards 
Metadata standards relate to the elements that are chosen to describe data, the terminology or 
controlled vocabularies that are used within those elements and the formats the metadata are 
stored in. 
 
Different metadata standards have different elements (for example, author, title, publisher) to 
describe data and sometimes identify the same element by different names.  Although a large 
number of different standards exist, there are some widely accepted and used international 
metadata standards, a major one being the Dublin Core Metadata Initiative 
(http://dublincore.org/), a set of metadata descriptions about resources on the Internet, 
containing 15 data elements including title, creator, subject, description, data, type and 
format.  Within the field of teaching and learning materials, the IMS Global Learning 
Consortium (http://www.imsproject.org/) defines and delivers interoperable, XML-based 
specifications for exchanging learning content and information about learners among learning 
system components. There are also accepted national standards such as the National 
Geospatial Data Framework (http://www.ngdf.org.uk/Metadata/met_guid.htm).  
 
In addition, there are National and International Standards Organisations.  The International 
Organization for Standardization (http://www.iso.ch/iso/en/ISOOnline.openerpage) has set 
more than 13,000 International Standards for business, government and society, including 
standards relevant to metadata and interoperability.  For example, the Dublin Core conforms 
to ISO11179 for the description of data elements. 
 
Most of the development of metadata standards proceeded from the viewpoint of library and 
other archive cataloguing.  Therefore, there are a number of well-established library metadata 
standards such as classification systems and cataloguing formats, most notably MARC 
(MAchine Readable Catalogue Format).  
 
6.1.3. Controlled vocabularies 
Within different subject areas, there are controlled vocabularies for describing subject matter 
and assigning keywords to aid in cataloguing and searching. Use of a controlled vocabulary 
can add immensely to the power of a finding tool.  If different data creators at different sites 
use the same limited set of keywords to describe the same subject content, then someone 
attempting to locate data on a particular topic can search far more precisely, and be sure that 
the resources discovered, even across widely different locations, correspond to the same 
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desired concept.  Use of controlled vocabularies and electronic thesauri help to mitigate some 
of the pitfalls of literal string or free-text searching such as use of multiple terms for a single 
concept (‘Holland’, ‘the Netherlands’, ‘the Low Countries’), or multiple alternative spellings 
(labor and labour) and can even serve to map concepts across different languages and 
disciplines (e.g. the European Language Social Science Thesaurus ELSST:         
http://www.limber.rl.ac.uk/Internal/Deliverables/D4_2_final_V2.doc).   
 
6.1.4. Interoperability and formats 
Interoperability may be defined as the cooperation, interaction, or sharing among different 
archives, publishers, text formats, or information sectors, permitted by the use of common 
metadata standards, e.g. for storage, access, cataloguing, or communication. 
 
In order to make an electronic collection automatically searchable by a wide audience, 
standards in terms of machine readability/understandability are also important.  If the 
metadata elements can be mapped on to a standard computer-readable format/language then it 
enables computers to search across many databases located at different sites and controlled 
by different organisations. The system which seems to be potentially the most valuable in 
terms of coding concepts as computer readable descriptions is XML – eXtensible Mark-up 
Language.  Whereas HTML (HyperText Mark-up Language) defines how elements are 
displayed (as in a web page), XML defines what those elements contain and allows tags to be 
defined by the developer. XML is a subset of SGML (Standard Generalized Mark-up 
Language) which is widely used in libraries.  SGML and XML use a separate Document 
Type Definition (DTD) file that defines the format codes or tags embedded within it. 
 
Interoperability is facilitated by standard query and communication standards such as SQL, 
Z39.50, CORBA and Microsoft COM.  This subject, however, is beyond the remit of this 
report, as it has more to do with the development of software tools to locate and manipulate 
data resources, and less to do with what the creators of these data resources must do to ensure 
their data are locatable and manipulable by those software systems.   
6.2. The Biomedical Sciences 
It should be emphasised that there are no universally accepted metadata standards specific to 
the Biomedical Sciences, less still specific to population-based research, although some 
controlled vocabularies are more widely used and accepted than others.  Often databases are 
set up that use their own controlled vocabularies and do not follow any predefined metadata 
standards. Although this report does not focus on metadata standards for genetic data, there is 
a separate section on XML and Biotechnology in Appendix 3. 
 
6.2.1. Controlled vocabularies 
The most widely used subject classification scheme for the medical sciences appears to be 
Medical Subject Headings (MeSH) from the National Library of Medicine 
(http://www.nlm.nih.gov/mesh/meshhome.html)  
 
MeSH consists of a set of terms or subject headings that are arranged in both an alphabetical 
and a hierarchical structure.  At the most general level are very broad headings such as 
‘Anatomy’.  At more narrow levels are found more specific headings such as ‘Ankle’.  There 
is also a separate chemical thesaurus and thousands of cross-references to assist in finding the 
most appropriate MeSH heading.  
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Examples of the application of MeSH in the UK include the Bristol Biomedical Image 
Archive (http://www.brisbio.ac.uk/)  and OMNI (Organising Medical Networked 
Information http://omni.ac.uk/) . The primary objective of Bristol BioMed was to make a 
shared resource of digital images available for reuse in the development of medical, dental 
and veterinary electronic learning and teaching materials. However, the usefulness of 
metadata originally attached to each image was frustrated by semantic and syntactic 
inconsistencies, use of multiple terms for a single concept and alternative spelling forms. To 
overcome this, MeSH was selected to fully exploit the metadata as an information retrieval 
resource. 
 
UK-based OMNI, one of BIOME’s (http://biome.ac.uk/) subject-specific gateways, offers 
free access to a searchable catalogue of Internet sites covering health and medicine and uses 
MeSH to index its records.  
 
Additional controlled vocabularies and classification schemes in the areas of medical related 
research can be found in Appendix 3. 
 
6.2.2. Emerging metadata standards 
One potentially relevant emerging metadata standard which might be particularly suitable for 
some types of population-based datasets is the DDI (Dataset Documentation Initiative) 
standard (http://www.icpsr.umich.edu/ddi).  This is an XML-based standard which is the 
outgrowth of an international collaboration of social science data professionals, and one upon 
which a number of medical-related developments have been based.  Health Canada’s Web-
DAIS system (http://www.hc-sc.gc.ca/) is based around it, as is the US Bureau of Census 
DataFerrett system (http://dataferrett.census.gov/TheDataWeb/index.html) which delivers a 
number of US government-produced medical-related datasets. The UKDA catalogues its 
datasets to this standard, and provides datasets such as the Health Survey for England via the 
Nesstar online data browsing tools which are based around it (http://www.nesstar.org). 
 
6.2.3. Metadata elements and formats 
Some examples are given in Appendix 3 of sites specifying certain metadata elements and/or 
formats for metadata storage for different kinds of data in the medical domain.  It can be seen 
that most of these are using XML.  Biotechnology and genomic metadata are also being 
increasingly specified in XML. 
 
6.2.4. Additional standards 
Additional standards, such as those used for interchange of information among clinical health 
care providers, appear in Appendix 3. 
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7. DATA SHARING POLICIES 
7.1. Introduction 
 
There are a number of drivers for establishing data sharing policies.   The key driver is that 
there is the growing world-view that ‘data’ are the primary building blocks of science.   
Second, legal requirements and public funding arguments are convincing motivations for 
research funders to establish mechanisms for enabling access to data.  Third, demand from 
the research communities to gain access to expensive already collected data and the 
willingness to share their own data helps to get the issue onto the policy agenda.  Finally, the 
dramatic advancements in the conduct of scientific research that collect massive amounts of 
data, that are often distributed and require expensive storage and analysis facilities, require 
suitable infrastructures to be in place.  Opposing the drivers are barriers that can complicate 
data sharing policies - those of property rights and public privacy – although neither of these 
are insurmountable. 
 
Enabling meaningful access to reliable scientific data merits attention to the preservation, 
archiving and sharing of scientific data.    
 
Many funding bodies now recognise that there are a number of convincing reasons for 
investing in data sharing.  The National Institute of Health (NIH, 2002) summarises these in a 
concise way, 
 
“Sharing data reinforces open scientific inquiry, encourages 
diversity of analysis and opinion, promotes new research, 
makes possible the testing of new or alternative hypotheses and 
methods of analysis, supports studies on data collection 
methods and measurement, facilitates the education of new 
researchers, enables the exploration of topics not envisioned by 
the initial investigators, and permits the creation of new data 
sets when data from multiple sources are combined.  By 
avoiding the duplication of expensive data collection activities, 
the NIH is able to support more investigators than it could if 
similar data had to be collected afresh de novo by each 
applicant.…  However, NIH recognises that sharing data about 
human research subjects presents special challenges. The 
rights and privacy of people who participate in NIH-sponsored 
research must be protected at all times. Thus, data intended for 
broader use should be free of identifiers that would permit 
linkages to individual research participants and variables that 
could lead to deductive disclosure of individual subjects. 
Similarly, NIH recognises the need to protect patentable and 
other proprietary data and the restriction on data sharing that 
may be imposed by agreements with third parties.” 
 
However, the take-up of investment in data sharing is, as yet, highly skewed across 
disciplines.  The social sciences and humanities have led the way in implementing and 
promoting data policies, in some cases boasting a 30-year investment profile. 
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Researchers of the natural environment have found formalised ways of archiving and sharing 
research data, largely driven by various Information Acts and international treaties that 
demand access to environmental information.  Dissemination of data from the Antarctic may 
be covered by the Antarctic Treaty and research data which constitute ‘environmental 
information’ within the meaning of the Environmental Information Regulations 1992, are 
often subject to the EC Directive on the Freedom of Access to Environmental Information. 
 
In the field of physics and astronomy, scientists are also highly successful in sharing and 
accessing very large amounts of data via modern grid technology and this is being extended 
to other areas of ‘Big Science’ including genomics and medical images. The latest e-science 
initiatives are exploring ways to create a national infrastructure and the tools for data storage 
and analysis facilities for the natural sciences. 
 
This section examines a number of data sharing practices across the world, drawing on 
practices from within and beyond the natural sciences, and provides short case studies as 
exemplars.  
 
7.2. The UK scene 
 
In the UK many research funders operate data sharing policies.  Guiding principles are most 
evident in the social sciences and humanities, whilst amongst the natural sciences only the 
Natural Environmental Research Council (NERC) has a formal data policy.  These policies 
vary in: how mandatory they are; how involved the recipient organisations are in appraising 
research applications and associated data management plans; the degree to which a budget 
line should be costed in for data preparation and documentation for archiving; and in rules on 
allowing researchers to place embargoes upon data.  
 
7.2.1. Case 1: The Natural Environmental Research Council Data Policy  
The Natural Environmental Research Council’s Data Policy was created in 1996 to be 
consistent with legal frameworks such as the Environmental Information Regulations, the 
Antarctic Treaty and contractual arrangements with other bodies where, for example, NERC 
holds their data on a confidential basis without owning the Intellectual Property Rights.  
 
NERC has a formal infrastructure of NERC Data Centres which work with NERC supported 
scientists to preserve data they create.  NERC realises the value of its data by using it to 
further scientific understanding, create wealth and improve the quality of life.   The Council 
recognises that this can be done in a variety of ways including: using datasets within NERC's 
own research and collaborative centres; giving, exchanging or licensing/selling them to other 
scientific researchers; licensing/selling them to commercial organisations which will 
themselves create wealth.  The fact that data may be seen as a tradable asset is recognised in 
the data charging policy, which has been driven by the Freedom of Information Act.  
 
The NERC Data Policy model is based on a distributed network of data centres with the 
NERC administration keeping the distributed system running smoothly.  NERC data holdings 
are dispersed amongst seven key specialist NERC data research and resource centres across 
the UK.  NERC's science-based archaeology community is further encouraged to deposit data 
with the Archaeology Data Service, part of the Arts and Humanities Data Service supported 
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by the AHRB and JISC (see Case 3).   Formal data management plans are required for all 
programme grants, and the data and research centres get involved in both peer review and 
planning.  
 
NERC ‘owns’ all the data created via programmes and undertaken at NERC centres, but 
license the use of smaller datasets created via response mode grants. The NERC data 
charging strategy ensure that teams and individuals who have collected datasets are allowed a 
reasonable period (set out as a maximum of two years) of exclusive use during which to 
analyse them and publish results.  
 
NERC has recently employed a Data Manager, located at one of the data centres,  to provide 
the much needed interface between the Council, NERC supported researchers and the data 
centres.  The NERC Data Policy is available on the web and as a published well-designed 
small A5 booklet.  
 
7.2.2. Case 2: The Economic and Research Council Datasets Policy 
The Economic and Research Council (ESRC) Datasets Policy was established in 1995 and 
reinforces and emphasises the ESRC's stated position relating to the acquisition and use of 
datasets, the requirements of which are now a condition of ESRC research funding. The 
ESRC requires all award-holders to offer for deposit copies of both machine-readable 
quantitative data, and machine- and non-machine-readable qualitative data, within three 
months of the end of the award.  This relates not only to datasets arising as a result of primary 
data collection, but also to derived datasets resulting from ESRC-funded work. 
 
In order to operate the Datasets Policy, the ESRC supports two Resource Centres with 
responsibilities for the cataloguing and archiving of data.  The UK Data Archive (UKDA) 
based at the University of Essex is responsible for acquiring, documenting, disseminating and 
preserving digital data created during the course of ESRC research grants. The Qualitative 
Data Service (Qualidata), also at Essex, has special responsibility for qualitative in both 
digital and non-digital form.  From January 2003, these will be combined within a single data 
archiving and dissemination service. 
 
UKDA/Qualidata has a co-ordinated quantitative/qualitative acquisitions strategy which 
encourages the stream of qualitative data destined for archiving.  Both centres have long-
standing experience dealing with all aspects of acquisition and data collections management, 
including licensing agreements, working with academic award holders in the process of 
depositing data, and established relationships with other data producers, such as other 
research funders, and are well placed to operate the Datasets Policy.   
 
The Datasets Policy requires that datasets must be deposited to a standard which would 
enable the data to be used by a third party, including the provision of adequate 
documentation. Depositors are advised to contact the two Resource Centres at the earliest 
opportunity should the nature of the data be such that it may be difficult to lodge the data.  
The earlier in the research process these discussions occur, the more likely researchers are to 
create datasets which are well-documented, free of confidentiality or licence constraints, and 
useable for secondary analysis.  Support for award holders and potential depositors is 
generally provided through web-based guidelines and notes on preparing data for deposit.   
Support extends to adopting a more proactive role, working to promote the importance of 
sharing and preserving data within the social sciences and actively alerting award holders to 
their obligations.   
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Copyright in data deposited with the UKDA is retained by the copyright holder(s).  Terms for 
access to the data are agreed with the copyright holder(s) and deposits are accompanied by a 
signed licence form.  Usage of data is also subject to the acceptance by the user of a 
formalised access agreement, wherein the user undertakes to comply with the terms and 
conditions of deposit. 
 
The UKDA holds a number of datasets from population studies and other socio-medical 
surveys, as outlined in Appendix 4.  
 
UKDA/Qualidata were instrumental in helping to set the ESRC Datasets Policy, and in 
October 2000 proposed a set of changes to the operational procedures that would create a 
more robust, systematic and accountable policy. One of the central concerns of the current 
policy is that improved three-way communication channels between the ESRC, the award 
holders and the data archiving and dissemination services would be highly beneficial to the 
Resource Centres.    The first suggestion was that the archiving and dissemination services 
should be involved across the life cycle of data generation, and, in particular enabling 
Resource Centre to have input at the grant application selection stage.   Second, and in order 
to put the first proposal into place, the ESRC need to establish a fully co-ordinated strategy 
in-house, with dedicated staff to ensure the smooth running and auditing of the policy.   
Finally the Policy would, like the NERC principles outlined above, benefit from a 
requirement by data creators to produce a formalised data management plan at the application 
or short-listing stage, particularly for expensive research programmes; and a more stringent 
view towards the length of time allowed for data embargo. 
 
The ESRC Datasets Policy is currently under review but a summary of the recent Policy can 
be found in section 17 of the ESRC Guide to Research Funding.  
 
7.2.3. Case 3: The Arts and Humanities Research Board Information and 
Communications Technology (ICT) Policy 
Through their research grants the Arts and Humanities Research Board (AHRB) seek to 
encourage the development of high-quality scholarly data resources in the arts and 
humanities. They support applied research in areas which promise to enhance or extend the 
use of ICT in the development and use of scholarly information resources and encourage the 
development of training and other related materials which seek to encourage effective 
scholarly use of digital resources and ICT.  As such, a draft joint ICT Policy between the 
AHRB and the Arts and Humanities Data Service (AHDS) was established in 1999.  This 
includes guidelines for AHRB grant applicants and award holders who include ICT in their 
projects. 
  
The AHDS was initially established by the Joint Information Systems Committee (JISC) in 
1994 as a distributed service comprising a managing Executive and five subject-based 
Service Providers offering data archiving and data resource provision to archaeology, history, 
the performing arts, textual studies, and the visual arts. Subsequently, the AHDS has received 
funding from the AHRB, who is now its major stakeholder. 
 
The AHDS has a major role in advising the AHRB on matters involving ICT which seek to 
extend and enhance scholarly uses of digital resources and information technologies in the 
arts and humanities.  In pursuit of this main aim they advise the AHRB in the technical 
assessment of those grant applications which seek to produce electronic materials, to conduct 
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applied research, or to develop training and other materials, and provide advice on standards 
and best practices.  Finally, the AHDS also contributes to selected AHRB-funded projects, 
and on a cost-recovery basis, a range of value-added expertise and services. 
  
The AHRB normally gives preference to applications which promise to make data, applied 
research, and training and related materials available to the arts and humanities research, 
teaching, and learning communities within the UK. Applicants proposing data creation 
projects must include a completed technical appendix describing the value added to the 
project by ICT and the project's proposed methods.  
 
As with the ESRC, under the Policy, data are licensed from the copyright holder(s) for 
dissemination by the AHDS by way of a non-exclusive licence agreement, which defines the 
terms and conditions for access by secondary analysts. 
 
7.2.4. Others UK 
The Joseph Rowntree Foundation (JRF) has a Project Funding Agreement that expects award 
holders to offer all machine readable data collected as part of the Project to the UKDA for 
deposit and, if required, to lodge the data and documentation, in an appropriate format, within 
six months of the completion of the project.   The Humanities Research Board of the British 
Academy also operates a formal data policy for large award holders, where data should be 
offered for deposit to the AHDS or UKDA within a reasonable time after the completion of 
the project.  
  
Finally, other social science and humanities funders have informal data sharing policies that 
both encourage and recommend grant holders to deposit data with the UKDA, Qualidata or 
the AHDS.  The Leverhulme Trust, The Wellcome History of Medicine Programme and the 
Society in Medicine Programme and The Carnegie Trust for Scottish Universities all operate 
such polices.  
 
At this time, the UK government has begun to take a closer interest in data sharing. The 
report Privacy and data-sharing: The way forward for public services, published by the 
Performance and Innovation Unit of the Cabinet Office in April 2002 looks at the issues of 
privacy and data-sharing in delivering public services, and charts the way forward.  One of 
the report's recommendations is:  
 
“To encourage widespread adoption of such standards, the 
Lord Chancellor’s Department, working in conjunction with 
the Public Record Office, should facilitate the development and 
dissemination of model data-sharing protocols and codes of 
practice as a resource to public sector organisations.  This 
work will need to draw on a wider understanding of the overall 
information architecture of government, which maps the 
creation, flows and uses of information sets, establishes criteria 
for its sharing, retention and disposal, and allocates 
responsibilities for sustaining access, quality, reliability and 
safe-keeping.” 
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7.3. The United States scene  
 
A number of federal agencies in the US have formal data sharing polices.  This is notably a 
result of US federal government law and policy, under which publicly funded information, 
including research data, should be in the public domain. National scientific organisations 
have made a commitment to the sharing and archiving of data through their ethical codes and 
publication policies.  Over 15 years ago, the National Academy of Sciences described the 
benefits of sharing data (Fienberg 1985).  For many years, the National Science Foundation 
(NSF) Economics Program, has required data underlying an article arising from an NSF grant 
to be placed in a public archive. Other Departments are committed to investment in providing 
public data access systems for data they collect. Moreover, many scientific journals require 
that authors make available the data included in their publications.  In the biological sciences, 
protein and DNA sequences are made available to researchers through data archives, such as 
GenBank.  
 
Finally, if data are cited in a Federal regulation or administrative order, then they may be 
accessible through the Freedom of Information Act (FOIA).  Wouters’ report (2000) further 
details the main principles and regulations in the US.  
 
7.3.1. Case 1: The National Science Foundation  
The National Science Foundation (NSF) advocates and encourages open scientific 
communication, and is committed to the principle that the various forms of data collected 
with public funds belong in the public domain.    The NSF expects significant findings from 
research and educational activities it supports to be promptly submitted for publication, with 
authorship that accurately reflects the contributions of those involved. It expects investigators 
to share with other researchers, at no more than incremental cost and within a reasonable 
time, the data, samples, physical collections, and other supporting materials created or 
gathered in the course of the work. It also encourages awardees to share software and 
inventions or otherwise act to make the innovations they embody widely useful and usable. 
 
The Division of Social and Economic Sciences (SES) has formulated a policy to facilitate the 
process of making data that has been collected with NSF support available to other 
researchers.  
 
As SES supports a wide range of disciplines, the nature of the data, the way they are 
collected, analysed, and stored, and the pace at which this reasonably occurs vary widely.   
Grant holders from all fields are expected to develop and submit specific plans to share 
materials collected with NSF support, except where this is inappropriate or impossible.   
These plans should cover how and where these materials will be stored at reasonable cost, 
and how access will be provided to other researchers, generally at their cost.   Data include 
quantitative, qualitative and experimental research data, and mathematical and computer 
models. 
 
For appropriate datasets, researchers should be prepared to place their data in fully cleaned 
and documented form in a data archive or library within one year after the expiration of an 
award.  Before an award is made, investigators will be asked to specify in writing where they 
plan to deposit their dataset(s). This may be the Inter-University Consortium for Political and 
Social Research (ICPSR) at the University of Michigan, but other public archives are also 
available.  Investigators are invited to consult with NSF program staff about the most 
appropriate archive for any particular dataset.  
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The Division of Earth Sciences (EAR) at the NSF, is responsible for the implementation of 
the Foundation's Data Sharing Policy on Earth Science data.  The overall purpose and 
fundamental objective of the policy is to ensure and facilitate full and open access to quality 
data for research and education in the Earth Sciences.  The Policy guidelines are considered 
to be a binding condition on all EAR-supported projects.  
 
7.3.2. Case 2: The National Institute of Health  
Since 1996 the National Institute of Health (NIH) has required data sharing in several areas, 
such as DNA sequences, mapping information, and crystallographic co-ordinates. 
 
In March 2002, the NIH further announced that it was developing a statement on data sharing 
that expects and supports the timely release and sharing of final research data from NIH-
supported studies for use by other researchers.  The statement on data sharing is an extension 
of NIH policy regarding sharing research resources, which expects that recipients of NIH 
support will provide prompt and effective access to research tools.  Furthermore, it is 
consistent with the policies of many scientific journals publishing the findings of NIH-
supported research. 
 
The NIH expects investigators supported by NIH funding to make their research data 
available to the scientific community for subsequent analyses where possible.  Consequently, 
the NIH will require that data sharing be addressed in grant applications and in the review of 
applications.  Funds for sharing or archiving data may be requested in the original grant 
application or as a supplement to an existing grant.  Investigators who incorporate data 
sharing in the initial design of the study can more readily and economically establish 
adequate procedures for protecting the identities of participants and provide a useful dataset 
with appropriate documentation.  Applicants whose research will produce data that are not 
amenable to sharing should include in the application reasons for not making the data 
available.  NIH encourages investigators to consult with an NIH Program Administrator prior 
to submitting an application to determine the appropriateness of data sharing and a suitable 
mechanism to disseminate the data.  
 
The policy is still in its consultation phase.  
 
7.3.3. Case 3: The National Center for Health Statistics  
The National Center for Health Statistics (NCHS) is the US’s principal health statistics 
agency, and is responsible for collecting accurate, relevant, and timely data.  NCHS' mission, 
and those of its counterparts in the Federal statistics system, focuses on the collection, 
analysis, and dissemination of information that is of use to a broad range of users. NCHS 
surveys and data collection systems include some high profile and much used population 
studies: the National Health and Nutrition Examination Survey (NHANES); the National 
Health Care Surveys (NHCS); the National Health Interview Survey (NHIS); the National 
Immunization Survey (NIS); the Longitudinal Studies of Aging (LSOA); and the National 
Vital Statistics System (NVSS). 
 
All data collected by NCHS are collected under the authority of the Public Health Service 
Act that demands the timely release of data and mandates that data be made available on as 
wide a basis as is practicable.  Public-use data files are released via web download as soon as 
they have been prepared and the necessary reviews and approvals have been obtained, 
including a full disclosure review.  Release, to a collaborator, of files that are not yet ready 
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for public release is permissible under NCHS confidentiality policy, but must be consistent 
with NCHS legislative authority, informed consent, and submissions for human subjects 
reviews.  Such releases are normally carried out under an agreement specifying how 
appropriate confidentiality protections are to be provided by the collaborator. 
 
NCHS does not "embargo" data that are otherwise ready for public release and does not 
provide collaborators with preferential early access to data files or tabulations that are 
otherwise ready for public release. 
 
 
7.3.4. Case 4: The Robert Wood Johnson Foundation,  
The Robert Wood Johnson Foundation, the largest health care philanthropic organisation in 
the United States, sponsors the Health and Medical Care Archive (HMCA) housed at ICPSR 
as its official data archive of the Foundation.  The Foundation is devoted to preserving and 
making available research data that have significant secondary-analytic value for expanding 
knowledge on, and ultimately contributing to the improvement of, the health of people in the 
United States. Included in this archive are surveys of health care professionals, investigations 
of access to and financing of medical care, evaluations of innovative programs for the 
delivery of health care, and surveys of substance abuse.  
 
From among the many research projects that it funds, the Foundation designates a selection 
of projects that are required to submit their data to HMCA. The timely submission of these 
data collections is closely monitored by the Foundation in collaboration with the archive. 
HMCA provides advice to grant holders on the preparation of their data collections for 
submission to the archive in a manner optimally useful for secondary analysis.  
 
7.3.5. Other US 
In the case of US clinical trial data, for example those relating to AIDS sponsored by the 
National Institute of Allergy and Infectious Diseases (NIAID), data are submitted to the 
National Technical Information Service (NTIS) for public use.  Examples of shared data from 
clinical trials include the Asymptomatic Cardiac Ischemia Pilot, the Intermittent Positive 
Pressure Breathing Study, and the Safety and Efficacy Trial of Zidovudine for Asymptomatic 
HIV Infected Individuals. 
 
The National Institute on Aging and the Substance Abuse and Mental Health Services 
Administration of (SAMHSA) the United States Department of Health and Human Services 
both support National Archives of Computerized Data managed and hosted by ICPSR.  Their 
missions are to advance research in these areas by helping researchers to profit from the 
under-exploited potential of a broad range of datasets.   The Archives promote the sharing of 
these data among academics, policymakers and service providers to enable greater 
understanding of the issues.  SAMHSA provides public use files from its major data 
collection systems for on-line analysis to provide ready access to substance abuse and mental 
health research data.  
 
The NYS GIS Data Sharing Cooperative is a group of governmental entities and not-for-
profit organisations that have executed Data Sharing Agreements for the purpose of 
improving access to GIS data among members.  The Data Sharing Cooperative was primarily 
developed to encourage public agencies in New York to share in the creation, use, and 
maintenance of GIS data sets at the least possible cost.  Two key features of the agreement 
are that data creators (primary custodians) retain ownership of their GIS datasets, but agree to 
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share it with other Cooperative members for free; and that secondary users of the GIS data 
pass updates, corrections, and revisions back to the creators of the data set, resulting in 
improved data quality.  
 
7.4. The international picture 
 
Since 2000 there has been a growing number of international collaborative efforts and 
projects that are committed to action on data sharing in the sciences.   The major initiatives in 
this area are discussed below, but it should be noted that much of the work is still very much 
in progress.  
 
7.4.1. CODATA (Committee on Data for Science and Technology ) Working Group on 
Archiving Scientific Data  
CODATA is an interdisciplinary Scientific Committee of the International Council for 
Science (ICSU) and has been in existence for over 30 years.  Over 20 countries from across 
the world are members, but UK does not appear to be listed.  In 2001, CODATA established 
a working group to focus on the special issues of archiving scientific data.   In October 2000, 
a planning meeting was held to review issues related to the archiving and preserving of 
scientific data, organised during the 17th International CODATA Conference.  
 
CODATA define scientific data as “numerical quantities or other factual attributes 
generated by scientists and derived during the research process (through observations, 
experiments, calculations and analysis)”.  
 
The working group aims are to propose a position paper on archiving scientific data that:  
 
• develops a comprehensive annotated bibliography on the subject;  
• documents the diversity of best practices and identifies the ‘best’ ones in the area of 
data archiving and preservation across the science domain;  
• describes the role and function of CODATA in preserving and archiving scientific 
data;  
• describes the major issues to be considered in archiving scientific and technology 
data;  
• identifies other efforts in data archiving and preservation (e.g. efforts by ICSTI, ISO, 
NARA, NRC etc.). 
 
The initial group was not representative of all scientific communities and other communities, 
especially from genomics, geo-sciences, astronomy, chemistry, high-energy physics, statistics, 
psychology, and museum collections have been approached.  In addition, various panels are to 
be constituted to give attention to the different science disciplines.   This progress of this group 
should certainly be followed up by MRC, and it is advised that the MRC contribute to the 
ongoing programme of work.  
 
7.4.2. OECD Working Group on Issues of Access to and Sharing of Research Data 
from Public Funding  
The third CSTP/OECD Global Research Village Conference held in 2000 addressed policy 
implications of the use of ICT for the global science system (OECD Working Group 2002).   
The key recommendation coming out of the Conference was to focus upon and draw up 
commonly agreed principles to guide access to publicly financed research (Access to and 
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Sharing of Research Data from Public Funding).  Over the summer of 2001, experts from the 
Netherlands, Denmark, Poland, US and the ESF initiated the programme of work.  Other 
member countries include Australia, Canada, Finland, Germany, Poland, but not UK.  The group 
works in close liaison with the ESF, NSF and CODATA (see above).  The working Group aim 
to produce a report that will include a science policy section, and a section on the impact of the 
sharing of data on the quality of the research process.   
 
Activities of the group include a range of data gathering exercises and expert meetings.  First in 
2002 Paul Wouters from the Netherlands Institute for Scientific Information Services (NIWI) 
produced an elementary study on the State of Affairs.  Second, US participants gained support 
from the NSF for a project combining scientific research and policy research into data sharing 
(to be finalised by Spring 2003). Third, a funded study on national legislation relevant to access 
to and sharing of research data was conducted by a professor of Law at Leiden University. 
 
Wouters' report (2002) found that over half of the countries who responded to his mini survey 
(21) considered data sharing to be an issue of science policy, and currently on the policy agenda. 
Very few countries had national legislation for data sharing, whilst others had various policies 
addressing data sharing. 
  
Following these activities an expert meeting was held on the economics and management of 
digital research data for the Global Science System held in Maastrict in September 2002.  MRC 
would be advised to follow the progress of this Working Group and volunteer to participate 
where appropriate. 
 
7.4.3. Bioinformatics initiatives 
The bioinformatics community has well-established data sharing practices, at the national, 
European and wider levels.  A good example is the European Molecular Biology Laboratory  
(EMBL) which is supported by 16 countries including nearly all of Western Europe and 
Israel, and consists of five research/data service facilities across Europe.   The UK facility, 
the European Bioinformatics Institute (EBI) is a non-profit academic organisation that forms 
part of this network.  The mission of the EBI is to ensure that the growing body of 
information, including databases from molecular biology and genome research is placed in 
the public domain and is freely accessible to all facets of the scientific community in ways 
that promote scientific progress.  The Institute manages databases of biological data including 
nucleic acid, protein sequences and macromolecular structures.  On the same site is the 
Wellcome Trust sponsored Sanger Institute for genome research and the UK Medical 
Research Council Human Genome Mapping Project Resource Centre (HGMP).  Together, 
the three institutes provide one of the world's largest concentrations of expertise in genomics 
and bioinformatics.   
 
An example of a high quality truly international product of the advanced collaborative 
activities in this field is the EMBL Nucleotide Sequence Database which constitutes Europe's 
primary nucleotide sequence resource.  This comprehensive database of DNA and RNA 
sequences is collected from the scientific literature and patent applications and directly 
submitted from researchers and genome sequencing groups.  Data collection is done in 
collaboration with GenBank (USA) and the DNA Database of Japan (DDBJ).  
 
In terms of a data sharing policy, it is a commonly accepted principle that European 
researchers wishing to publish in the field of genomics and protein data research should 
deposit their sequences and analyses with one of the three genetic data bank sites. 
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7.4.4. EU DataGrid Project  
DataGrid is a project funded by European Union with the main objective of building the next 
generation computing infrastructure providing intensive computation and analysis of shared 
large-scale databases, at the PetaBytes level, across widely distributed scientific 
communities.  The DataGrid project brings together scientists from Biological Sciences, 
Earth Observation and High-Energy Physics where large-scale, data-intensive computing is 
essential. 
 
In April 2002, The UK government officially opened the National e-Science Centre (NeSC), 
a centre that is part of an international effort to enable scientific researchers to take advantage 
of the computing power distributed across the globe.  In March 2002, the project released a 
version of its Testbed middleware software, that has proved capable of reliable job 
distribution over the five main sites, including RAL and CERN.   The projects Biology 
testbed aims to provide a platform upon which to store, share and analyse databases of 
genomic data and medical images. 
 
7.5. Conclusion 
 
This report has highlighted some of the key national and international data-sharing activities.  
The UK and the US provide notable examples of the will to share publicly funded data for 
research purposes, and have established data sharing procedures and regulations.    
 
The bio-medical sciences, with the exception of the fields of genomics and medical imaging, 
are perhaps the least advanced in this respect, but efforts to examine the benefits of data 
sharing policies are taking place at the national level (MRC) and at the international level. 
 
In summary, and drawing on Wouter's report (Wouters' 2000) data sharing principles rest 
upon a number of key issues: 
 
• whether public access to data is stated as a basic policy principle; 
• what the motivation for data sharing rules are; 
• whether data sharing is a condition of research funding; 
• who is responsible for providing access to data; 
• whether data types are distinguished; 
• how issues of property rights are treated; 
• how the limits of data sharing are recognised. 
 
The timing of these new developments is opportune for MRC in considering a data sharing 
policy.  MRC should draw on work in progress arising from the rising tide of activity seeking 
to explore and implement data-sharing policies in the sciences.  
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8. MODELS OF SERVICE PROVISION 
 
Drawing on the lessons of the site visits and the examples of other data organisations and 
research funding bodies, it is now possible to draw a series of possible architectural models 
for the provision of data archiving and access services for MRC population-based research.  
These models fall in a continuum from centralised and integrated to de-centralised and 
distributed. 
 
8.1. Fully centralised: the national archive model 
 
8.1.1. Description 
Under a fully centralised model, data archiving and dissemination all occur within a single 
centralised facility.  Researchers would be required to pass over data and documentation to 
the centre, likely under a rights management framework which either cedes copyright to the 
centre, or sets out the conditions under which the centre is permitted to disseminate the data.  
This model was the basis of the original ESRC Data Archive. 
 
8.1.2. Advantages 
• Centralised services are often the most cost effective, since infrastructural costs need 
not be replicated across multiple sites, and often there are economies of scale.   
• A centralised MRC archive would presumably be staffed by trained data archivists, 
and therefore issues such as development of and adherence to standards could be 
more easily managed and enforced.   
• By centralising expertise, extensive training in data preservation and management 
within data producing units is not necessary, also a cost saving.   
• From the secondary analyst’s perspective, there is a simple ‘one-stop-shop’ for 
locating and accessing data and for supporting the use of those data.   
• A unified, standardised rights management framework is also easier for users to 
navigate - a single user license could cover the entire collection.  
• The service would remove the burden of data preservation and dissemination from 
research staff, who may not be equipped, skilled, or resourced to deal with it. 
 
8.1.3. Disadvantages 
• This is the least popular solution among Principal Investigators, largely because too 
much control would be relinquished.   
• A single centralised service cannot possibly provide expert content support for each 
and every dataset in its collection (‘jack of all trades, master of none’ syndrome). 
• Not all datasets can be adequately anonymised, and therefore to protect fully 
respondent confidentiality, onsite collaboration with PIs rather than a centralised 
service would be the appropriate dissemination mechanism. 
 
8.2. Centralised infrastructure/distributed expertise: the AHDS/ESRC model 
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8.2.1. Description 
This model is a compromise which attempts to harness the advantages of both the centralised 
and distributed models.  In it, the basic infrastructure and mechanics of acquiring, validating, 
preserving, and disseminating data are undertaken by a central service.  Supporting users in 
the use of particular datasets, however, remains the responsibility of centres of expertise; 
most likely the researchers who created the data themselves, or those with particular expertise 
in a certain type of data, methodological approach, or subject matter. 
 
Examples of this model include the Arts and Humanities Data Service (AHDS), and the new 
ESRC data archiving and dissemination service.  There is a core management and 
coordination function which oversees the preservation of data, the machine infrastructure, 
and the development of the service; whilst the support and promotion of the use of the data 
falls to specialist services on a subject basis (AHDS) or a data type/methodology basis 
(ESRC). 
 
8.2.2. Advantages 
• This model maintains most of the centralised advantage of reducing infrastructure 
costs. 
• Centralised control of preservation ensures enforcement of standards. 
• If the coordination is well-managed, the service still appears to be a seamless ‘one-
stop-shop’ from the user’s point of view. 
• Unified rights management framework, as above. 
• Lifting the burden of preservation and dissemination off the researcher. 
• User support is high quality, better focused, and more complete than a purely 
centralised model. 
• Researchers may maintain a measure of involvement in the use of their data. 
 
8.2.3. Disadvantages 
• PIs may still object to loss of control over data. 
• Issues of anonymisation still apply. 
• Will be more expensive than a centralised model. 
 
8.3 Subject-focused distributed service: the NERC model 
 
8.3.1. Description 
Under this model, the data world is divided into a number of subject areas, and a series of 
data centres are established with responsibility for data within each area.  Each data centre 
replicates the functions of data acquisition, validation, preservation, dissemination, and user 
support.  An example of this model is the Natural Environmental Research Council’s Data 
Centres. 
 
8.3.2. Advantages 
• Since data within certain subject areas may have certain commonalities, data 
management practices can be better tailored to the specific data types. 
• Likewise preferred methods of accessing and using data may share commonalities 
within subject areas, so dissemination services can also be better tailored. 
• User support is likely to be more focused and of higher quality, particularly if (as is 
the case with NERC) these data centres are also research centres. 
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8.3.3. Disadvantages 
• Much more costly, as services, infrastructure and expertise are replicated across sites. 
• Still requires PIs to give up control; and may in fact be potentially more contentious, 
as control might be ceded to researchers who are actually viewed as competitors in 
their field. 
• Without some fairly strong overarching management, standards and rights 
management frameworks may be difficult to agree and enforce. 
• Whilst satisfying the mainstream disciplinary researcher as an appropriate “one stop 
shop” it may discourage cross-disciplinary and multi-disciplinary research, since 
multiple “shops” would need to be navigated. 
• Potential confusion amongst both users and depositors, as disciplinary boundaries are 
not always clear. 
 
8.4. Virtual integration only: the GRID model 
 
8.4.1. Description 
This model is a more purely distributed model, where local data producers make their data 
available via common standard interoperability protocols, and the integration occurs on the 
user’s desktop.  This is a very flexible model, in that it allows for the inclusion of a 
tremendous range of data held anywhere in the world, the only caveat being that the data 
must be presented in such a way that the virtual tools can read them.  Whilst harnessing the 
widest range of data resources and taking fullest advantage of the incredibly rich existing 
information landscape, it does not in itself mandate or control the preservation of those 
resources – this is left to the individual sites.   
 
8.4.2. Advantages 
• Control over the data is left in the hands of those who know and understand it best. 
• Potential for innovative cross-disciplinary, cross-method research increased. 
• Cost of the service essentially falls to the local data producer (but has to be provided 
for somehow). 
• Provenance of the data is immaterial, since the tools locate and present them as 
virtually integrated. 
• Takes best advantage of the existing investment of other organisations worldwide. 
 
8.4.3. Disadvantages 
• Preservation is left to the data producer.  If adequate preservation is mandated, then 
each data producer is required to acquire the hardware and skills to undertake it 
him/herself, or outsource it. 
• Rights management is a potential stumbling block in this model, as either only freely 
available data are included, or the user must jump through multiple authorisation 
hoops to gain access to multiple resources.  
• User support is left to the data producer – no one stop shop for support in using the 
data (although presumably what content support there is would be highly focused and 
very expert). 
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8.5. The portal approach: the RDN model 
 
8.5.1. Description 
This is not strictly a data archiving and access model at all.  In it, data access is enabled by 
the funding not of an archiving or dissemination service, but of a service which establishes 
and maintains a portal which links through to existing resources elsewhere.  The service 
consists in the identification and creation of searchable, browsable metadata for resources 
which actually reside anywhere in the world.  It is a useful service for users, a one-stop shop 
for the location and identification of resources, but it does not in itself provide for accessing 
or acquiring resources.  Preserving data is not in the service’s brief, although it would of 
course maintain and preserve its own metadata repository. The Resource Discovery Network 
(RDN http://www.rdn.ac.uk/) is an example of this model.   
 
8.5.2. Advantages 
• A portal is much less costly than a full-blown archive. 
• Would assist in locating data resources outside of MRC science. 
• Can bring together research data resources with other resources (articles, publications, 
web sites, etc) in one metadata framework and one search/browse environment. 
 
8.5.3. Disadvantages 
• Does not provide for either short or long term data preservation. 
• Does not ensure data access, only access to information about research data; thereafter 
researchers are left to negotiate access to data resources themselves. 
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9. RECOMMENDATIONS 
 
It is beyond the scope of this report to present specific recommendations to the MRC 
concerning the specific form and content of its data archiving and access policy and service 
provision.  However, this report offers some general observations and lessons learned from 
the course of the site visits and accompanying research. 
9.1.  Encouraging the culture of data sharing 
 
It is clear that most researchers support the idea of data sharing. However, in discussion of 
the mechanisms of how access would operate, there is a reluctance to relinquish control.  
There are significant cultural barriers that need to be overcome, and researchers need to be 
encouraged to think in terms of sharing data as a normative activity, as it is in other areas of 
MRC science.  Formalising access control procedures and protocols might serve to make 
researchers more comfortable with data sharing.  It is important that a policy which mandates 
data sharing not be confused with a requirement to open all data to free and uncontrolled 
access.  Researchers will understandably feel far more comfortable if there is a sense that 
secondary users have been in some measure "vetted" before access is allowed to potentially 
sensitive or particularly complex data.  Depending upon the access control procedures 
implemented, such protocols, however, may come to seem unnecessarily onerous to the 
secondary analyst, who may quite reasonably feel that the peer review process already in 
place for research proposals and resulting publications would obviate such a requirement.  
Enforcing the sharing of data may require both "carrots" and "sticks" in the form of additional 
funds to researchers to prepare their data for secondary analyses, and perhaps making the 
incorporation of data sharing into the research plan a condition of the grant award. 
9.2.  Standards and guidelines 
 
It is clear that there is a demand for the re-use of population data in the medical research 
field, as well as a good scientific and economic rationale for its preservation and 
dissemination.  It is also equally clear that in order for data to be reasonably re-usable and 
preservable, certain standards, particularly of dataset documentation, must be met, and that 
researchers would welcome assistance in meeting them, particularly in the form of published 
guidelines and advice. 
9.3.  Rights management framework 
 
A good rights management framework is essential for the establishment of a data archiving 
and access service.  Rights management in its broadest sense covers not only the relationship 
between the data creators and secondary data users, but also protects the rights of institutions, 
funders of research and even research subjects.  A unified rights management framework for 
MRC data would greatly improve a data access service, no matter what the particular model 
of service provision. 
9.4.  Consent 
 
Consent arrangements need not preclude the use of data for secondary analysis, and it is 
recommended that the MRC draft appropriate guidelines for the wording of consent 
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agreements which would allow secondary analysis.  It is important when issuing guidelines 
on consent and data sharing that the MRC educate both researchers and other bodies who are 
concerned with the ethics of research with human subjects. 
9.5.  Selection of data for DAA 
 
All data are not created equal, and in a world of limited resources, priorities for DAA must be 
drawn.  Investigators’ views should be of great value in helping MRC to consider a strategy 
for both assessing and prioritising datasets for archiving. In summary, the following criteria 
may be most appropriate for making these decisions, some of which were previously 
suggested from the MRC DAA Phase I survey:  
 
• the degree of uniqueness or the size/longevity of the study/dataset; 
• the reputability and quality of the study methods and dataset; 
• the potential to answer new important research questions cost-effectively; 
• the likelihood that a dataset can be pooled or combined with other data to provide 
power that individual datasets cannot provide; 
• the degree to which the study fulfils ethical and legal requirements to enable the re-
use of personal information; 
• the degree of MRC sponsorship; 
• the anticipated cost of preparing a dataset to professional archival standards;  
• studies that were conducted recently; 
• building in prospective data preparation and documentation plans that enable 
secondary access for all new studies . 
 
A set of criteria such as these would provide the framework in which to apply independent 
evaluation of MRC datasets for archiving. 
9.6.  Desired services 
 
There was nearly unanimous support among researchers for published guidelines for good 
practice in the management of data and their preservation.  Many also supported the idea of a 
data archiving and access advisory service.  A central registry of research instruments also 
received strong support, particularly among younger researchers and project managers.  
Support for a freestanding data archiving and dissemination service was mixed, as many 
researchers feared losing control altogether; support was stronger for a preservation service. 
9.7.  Service provision 
 
There are a number of different possible models for the architecture of service provision for 
data archiving and access, ranging along a continuum from completely centralised to 
completely virtual and distributed.  Each model has advantages and disadvantages which 
must be weighed, including cost effectiveness, quality and focus of service and support, and 
ease of use and navigation for both data creators and data users, and support among the 
research community.  Centralised services are often most cost effective because of lack of 
replication of infrastructure and expertise, and may be an easy focal point or “one stop shop” 
for secondary users and data creators, but may also offer the least focused user support, and 
may face the greatest resistance from researchers concerned about access control.  Different 
models also require, and enable, different degrees of data and metadata standardisation. The 
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MRC must determine the relative priority of these competing factors in choosing a model for 
service provision. 
9.8.  Policy and resources 
 
Regardless of the model of service provision, funding is required for long-term preservation 
and to facilitate data access and user support.  Any data archiving and access policy needs to 
be adequately resourced, and may also require some contractual "teeth" to overcome cultural 
barriers and ensure compliance. 
 
MRC POPULATION DATA ARCHIVING AND ACCESS PROJECT CONSULTANTS’ REPORT       DRAFT 2.0 
DRAFT ONLY -- DO NOT QUOTE WITHOUT PRIOR PERMISSION FROM THE AUTHORS  65 
APPENDIX 1: SITE VISIT SUMMARIES 
 
N.B. These are not yet available for distribution 
 
I. MRC SOCIAL, GENETIC AND DEVELOPMENTAL PSYCHIATRY RESEARCH CENTRE, 
INSTITUTE OF PSYCHIATRY, LONDON 
II. MRC ENVIRONMENTAL EPIDEMIOLOGY UNIT, SOUTHAMPTON 
III. MRC SOCIAL AND PUBLIC HEALTH SCIENCES UNIT, GLASGOW 
IV. DEPARTMENT OF COMMUNITY HEALTH SCIENCES, UNIVERSITY OF EDINBURGH 
MEDICAL SCHOOL 
V. PARKINSON’S DISEASE DNA BANK, DEPT. OF NEUROLOGY, DUDLEY ROAD CITY 
HOSPITAL, BIRMINGHAM 
VI. MRC NATIONAL SURVEY OF HEALTH AND DEVELOPMENT, UNIVERSITY COLLEGE 
LONDON 
VII. MRC CLINICAL TRIALS UNIT, LONDON 
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APPENDIX 2: DATASET DESCRIPTIONS 
 
1. Twins' Early Development Study (TEDS) 
Study Title  Twins' Early Development Study 
Study 
Acronym TEDS 
Unit/Centre 
Name MRC Social, Genetic and Developmental Psychiatry Research Centre (SGDP) 
Unit/Centre 
Address 
Institute of Psychiatry, London 
http://www.iop.kcl.ac.uk/main/ResRep/Centre.htm 
http://www.iop.kcl.ac.uk/IoP/Departments/SGDPsy/research/TEDS.stm 
Unit/Centre 
Director Prof Peter McGuffin 
Date of site 
visit 15/05/2002 
PI Prof Robert Plomin 
Summary of 
major aims 
Genetic and environmental investigation of the early emergence and 
persistence of language difficulties and other problems and their links to 
externalising behaviour problems.  About 16,000 pairs of twins born in 1994-
96 in England and Wales have been recruited. Twins showing persistent 
difficulties through to 4 years of age (and an unselected control group) are 
selected for intensive study in their homes.  Quantitative genetic analyses of 
the total sample and the selected subsamples will be performed in order to 
elucidate the interplay between genetics and environment in the early 
development of these mild mental disorders and their co-occurrence with 
behaviour problems.  
Study 
Location England and Wales 
Duration 1995-2000  2000-2005 
Start Date 1995 
Principal 
funding 
source 
MRC 
Study type Longitudinal 
Variables Approx. 1500 
Cases 33,000 
Variable 
types 99% coded, a little verbatim text, a few dates, heights/weights 
 
2. Depression Case Control (DeCC) Study 
Study Title  Depression Case Control Study - A DNA collection for Case-Control studies 
of unipolar depression 
Study 
Acronym 
DeCC 
Unit/Centre 
Name 
MRC Social, Genetic and Developmental Psychiatry Research Centre (SGDP) 
Unit/Centre Institute of Psychiatry, London 
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Address http://www.iop.kcl.ac.uk/main/ResRep/Centre.htm 
Unit/Centre 
Director 
Prof Peter McGuffin 
Date of site 
visit 
15/5/2002 
PI Prof Peter McGuffin 
Summary of 
major aims 
Family, twin and adoption data provide a compelling case that major 
depression is strongly influenced by genes, but suggest that this is likely to be, 
as with other common conditions, the result of several, perhaps many genes of 
small effect.  The genetic contribution is complicated and almost certainly 
involves an interplay between multiple genes and environmental factors. 
 
This project aims to establish a resource for one of the main methods of 
locating and identifying genes, allelic association. 
 
The DNA collection is comprised of samples from patients suffering from 
severe recurrent unipolar depressive disorder and ethnically matched controls 
screened for absence of psychiatric disorder.  The depressed participants are 
over the age of eighteen and have had two or more episodes of depression as 
defined by the research criteria of ICD10 and by DSMIV.  The sample size 
will allow sufficient power to detect or replicate associations with 
susceptibility loci of modest or small effect and will be suitable both for 
candidate gene studies and linkage disequilibrium mapping in genomic 
regions of interest identified by linkage studies. 
Study 
Location 
SGP Research Centre/South London & Maudsley NHS Trust, Cardiff, 
Birmingham 
Duration 2000-2003 
Start Date Grant Awarded 2000 
Principal 
funding 
source 
MRC 
Study type Genetic, trial 
Variables Approx. 1800 
Cases 365 current, 800 target 
Variable 
types 
most coded, some ordinal, few dates 
 
3. Isle of Wight Studies 
Study Title  Isle of Wight Studies 
Study 
Acronym 
IoW 
Unit/Centre 
Name 
MRC Social, Genetic and Developmental Psychiatry Research Centre (SGDP) 
Unit/Centre 
Address 
Institute of Psychiatry,  London 
Http://www.iop.kcl.ac.uk/main/ResRep/Centre.htm 
Unit/Centre 
Director 
Prof Peter McGuffin 
Date of site 15/05/2002 
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visit 
PI Prof Sir Michael Rutter 
Dr Barbara Maughan 
Jack Tizzard 
Summary of 
major aims 
Wave A: To assess the prevalence and correlates of psychiatric disorder and 
reading difficulties in childhood and adolescence, and the implications for the 
provision of services.  
Wave B: To examine continuity and discontinuity of disorders/difficulties 
over time (changes between childhood, adolescence and adulthood). 
Study 
Location 
Isle of Wight 
Duration 1964/65 1968/69 Ongoing followup 
Start Date Start of grant: 1963 Start of data collection 1964 
Principal 
funding 
source 
Current funders: MRC.  Previous funders: DoE, Nuffield Foundation, SSRC 
(ESRC) 
Study type Longitudinal 
Variables Approx. 5000 
Cases 2300 adults with detailed assessment; intensive interviews for 615 children 
and 350 adults. 
Variable 
types 95% coded, 5% scores, real numbers (weights) 
 
4. Southampton Women's Survey (SWS) 
Study Title  Southampton Women's Survey 
Study 
Acronym SWS 
Unit/Centre 
Name MRC Environmental Epidemiology Unit 
Unit/Centre 
Address 
University of Southampton, Southampton General Hospital, Southampton, 
SO16 6YD  
http://www.mrc.soton.ac.uk/project.asp?proj=37, 
http://www.swsurvey.soton.ac.uk/sws/default.htm 
Unit/Centre 
Director Prof David Barker 
Date of site 
visit 11/06/2002 
PI Dr Hazel Inskip 
Summary of 
major aims 
The Southampton Women's Survey (SWS), a large-scale epidemiological 
study, is looking at 20,000 20-34 year old women in the Southampton area. It 
looks at their health and nutrition before they conceive and during their 
pregnancy and relates these factors to the subsequent health of their babies. Its 
aim is to understand how issues such as a woman's diet and body composition 
before and during pregnancy, and her own growth in the womb, affect the 
development of her foetus.  
Study 
Location Southampton 
Duration 1998-2002/3  
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Start Date Dunhill Grant : 1998, later funding from MRC 
Principal 
funding 
source 
MRC, Dunhill Medical Trust,  5 yr funding to continue project sought from 
British Heart Foundation 
Study type Longitudinal 
Variables Approx. 5200 
Cases 20,000 women, target 3000 babies 
Variable 
types 85% coded, 10-15% physical measurements, some dates 
 
5. Wessex Fracture Prevention Study 
Study Title  Wessex Fracture Prevention Study 
Study 
Acronym Wessex Fracture 
Unit/Centre 
Name MRC Environmental Epidemiology Unit 
Unit/Centre 
Address 
University of Southampton, Southampton General Hospital, Southampton, 
SO16 6YD  
http://www.mrc.soton.ac.uk/project.asp?proj=21 
Unit/Centre 
Director Prof David Barker 
Date of site 
visit 11/06/2002 
PI Prof Cyrus Cooper 
Summary of 
major aims 
Do annual intramuscular injections of vitamin D, given with the well-
established influenza immunisation, reduce the risk of non-vertebral fractures 
sustained by men and women aged over 75 years old in general practice? 
Study 
Location Wessex, Isle of Wight, West Sussex and Somerset 
Duration Ongoing.  Report expected 2004/5 
Start Date Data Collection 1998 
Principal 
funding 
source 
MRC, NHS R&D 
Study type Trial 
Variables 550 
Cases 10,000 
Variable 
types 95% coded, some dates, real numbers 
 
6. Study of the effect of formaldehyde on the mortality of workers in the UK 
chemical industry 
Study Title  Study of the effect of formaldehyde on the mortality of workers in the UK 
chemical industry 
Study 
Acronym Formaldehyde 
Unit/Centre MRC Environmental Epidemiology Unit 
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Name 
Unit/Centre 
Address 
University of Southampton, Southampton General Hospital, Southampton, 
SO16 6YD  
http://www.mrc.soton.ac.uk 
http://www.mrc.soton.ac.uk/project.asp?proj=52 
Unit/Centre 
Director   
Date of site 
visit 11/06/2002 
PI Prof David Coggon 
Summary of 
major aims 
To determine the mortality attributed to cancer and to other causes of death in 
workers exposed to formaldehyde in comparison with men of the same age in 
the same geographical region of England.  Cohort design based on registers of 
all men ever employed by companies in which exposure to formaldehyde 
began before 1960 and which retained records identifying all previous 
members of the workforce at least since 1960.  Identification and exposure 
details. 
Study 
Location UK 
Duration Ongoing with follow-up every 10 years 
Start Date Original Project 19xx, Follow Up : 2001 
Principal 
funding 
source 
MRC (funding follow-up), original funders Chemical Industry Association 
and Colt Foundation 
Study type Longitudinal 
Variables 38 
Cases 13,500 
Variable 
types Nearly all coded, couple dates 
 
7. SHARE: Does Teacher Led Sex Education Reduce Sexual Risk Taking? 
Study Title  SHARE: Does Teacher Led Sex Education Reduce Sexual Risk Taking? 
Study 
Acronym SHARE 
Unit/Centre 
Name MRC Social and Public Health Sciences Unit 
Unit/Centre 
Address 
University of Glasgow, 4 Lilybank Gardens, Glasgow, G12 8RZ 
http://www.msoc-mrc.gla.ac.uk/ 
Unit/Centre 
Director Prof Sally Macintyre 
Date of site 
visit 19/06/2002 
PI Dr Danny Wight 
Ms Marion Henderson 
Summary of 
major aims 
A randomised controlled trial (RCT) of a previously piloted, teacher-led sex 
education programme in schools in Lothian and Tayside, Scotland.  Half the 
schools randomised to receiving training in and to deliver the SHARE 
programme, and half delivering their usual sex education programme.  The 
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outcome measures are attitudes and behaviours of pupils, assessed through 
baseline and post-programme questionnaires of the whole sample.  The 
process of delivering the SHARE programme is being investigated through 
qualitative research involving teacher questionnaires and interviews with 
senior schools managers, supplemented with detailed studies of a selection of 
programme and comparison schools. 
Study 
Location Lothian and Tayside, Scotland 
Duration 1996-2000 
Start Date 1996 
Principal 
funding 
source 
MRC 
Study type Socio, trial 
Variables 100-200 
Cases 110 
Variable 
types 94% coded, 5% real numbers, 1% text 
 
8. Masculinity and Health: The Social Factors Affecting Men’s Health 
Study Title  Masculinity and Health: The Social Factors Affecting Men’s Health 
Study 
Acronym Masculinity 
Unit/Centre 
Name MRC Social and Public Health Sciences Unit 
Unit/Centre 
Address 
University of Glasgow, 4 Lilybank Gardens, Glasgow, G12 8RZ 
http://www.msoc-mrc.gla.ac.uk/ 
Unit/Centre 
Director Prof Sally Macintyre 
Date of site 
visit 19/06/2002 
PI Dr Ros O'Brien 
Summary of 
major aims 
Examines the social factors that affect men’s health.  It aims to discover how 
men understand their own health and the meanings that they invest in health 
practices – and how these are related to masculinity.  There are two stages.  
The first comprises twenty focus groups to explore men’s health, using 
purposive sampling to structure the groups (e.g. to create particular age 
groups) and achieve diversity (e.g. of occupational environment).  The output 
will be information about the wider social factors that shape men’s health.  
The second stage comprises tape-recorded in-depth interviews designed to add 
specific histories of masculinity and health to the focus group data.  
Study 
Location Glasgow & London (some groups only) 
Duration 2000-2001 
Start Date Fieldwork : Feb 2000 
Principal 
funding 
source 
MRC 
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Study type Socio 
Variables n.a. 
Cases 9 
Variable 
types NVIVO coding on themes 
 
9. Racist and Sectarian Graffiti in Glasgow – A Pilot Study 
Study Title  Racist and Sectarian Graffiti in Glasgow – A Pilot Study 
Study 
Acronym Graffiti 
Unit/Centre 
Name MRC Social and Public Health Sciences Unit 
Unit/Centre 
Address 
University of Glasgow, 4 Lilybank Gardens, Glasgow, G12 8RZ 
http://www.msoc-mrc.gla.ac.uk/ 
Unit/Centre 
Director Prof Sally Macintyre 
Date of site 
visit 19/06/2002 
PI Ms Anne Ellaway 
Summary of 
major aims 
A systematic exploration of the location and content of sectarian and racist 
graffiti in Glasgow, Scotland.  The project stems from perceptions and 
observations that graffiti and discrimination based on race in the west of 
Scotland is associated with poor health. It was not the aim of this project to 
add immediately to the understanding of mechanisms that might link 
neighbourhood graffiti and health.  Instead, it addressed issues such as the use 
of graffiti as a public statement of prejudice, to represent affiliation with a 
cause, or to mark territory.  In this pilot project , the content and location of 
graffiti in a selection of locations in Glasgow were recorded by photography 
and mapped to social and physical features of the environment.  No research 
data were recorded relating to individuals. 
Study 
Location Glasgow, Scotland 
Duration 2000 
Start Date 2000 
Principal 
funding 
source 
MRC 
Study type Socio 
Variables n.a. 
Cases n.a. 
Variable 
types Maps and photographs 
 
10. The West of Scotland Twenty-07 Study 
Study Title  The West of Scotland Twenty-07 Study 
Study 
Acronym Twenty-07 
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Unit/Centre 
Name MRC Social and Public Health Sciences Unit 
Unit/Centre 
Address 
University of Glasgow, 4 Lilybank Gardens, Glasgow, G12 8RZ 
http://www.msoc-mrc.gla.ac.uk/ 
Unit/Centre 
Director Prof Sally Macintyre 
Date of site 
visit 19/06/2002 
PI Prof Sally Macintyre 
Summary of 
major aims 
A longitudinal survey based in the Central Clydeside Conurbation, Scotland.  
The study seeks to explain the social patterning in a number of health 
measures by social class, gender, marital status, age, area of residence and 
ethnicity. The study comprises 3 cohorts, who were aged 15, 25 and 55 when 
first studies in 1987/88.  The study is currently in its third sweep.  It examines 
the relative importance of factors that may cause variations in physical and 
mental health and wellbeing.  These factors include lifestyle behaviours, such 
as diet, smoking and exercise; selection by health into social positions, e.g. 
unemployment, marriage; financial and material resources; and exposure to 
physical and social risk. 
Study 
Location Central Clydeside Conurbation, Scotland 
Duration 1987-2007 
Start Date 1987 
Principal 
funding 
source 
MRC 
Study type Longitudinal 
Variables  
Cases Approx. 3,000 
Variable 
types Most coded, some measurements 
 
11. MRC Scottish Colorectal Cancer Study (SOCCS) 
Study Title  MRC Scottish Colorectal Cancer Study  
Study 
Acronym SOCCS 
Unit/Centre 
Name Dept. of Community Health Sciences 
Unit/Centre 
Address 
Public Health Sciences, University of Edinburgh Medical School, Teviot 
Place, EH8 9AG 
Unit/Centre 
Director Dr Harry Campbell 
Date of site 
visit 20/06/2002 
PI Dr Harry Campbell 
Summary of 
major aims 
Population based DNA sample collections from colorectal cancer patients' 
close relatives and matched controls. 
Study Scotland 
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Location 
Duration 2001-2004 
Start Date March 2001 
Principal 
funding 
source 
MRC 
Study type Genetic 
Variables Approx. 300 
Cases 8,500 (4000 cases, 4000 controls, 500 family members) 
Variable 
types 75% coded, some dates, nutrient values, measurements 
 
12. Parkinson's Disease DNA Bank 
Study Title  Parkinson's Disease DNA Bank 
Study 
Acronym PDGEN 
Unit/Centre 
Name University of Birmingham Clinical Trials Unit (BCTU) 
Unit/Centre 
Address 
Park Grange, 1 Somerset Road, Edgbaston, Birmingham. B15 2RR 
http://www.bctu.bham.ac.uk/ 
Unit/Centre 
Director Dr Carl E Clarke 
Date of site 
visit 24/06/2002 
PI Dr Carl E Clarke 
Summary of 
major aims 
To develop a Birmingham-based DNA bank from patients with PD and 
controls using samples from large pragmatic randomised controlled trials 
(RCT) such as PD MED and PD SURG and to distribute these samples to 
approved researchers working in the field. 
Study 
Location UK 
Duration 2000 onwards 
Start Date August 2000 
Principal 
funding 
source 
MRC, BCTU 
Study type Genetic 
Variables  
Cases 8,000 
Variable 
types Genetic samples 
 
13. PDMED Parkinson’s Disease Drugs Assessment Randomised Trial 
Study Title  A large randomised assessment of the relative cost-effectiveness of classes of 
drugs for Parkinson’s disease 
Study 
Acronym PDMED 
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Unit/Centre 
Name University of Birmingham Clinical Trials Unit (BCTU) 
Unit/Centre 
Address 
Park Grange, 1 Somerset Road, Edgbaston, Birmingham. B15 2RR 
http://www.bctu.bham.ac.uk/ 
http://www.bctu.bham.ac.uk/PDMED/PDMEDintro.htm 
Unit/Centre 
Director Dr Carl E Clarke 
Date of site 
visit 24/06/2002 
PI Dr Carl E Clarke 
Summary of 
major aims 
PDMED is a large, simple, "real-life" open-label randomised trial to evaluate 
the roles of different classes of drugs as therapy for both early and later PD.   
Study 
Location UK 
Duration 2000-2005 
Start Date August 2000 
Principal 
funding 
source 
NHS R&D, BCTU 
Study type Trial 
Variables  
Cases 5,000 (3000 early PD and 2000 later PD) 
Variable 
types 90% coded, 10% real numbers/uncoded text, some dates 
 
14. PDSURG Parkinson’s Disease Surgery Assessment Randomised Trial 
Study Title  A large randomised assessment of the relative cost-effectiveness of surgery 
for Parkinson’s disease 
Study 
Acronym PDSURG 
Unit/Centre 
Name University of Birmingham Clinical Trials Unit (BCTU) 
Unit/Centre 
Address 
Park Grange, 1 Somerset Road, Edgbaston, Birmingham. B15 2RR 
http://www.bctu.bham.ac.uk/ 
http://www.bctu.bham.ac.uk/PDSURG/PDSURGintro.htm 
Unit/Centre 
Director Dr Carl E Clarke 
Date of site 
visit 24/06/2002 
PI Dr Carl Clarke 
Summary of 
major aims 
PDSURG is a large, simple, "real-life" randomised trial to evaluate the role of 
surgery as therapy for PD.   
Study 
Location UK 
Duration 2000-2010 
Start Date 2000 
Principal 
funding MRC, BCTU, Parkinson's Disease Society 
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source 
Study type Trial 
Variables  
Cases 28 to date, 400-600 target 
Variable 
types 90% coded, 10% real numbers/uncoded text, some dates 
 
15. MRC National Survey of Health and Development 
Study Title  MRC National Survey of Health and Development 
Study 
Acronym NSHD aka 1946 Birth Cohort 
Unit/Centre 
Name MRC National Survey of Health and Development Unit 
Unit/Centre 
Address 
University College London 
http://www.ucl.ac.uk/epidemiology/mrc/mrc.html 
Unit/Centre 
Director Prof Mike Wadsworth 
Date of site 
visit 25/06/2002 
PI Prof Mike Wadsworth 
Summary of 
major aims 
A long term follow-up of a national cohort of 5,362 births from 1946 to the 
present day. Information has been collected regularly from birth so far to the 
age of 43 years on this study population, and current concerns are with 
subjects' mid-life physical and mental health, and their rates of change of 
health with age. Data on social circumstances and health in childhood, 
adolescence and adult life are used to investigate the precursors of change in 
health, health risk factors and ill health in middle life.  
Study 
Location GB 
Duration 1946-ongoing 
Start Date 1946 
Principal 
funding 
source 
MRC currently 
Study type Longitudinal 
Variables Appx 13,000 
Cases Originally 4695; 3035 in last wave 
Variable 
types 90% coded, rest real numbers, very little free text 
 
16. CONCORDE - MRC/INSERM trial of zidovudine in HIV infection 
Study Title  CONCORDE - MRC/INSERM trial of zidovudine in HIV infection 
Study 
Acronym CONCORDE 
Unit/Centre 
Name MRC Clinical Trials Unit (CTU) 
Unit/Centre 222 Euston Road, London, NW1 2DA 
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Address http://www.ctu.mrc.ac.uk/hiv_division/hiv_home.asp 
Unit/Centre 
Director Prof Janet Darbyshire 
Date of site 
visit 02/07/2002 
PI Prof Ian Weller 
Summary of 
major aims 
To compare immediate treatment with zidovudine with treatment deferred 
until the onset of symptomatic disease in terms of survival and disease 
progression and of toxicity in asymptomatic HIV infected individuals. 
Study 
Location UK & France.  Follow-up ongoing in UK. 
Duration 1988-1993 
Start Date 01/01/1988 
Principal 
funding 
source 
MRC, Wellcome, ANRS, INSERM 
Study type Trial 
Variables  
Cases 1749 (half U.K.) 
Variable 
types   
 
17. ESPRIT - A study of subcutaneous recombinant IL-2 (Proleukin®) in patients 
with HIV 
Study Title  Evaluation of Subcutaneous Proleukin® in a Randomised International Trial 
Study 
Acronym ESPRIT 
Unit/Centre 
Name MRC Clinical Trials Unit (CTU) 
Unit/Centre 
Address 
222 Euston Road, London, NW1 2DA 
http://www.ctu.mrc.ac.uk/hiv_division/hiv_home.asp 
http://www.espritstudy.org/ 
Unit/Centre 
Director Prof Janet Darbyshire 
Date of site 
visit 02/07/2002 
PI Prof Brian Gazzard 
Summary of 
major aims 
A large randomised, open-label, phase III, international study of subcutaneous 
recombinant IL-2 (Proleukin®) in patients with HIV-1 infection and CD4+ 
cell counts of 300/mm3 or greater.  The purpose of the trial is to compare the 
effects of IL-2 or no IL-2 on progression of HIV disease and mortality over a 
5-year period in patients taking combination anti-retroviral therapy.  
Study 
Location 24 UK sites & 22 other countries 
Duration 1998-2004 
Start Date 1998 
Principal 
funding MRC, NIH 
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source 
Study type Trial 
Variables   
Cases 400 (300 U.K.) 
Variable 
types   
 
18. INITIO - comparing different combination anti-retroviral treatment in HIV 
infected individuals 
Study Title  INITIO - An open randomised trial to evaluate different therapeutic strategies 
of combination therapy for HIV-1 infection 
Study 
Acronym INITIO 
Unit/Centre 
Name MRC Clinical Trials Unit (CTU) 
Unit/Centre 
Address 
222 Euston Road, London, NW1 2DA 
http://www.ctu.mrc.ac.uk/hiv_division/hiv_home.asp 
http://www.ctu.mrc.ac.uk/initio 
Unit/Centre 
Director Prof Janet Darbyshire 
Date of site 
visit 02/07/2002 
PI Prof Jonathan Weber 
Summary of 
major aims 
International trial involving 17 countries, comparing different strategic 
approaches to combination anti-retroviral therapy that includes both the first 
and subsequent regimens (if a change is necessary for therapeutic failure or 
intolerance) in individuals with HIV infection who wish to start treatment. 
Study 
Location UK, and 16 other countries 
Duration 1998-2004 
Start Date 1998 
Principal 
funding 
source Roche, SmithKline Beecham, Bristol Myers, and Verco.  Plus MRC Core.   
Study type Trial 
Variables 23 Files with variables 
Cases 950 (77 U.K.) 
Variable 
types Approx. 90%, 70% real numbers 
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APPENDIX 3: METADATA STANDARDS AND INTEROPERABILITY IN THE 
BIOMEDICAL SCIENCES 
 
 
THE BIOMEDICAL SCIENCES 
 
It should be emphasised that there are no universally accepted metadata standards specific to 
the Biomedical Sciences, although some controlled vocabularies are more widely used and 
accepted than others.  Often databases are set up that use their own controlled vocabularies 
and do not follow any predefined metadata standards. Although this report does not focus on 
metadata standards for genetic data, there is a separate section on XML and Biotechnology in 
the Metadata Elements and Formats section below. 
 
CONTROLLED VOCABULARIES 
 
Medical Subject Headings (MeSH) 
(www.nlm.nih.gov/mesh/meshhome.html)  
 
 (MeSH)  is the National Library of Medicine’s (NLM 
www.nlm.nih.gov/nlmhome.html) controlled vocabulary thesaurus. Keywords from 
MeSH are assigned to MEDLINE, NLM’s database of more than 11 million 
bibliographic citations and abstracts covering the fields of medicine, nursing, 
dentistry, veterinary medicine, health care systems and preclinical sciences. MeSH is 
one of the world’s pre-eminent controlled vocabularies and is widely used 
internationally. 
 
MeSH consists of a set of terms or subject headings that are arranged in both an 
alphabetical and a hierarchical structure.  At the most general level are very broad 
headings such as ‘Anatomy’.  At more narrow levels are found more specific headings 
such as ‘Ankle’.  There is also a separate chemical thesaurus and thousands of cross-
references to assist in finding the most appropriate MeSH heading.  
 
Examples of the application of MeSH in the UK include the Bristol Biomedical Image 
Archive (www.brisbio.ac.uk/) and OMNI (Organising Medical Networked 
Information omni.ac.uk/). The primary objective of Bristol BioMed was to make a 
shared resource of digital images available for reuse in the development of medical, 
dental and veterinary electronic learning and teaching materials. However, the 
usefulness of metadata originally attached to each image was frustrated by semantic 
and syntactic inconsistencies, use of multiple terms for a single concept and 
alternative spelling forms. To overcome this, MeSH was selected to fully exploit the 
metadata as an information retrieval resource. 
 
UK-based OMNI, one of BIOME’s (biome.ac.uk/) subject-specific gateways, offers 
free access to a searchable catalogue of Internet sites covering health and medicine 
and uses MeSH to index its records.  
 
Unified Medical Language System (UMLS)  
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(www.nlm.nih.gov/research/umls/)  
 
The NLM’s Unified Medical Language System (UMLS) project develops and 
distributes multi-purpose, electronic “Knowledge Sources” and associated lexical 
programs.  The purpose is to aid the development of systems that help health 
professionals and researchers retrieve and integrate electronic biomedical information 
from a variety of sources and to make it easy to link disparate information systems, 
including computer-based patient records, bibliographic databases, factual databases 
and expert systems.  There are 3 UMLS knowledge sources: UMLS Metathesaurus, 
Specialist Lexicon and UMLS Semantic Network.  The Metathesaurus provides a 
uniform, integrated distribution format from over 60 biomedical vocabularies and 
classifications, and links many different names for the same concepts.  The Lexicon 
contains syntactic information for many terms, component words and English words, 
including verbs, that do not appear in the Metathesaurus.  The Semantic Network 
contains information about the types or categories to which all Metathesaurus 
concepts have been assigned and the permissible relationships among these types.  
NLM also distributes associated lexical programs and software helpful in producing 
customised versions of the UMLS Metathesaurus. 
 
Additional controlled vocabularies and classification schemes (not an exhaustive list) 
Systematized Nomenclature of Medicine (SNOMED)  
(www.snomed.org/)  
Selected as the standard for the UK NHS Electronic Patient Record (EPR). 
 
Multilingual Glossary of technical and popular medical terms in nine 
European Languages (EUGLOSS) 
(allserv.rug.ac.be/~rvdstich/eugloss/welcome.html)  
 
The European multilingual thesaurus on health promotion in 12 
languages 
(www.hpmulti.net/) 
Relationships between medical terminologies used within Europe.  
 
Bioethics Thesaurus 
(www.georgetown.edu/research/nrcbl/ir/BT99about.htm) 
Published by the Kennedy Institute of Ethics. Each element is assigned a two-
letter qualifier e.g. KW – Keyword, PT – Publication Type. 
 
Life Sciences Thesaurus – Cambridge Scientific Abstracts (CSA) 
(www.csa.com/helpV3/lscthes.html) 
CSA is a privately owned information company located in Bethesda, 
Maryland. Life Sciences Thesaurus is used to aid searching of various CSA 
databases. 
Dewey Decimal, Library of Congress and NLM Classification Schemes 
Traditional generic and specific library classification schemes. 
Royal College of Nursing (UK) thesaurus.   
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International Statistical Classification of Diseases and Related Health 
Problems, 10th Revision (ICD-10) 
(www.who.int/msa/mnh/ems/icd10/icd10.htm)  
Classification of diseases and related health problems for the collation of 
medical statistics. Widely used in Europe, it has not yet supplanted the part of 
the 9th Edition commonly referred to as ICD-9-CM in the US. 
 
METADATA ELEMENTS AND FORMATS  
 
Some examples are given below of sites specifying certain metadata elements and/or formats 
for metadata storage.  It can be seen that most of these are using eXtensible Mark-up 
Language ( XML).  There is a separate section on 'XML and biotechnology'. 
 
MEDLINE and PubMed 
Publishers whose journals are indexed in MEDLINE can submit citation and abstract 
data electronically for inclusion in PubMed.  Submissions are required in a standard 
tagged XML format (with required and optional tags) and resources are available to 
assist with this including a PubMed DTD and XML File Validator 
(www.ncbi.nlm.nih.gov/entrez/query/static/spec.html). Where possible, ISO standards 
are followed. For example, the optional language tag requires the user to choose from 
the language codes in ISO 639. MeSH can also be downloaded in XML, ASCII and 
MARC (Machine Readable Catalogue Format) formats. 
 
 
Bristol BioMedical Image Archive (UK) 
Control and standardisation of catalogue records was achieved by use of the Dublin 
Core Metadata Element Set, extended to accommodate the range and variety of 
biomedical subject matter. 
 
HealthInsite (Australia)  
(www.healthinsite.gov.au) 
HealthInsite is a Commonwealth Government of Australia initiative which aims to 
improve the health of Australians by providing easy access to quality information 
about human health.  Standards are compliant with Australian Government Locator 
Service specification which is based on the Dublin Core standard. There is also 
extended syntax provided to enable external search engines to recognise keywords 
since Dublin Core syntax is not recognised by many external search engines.  
Metadata is recorded in HTML.  
 
National electronic Library for Health (NeLH)  
(www.nelh.nhs.uk/)  
Conforms to the UK e-Government Interoperability Framework (e-GIF) 
recommendations to adopt the Internet and World Wide Web standards for all 
government systems.  There is a strategic decision to adopt XML as the core standard 
for data integration and management of presentational data.  The NeLH will take the 
lead in some areas of schema development, for example, in national guidelines 
publication. 
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Health Information Disclosure, Description and Evaluation Language 
(HIDDEL)  
(www.medcertain.org/english/metadata/index.htm) 
This metadata standard will allow webmasters to describe their privacy, ethics, 
advertising, content and data quality policies using XML. 
The vocabulary is expected to be used to achieve interoperability between third-party 
rating/evaluation services such as OMNI. The vocabulary will allow users to express 
their own preferences and needs (e.g. the desired target audience of a site) in a 
standard language (using an add-on to their browser). Tag usage is explained at two 
levels, suitable for use by healthcare professionals and non-professionals.  
 
Clinical Data Interchange Standards Consortium Operational Data Model 
(CDISC ODM)  
(www.cdisc.org/models/odm/v1.1/odm1-1-0.html) 
The Operational Data Model (ODM) provides a format for representing the study 
metadata, study data and administrative data associated with a clinical trial. It 
represents only the data that would be transferred among different software systems 
during a trial, or archived after a trial. Metadata is used to version study data. The data 
structure is defined as an XML Document Type Definition. 
 
metaRegister of Controlled Trials and International Standard Randomised 
Controlled Trial Number  
(www.controlled-trials.com/) 
The metaRegister of Controlled Trials (mRCT) contains more than 10,000 records and 
is a major international searchable database of ongoing randomised controlled trials in 
all areas of healthcare, built by combining registers held by public, charitable and 
commercial sponsors of trials. At the moment the mRCT also contains some 
completed trials. The mRCT is a free service that allows users to search all 
participating registers, all of which are asked to submit trial records including 
specified essential data items. The content of all the trial records in the mRCT has 
been indexed so that they can be searched efficiently. 
 
Essential data items come under the headings of identification, trial details, funding 
and contact.  Identification details include an International Standard Randomised 
Controlled Trial Number (ISRCTN). The ISRCTN is a simple numeric system for the 
identification of randomised controlled clinical trials worldwide. It will simplify the 
identification of trials and provide a unique number that can be used to track all 
publications and reports resulting from each trial. The ISRCTN Register is a database 
of trials with ISRCTNs. It is still being developed and is not yet available online.  
 
Current Controlled Trials (CCT)   
(www.controlled-trials.com/links/)  
CCT Links give access to more than 200 other online registers of controlled trials, 
some of which are in languages other than English. 
 
The Open Healthcare Group  
(www.openhealth.org/) 
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The Open Healthcare Group is an organisation devoted to the promotion and 
distribution of an open source health record, XChart using XML Internet technology 
 
XML AND BIOTECHNOLOGY 
XML has become the foundation of several mark-up languages for storing biological 
data, a selection of which are listed below: 
 
BIOpolymer Mark-up Language (BIOML)  
BIOML was designed to be used to describe experimental information about 
proteins, genes and other biopolymers). 
 
Protein Sequence Database Mark-up Language (PSDML) 
(pir.georgetown.edu/)  
An open-standard mark-up language used to store protein information in the 
Protein Information Resource (PIR) database.   
 
Bioinformatic Sequence Mark-up Language (BSML) 
(www.ncbi.nlm.nih.gov/ & www.labbook.com) 
An open-standard protocol for the encoding and display of graphic genomic 
displays of DNA, RNA, and protein sequence information.  The web-based 
Basic Browser can import gene sequences from local or remote repositories 
such as GenBank (the US National Institutes of Health's genetic sequence 
database, an annotated collection of all publicly available DNA sequences. 
 
Genome Annotation Markup  Elements (GAME) 
(www.bioxml.org/Projects/game)  
A mark-up language used in molecular biology for annotation of  biological 
sequences.  
 
Gene Expression Mark-up Language (GeneXML) 
(www.ncgr.org/genex/) 
An open-standard mark-up language for DNA microarray and gene expression 
data. GeneXML was recently renamed from GEML. 
 
Chemical Markup Language (CML) 
(www.xml-cml.org) 
 
ADDITIONAL STANDARDS 
ISO TC215 & CEN/TC251 Health Informatics. 
(www.centc251.org)Used for the interchange of information between health care 
providers within Europe, and elsewhere around the world.  
 
Health Level Seven HL7 
(www.hl7.org/about/) 
Health Level Seven, the basis of an ISO standard, aims to provide standards for the 
exchange, management and integration of data that support clinical patient care and 
MRC POPULATION DATA ARCHIVING AND ACCESS PROJECT CONSULTANTS’ REPORT       DRAFT 2.0 
DRAFT ONLY -- DO NOT QUOTE WITHOUT PRIOR PERMISSION FROM THE AUTHORS  84 
the management, delivery and evaluation of healthcare services. It is widely used in 
US hospitals. HL7-sanctioned national groups also exist in Australia, Germany, 
Japan, the Netherlands and New Zealand. 
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APPENDIX 4: SECONDARY USAGE OF MEDICAL-RELATED DATA 
MEDICAL-RELATED DATA AT THE UK DATA ARCHIVE 
 
At present, datasets with medical-related content account for 319 (or around 7 per cent) of the 
UK Data Archive’s 4,500-strong collection. Of these 319 datasets, more than four-out-of-five 
(268) contain data on the health, lifestyle, behaviour or beliefs of respondents; around a third 
(97) contain epidemiological data; one-in-ten (34) deal with patient satisfaction; and just 3 
per cent (10) focus on trial data. In addition, around one-in-seven (44) are ‘general’ surveys 
(e.g. the General Household Survey) that include questions on health-related topics. 
 
 
Table 1: Medical-related Datasets and Usage (1993*-present) 
 
Type of data N studies N orders Ratio – 
orders: 
studies 
   
TRIAL DATA 10 3 0.3 
Epidemiological 97 1781 18.4 
HALS/behaviour/beliefs 268 3657 13.6 
Patient satisfaction 34 17 0.5 
General (inc. health) 44 1408 32.0 
   
Totals 319 3876  
 
* Usage can only be measured from 1993 onwards.  
Note: Columns do not add up due to some studies being allocated to more than one category (e.g. National 
Surveys of NHS Patients are categorised as both ‘HALS/behaviour/beliefs’ and ‘patient satisfaction’). 
 
 
Medical-related data and its usage 
 
Despite their relatively small representation in the Archive’s holdings, the 319 medical-
related datasets have, between them, been ordered more than 3,800 times over the past 
decade.   
 
In terms of the number of orders, usage has been concentrated on the 
HALS/behaviour/beliefs datasets (3,657 orders have included a dataset with HALS content), 
with epidemiological and general surveys also proving popular. In contrast, datasets with a 
patient satisfaction or trial data focus have been ordered only very occasionally (only 20 
orders in total). 
 
It is not clear whether the lack of interest in patient satisfaction and trial data indicates that 
there is little demand for this kind of data among researchers who use the UKDA, or whether 
low interest is a reflection of the fact that the Archive’s holdings are not extensive in these 
areas. In support of the former explanation, the ratio of orders to studies is very low for 
patient satisfaction and trial data – certainly in comparison to the same ratios for 
epidemiological, HALS or general data. However, in support of the latter explanation, it 
should be noted that much of the patient satisfaction and trial data dates back to the 1970s 
and is unlikely to be relevant to current researchers.    
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A contributing factor may also be the level of promotion and ease of accessibility of the 
datasets. Relatively few of these datasets are supported by specialist ‘major studies’ UKDA 
web pages, or are available via the Nesstar online analysis tools or Direct Download service. 
We know that when lesser-used datasets are made more readily available their usage does 
increase (e.g. comparing the nine months before and after the mounting of the ONS Omnibus 
surveys on Nesstar and via Download, usage increased by over 400%). 
 
 
MRC-funded data and its usage 
 
Datasets funded/sponsored by the MRC account for 8 per cent (25/319) of the Archive’s 
medical-related data holdings. The type of data deposited and the pattern of usage are very 
similar to the wider medical-related holdings. As is the case generally, almost all the MRC-
funded datasets have some HALS/behaviour/beliefs content (24/25). Much lower proportions 
of MRC-funded datasets contain epidemiological data (7/25), trial data (4/25) or patient 
satisfaction scores (1/25). 
 
 
Table 2: MRC-Funded Datasets and Usage (1993-present) 
 
Type of data N studies N orders Ratio – 
orders: 
studies 
   
TRIAL DATA 4 0 0.0 
Epidemiological 7 231 33.0 
HALS/behaviour/beliefs 24 336 14.0 
Patient satisfaction 1 1 1.0 
General (inc. health) 0 0 n/a 
   
Totals 25 336  
 
Note: Columns do not add up due to some studies being allocated to more than one category. 
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Table 3: Full Listing of Medical-Related Datasets and Usage 
 
UKDA 
SN/GN Title 
N 
studies
MRC-
funded
Trial 
data 
Epidemio
-logical
HALS/
behavi
our/ 
beliefs
Patient 
satis-
faction 
Gener
al (inc. 
health) 
N 
availab
le 
Nessta
r 
N 
available
Downloa
d 
Major 
studies 
pages 
N orders
  
4476Project SIGMA : Gay Men's Panel 
Study, 1987-1994  1 Yes 1 0
33326 National Surveys of NHS Patients, 
1998-  2 2 2 7
4449Quality of Life Among People Aged 
75 and Over in Great Britain, 1994-
1998  1 Yes 1 1 0
4442Alcohol and Suicide, Jews and 
Protestants, 1999-2000  1 1 0
43501918-1919 Influenza Pandemic 
Mortality in England and Wales  1 1 2
4127Decline of Infant Mortality in 
England and Wales, 1871-1948 : A 
Medical Conundrum; Vaccination 
Registers, 1871-1913  1 1 1
33090General Household Survey, 1971- 28 28 28 5 12 Yes 1342
33071National Food Survey, 1974-  26 26 56
33241Health and Lifestyle Survey  3 3 201
33261Health Survey for England, 1991-  10 10 10 2 9 Yes 445
4351Scottish Household Survey, 1999 
and 2000  1 1 1 1 37
33267Road Accident Data  10 10 58
33260Continuous Household Survey  15 15 15 28
33282OPCS/ONS Surveys of Psychiatric 
Morbidity  5 5 5 55
33004National Child Development Study, 
1958-  6 6 6 1 6 Yes 586
33275National Diet and Nutrition Surveys 3 Yes 3 101
4226Adult Dental Health Survey (ADH), 
1998  1 1 1 2
33308Scottish Migration and Emigration, 
1861-1911  3 3 2
33263Smoking, Drinking and Drug Use 
Among Young Teenagers  9 9 23
33302National Study of Health and 
Growth  3 3 1
4175Dietary Survey of Vegetarians in 
Great Britain, 1994-1995  1 1 5
33310Vital Statistics for England and 
Wales  18 18 78
4176Welsh Health Survey, 1998  1 1 1 1 6
33294Health Education Monitoring 
Survey (HEMS)  4 4 19
33307Teenage Smoking Attitudes 
Surveys  3 3 5
4118Southampton Ageing Project, 1977-
1998  1 1 0
33305Great Britain Historical Database 
Online, 1841-1939  10 10 27
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4109TAPS Study of Long-term Non-
demented Patients, 1985-1998  1 1 1 1 1
4090Disability Follow-up to the 1996/97 
Family Resources Survey  1 1 20
4093Digest of Welsh Historical 
Statistics: Population, 1570-1974 1 1 2
4005Management of Back Pain, 1996  1 1 1 0
3976Social Variations in Health in Early 
Old Age : Investigation of 
Precursors in a 60 Year Follow-Up 
Study, 1998  1 1 0
3831Nottingham Study of Food Choice 
in Later Life, 1994-1996  1 1 1
33320Scottish Health Surveys, 1995-  2 2 2 2 41
3903General Household Survey, 1994 : 
Follow-Up Survey of the Health of 
People Aged 65 and Over  1 1 1 19
33251Infant Feeding Survey  3 3 5
3569Income, Expenditure and Disability, 
1993  1 1 2
3808Young People's Involvement in 
Sport, March 1993 - October 1994 1 1 3
3779Physical Health of Prisoners, 1994 1 1 0
332291970 British Cohort Study (BCS70) 6 Yes 6 6 1 7 Yes 231
3759Infant Feeding in Asian Families, 
1994-1996; Waves 1-5  1 1 4
3641PPRU Surveys of Disability, 1989-
1990  1 1 1 3
3546Heights and Weights of British 
Schoolchildren, 1908-1950  1 1 3
3552Causes of Death in England and 
Wales, 1851-60 to 1891-1900 : The 
Decennial Supplements  1 1 17
3625Local Mortality Datapack : 
Population and Deaths by Cause, 
1979-1992  1 1 12
3554Young People and Sport in 
England, 1994  1 1 9
3469Northern Ireland Health and Activity 
Survey, 1994  1 1 1 0
33270Trent Health Lifestyle Survey  2 2 2
33280Population Based Computer 
Assisted Telephone Interviewing 
Survey of Lifestyles and Health  2 2 2
33272Cambridge Prenatal Screening 
Study  2 2 2 1
3464Expectations and Experiences of 
Childbirth, 1987  1 1 1 0
3434National Survey of Sexual Attitudes 
and Lifestyles, 1990  1 1 45
3303Allied Dunbar National Fitness 
Survey, 1990  1 1 27
3304Health Education Authority National 
Survey of Activity and Health, 1991 1 1 8
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3212Families of Teenagers with Down's 
Syndrome; Parent, Child and 
Sibling Adaptation, 1991  1 1 0
3150Scottish Heart Health Study, 1984-
1986 and the First Scottish 
MONICA Survey, 1986  1 1 1 3
3149Jewish Depression, 1991-1993  1 1 0
3108Anthropometric Data Relating to 
Working-Class Children, 1841  1 1 4
2987Living with AIDS : The Experience 
of Homosexual Men with HIV 
Infection Or AIDS, 1988-1989  1 1 0
2984Outpatients and their Doctors : A 
Study of Patients, Potential 
Patients, General Practitioners and 
Hospital Doctors, 1989  1 1 1 0
2985Life Before Death, 1987  1 Yes 1 1 1
2982Contraceptive Services and Recent 
Mothers, 1989  1 1 1
2943Family Expenditure Survey Follow-
up Survey of Disabled Adults, 
1986-1987  1 1 8
2902Historic Mortality and Population 
Data, 1901-1992  1 1 9
2861Coale Indices of Fertility and 
Nuptiality in Scotland, 1881-1911  1 1 0
2836Dietary and Nutritional Survey of 
British Adults, 1986-1987  1 1 1 123
2834Adult Dental Health, 1988  1 1 1 6
2738Substance Abuse and Perceptions 
of Risk : Young People's Attitudes 
to Personal Health, 1990  1 1 1
2713Young People's Leisure and 
Lifestyles in Modern Scotland, 1987 1 1 2
2708Census Enumerators' Books : Four 
Rural Areas, 1851-1881  1 1 8
2693Survey of Family Planning Services 
in Scotland, April - July, 1982  1 1 1 2
2658Care for Elderly People at Home, 
1989  1 1 1
2657Schoolchildren's Dietary Survey, 
1983  1 1 14
33214OPCS Surveys of Disability in 
Great Britain  4 4 4 56
2592Census Enumerators' Books, 
Keighley, West Yorkshire, 1851-
1881  1 1 6
2552More Trouble with Feet : a Survey 
of the Feet Problems and 
Chiropody Needs of the Elderly, 
1985 1 1 1 0
2529Impact of Life Events on Heroin, 
Alcohol and Tobacco Use, 1985-
1986  1 1 2
2503Focus on Health Care : Surveying 
the Public in Four Health Districts, 
1987  1 1 1 3
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2445Diet in the Home, 1969  1 1 0
2316Transition to Parenthood, 1979-
1981  1 1 2
2310Survey of Smoking Attitudes and 
Behaviour, 1981  1 1 1
2312Wessex Survey of Marathon 
Runners, 1984-1985  1 1 1
2308AIDS Advertising Evaluation, 1986-
1987  1 1 1
2264Disability in Adolescence, 1977-
1979 : the Psychological and Social 
Problems of Teenagers with 
Cerebral Palsy and Spina Bifida 
with Hydrocephalus  1 1 0
2174Elderly and Their Medicines, 1984 1 1 1
2216Health Evaluations, 1984-1985  1 1 6
2175Teenage Mothers and Their 
Partners, 1979-1980  1 1 1
2126Handicapped and Impaired in Great 
Britain, 1968-1969  1 1 1 0
2097Factors Mediating the Effects of 
Unemployment on Health, 1982-
1984  1 1 0
33178Long-Term Changes in Nutrition, 
Welfare and Productivity in Britain  4 4 4 12
2100Richmond Fellowship of Australia, 
1983  1 1 1 0
2137Perinatal Mortality Survey, 1958  1 1 22
2087Alternative Medicine, 1984  1 1 1 2
2032Visually Handicapped in the City of 
Nottingham 1 Yes 1 0
2026Social and Psychological 
Consequences of Unemployment in 
Young People, 1982-1983  1 Yes 1 0
2046National Heights and Weights 
Survey, 1980  1 1 20
2053Caring for the Health of Young 
Children, 1982  1 1 0
1900Family Formation Survey, 1976  1 1 1 3
1903Hearing and Vision Screening in 
Pre-School Children  1 1 1 0
1943Pedestrian Accidents  1 1 0
1786Life After a Death : a Study of the 
Elderly Widowed 1 1 1
1818Survey of Residents of Two 
Therapeutic Communities for 
Former Drug Users, 1973  1 1 1
1824Towards the Rationalisation of Pre-
Employment Health Assessments, 
1971-1978  1 1 0
1587Norfolk Health Care Survey, 1980  1 1 1 0
1687Rethinking General Practice : 
Dilemmas in Primary Medical Care 1 1 1 0
1169Life Stress, Symptomatology and 
First Year Examination 
Performance in Overseas Students 1 1 1
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1171Studies Using the Nottingham 
Health Index, 1976-1977  1 1 0
1263Experiences of Childbearing : the 
Dignity of Labour?  1 1 1 0
1266Psychological Adjustment of 
Immigrants  1 1 1 1
1278Changes in the Structure of 
General Practice : the Patient's 
Viewpoint 1 1 1 0
1317Young People's Knowledge of Sex 
and Birth Control  1 1 1
1410Aircraft Noise and Prevalence of 
Psychiatric Disorders, 1977  1 Yes 1 1 0
1427WHO/ICS Medical Care Utilization 
Study Data, 1968-1969  1 1 1 0
1493Hospitalised Children in Swansea  1 1 1 0
1650Attitudes to the National Health 
Service  1 1 0
33127Socio-Psychiatric Survey on 
Distribution and Aetiology of 
Psychiatric Disorder, 1969-1976  2 Yes 2 2 0
33162Surveys on Smoking, 1976  5 5 0
961School Child Chest Health Survey, 
1966  1 1 1 0
962Patients and Their Doctors in 1977 1 1 1 0
965Measurement of Psychological 
Disturbance in Asian Immigrants  1 1 0
1005Transport Services in General 
Practice  1 1 1 1 0
71007Consumers' Association Survey: 
Maternity Services, 1981 1 1 0
33053Patients and Their Doctors, 1964  10 10 10 0
33038Child Development Research Unit 
Longitudinal Study  6 Yes 6 3
808Longitudinal Study of Child 
Development  1 Yes 1 0
526Family Planning in Trinidad : the 
Problem of Discontinuation  1 1 0
362Survey of Old People in Telford  1 1 0
392Trouble with Feet  1 1 1 0
396Study of Family Size and Family 
Spacing, 1973  1 1 0
399Problems of Hospital 
Communication : An Experimental 
Study, 1964; Stage I  1 1 1 0
1470Personal Injury Survey, 1966-1973 1 1 0
33085Birth Control Services, 1970  5 5 0
718Southampton Health Centre Study, 
1973  1 1 1 0
393Life Before Death, 1969  1 1 1
114MRC 83 County Boroughs Study, 
1948-1973  1 Yes 1 0
33054Survey of Abortion Patients for the 
Committee on the Working of the 
Abortion Act, 1972  3 3 0
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 Totals (studies/orders) 319 10/3 97/1781
268/36
57 34/17
44/140
8 3876
 
 
 
 
 
Table 4: MRC-Funded Datasets and Usage 
 
UKDA 
SN/GN Title 
N 
studies
MRC-
funded
Trial 
data 
Epid
emio
logic
al 
HALS/
behavi
our/ 
beliefs
Patien
t satis-
faction
Gener
al (inc. 
health) 
N 
availabl
e 
Nesstar 
N 
available 
Downloa
d 
Major 
studies 
pages 
N orders 
  
4476Project SIGMA : Gay Men's Panel 
Study, 1987-1994  1 Yes 1 0
4449Quality of Life Among People Aged 
75 and Over in Great Britain, 1994-
1998  1 Yes 1 1 0
33275National Diet and Nutrition Surveys 3 Yes 3 101
332291970 British Cohort Study (BCS70) 6 Yes 6 6 1 7 Yes 231
2985Life Before Death, 1987  1 Yes 1 1 1
2032Visually Handicapped in the City of 
Nottingham 1 Yes 1 0
2026Social and Psychological 
Consequences of Unemployment in 
Young People, 1982-1983  1 Yes 1 0
1410Aircraft Noise and Prevalence of 
Psychiatric Disorders, 1977  1 Yes 1 1 0
33127Socio-Psychiatric Survey on 
Distribution and Aetiology of 
Psychiatric Disorder, 1969-1976  2 Yes 2 2 0
33038Child Development Research Unit 
Longitudinal Study  6 Yes 6 3
808Longitudinal Study of Child 
Development  1 Yes 1 0
114MRC 83 County Boroughs Study, 
1948-1973  1 Yes 1 0
  
 Totals (studies/orders) 25 4/0
7/23
1 24/336 1/1 0/0 336
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APPENDIX 5: DATA ARCHIVING & ACCESS: CASE STUDY TOOL 
 
ADMINISTRATIVE INFORMATION 
Contact:  
Address:  
Tel:  
Email  
website:  
etc. 
 
QUESTIONS FOR THE PRINCIPAL INVESTIGATOR(S) 
OVERALL ACTIVITY 
1. How many data sets is the Unit / project managing in total? 
2. How many are closed to new accrual of data? 
RESOURCES 
3. Brief funding history 
SCIENTIFIC VALUE AND POTENTIAL FOR NEW RESEARCH 
4. What are the overall scientific objectives for which this dataset has been assembled?  
5. What other evidence have you of the value put on the study / dataset by external users 
e.g. peer review of the research or publications?  Have your research 
techniques/instruments/scales that relate to this study been adopted 
elsewhere/published?  
6. In what way is the study unique? PROBE:  its objectives, methodology, scale, study 
population, measures…?) 
7. What other studies are there with which this dataset could be compared or pooled (e.g. 
through formal meta-analysis)? 
8. What is the expected "lifetime" of active research by the PI and his/her team on these 
data?  What is the expected "lifetime" of the data in terms of their utility for 
secondary research? 
9. Do you see any particular issues concerning re-use after a PI has retired or funding 
has come to an end?  Have you a successor custodian in mind? 
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10. What valuable research questions might such pooling / mining address, either in terms 
of improving the questions the data-set is currently designed to address, or – 
potentially – new questions?  
ACCESS 
11. What were the terms of the consent with study participants?  PROBE: Study team 
require copies of up-to-date sample consent forms and patient information 
12. What would be involved in anonymising (unlinked) these data?  If all identifying 
characteristics were removed, would the remaining data be useful for secondary 
analysis? 
13. What, if any, would be any barriers be to further exploitation of the dataset by a 
secondary analyst?  PROBE: cost, data completeness, data ownership/intellectual 
property/copyright, data quality, consent/confidentiality issues 
14. How widely known is your dataset? PROBE: What is the audience for information 
about the research – own or wider research communities, policy makers, 
practitioners… and how do people find out about your dataset?  PROBE: Research 
literature, Web site, the media, active promotion e.g. through a Data Archive 
15. What scale is the access by new collaborators / others to the data-set (how often / how 
much…?)  What is the nature of their requests?  How many requests do you receive?  
And how many do you accept [standardise – over the past 12 months / 2 years?]. 
16. What motivates you to accept new collaborations / new uses?  PROBE how much do 
you consider their proficiency/ability to use the data? 
17. What motivates you not to accept new collaborations / new uses? 
18. What methods of access control would you favour/do you see as necessary for this 
collection? PROBE: vetting by PI; 'guided' access by team; ethics committee 
review 
19. Do you have formal criteria and processes to decide whether or not to collaborate / 
give access?  If so, what are they? If no, what are your informal criteria and processes 
to decide whether or not to collaborate / give access? PROBE: Is there independent 
involvement?  Is there representation from the participants? 
OWNERSHIP 
20. Who, in your opinion, owns the dataset – and what do you mean by ownership? What 
rights and responsibilities do you consider that you (as the PI) have over the use of the 
data now and it the future? Particularly with respect to: 
• Archiving the data (to what kinds of level / quality) 
• Ensuring wider use by the scientific / policy community? 
• Ensuring commercial exploitation opportunities are identified and managed? 
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21. What rights and responsibilities rights do you consider your employer or funder or 
have?  
22. Is this codified as an explicit institutional agreement or policy? (If so, what?) 
23. Are any other funders likely to have a proprietorial interest? If so, what particular 
issues might this raise with respect to archiving /re-use? PROBE: 
ownership/copyright/ability to agree 
24. Do you make any formal written agreements with your collaborators and any 
independent new users about ownership, further use and new use? 
25. Do these data contain or incorporate data created elsewhere (e.g. quality of life or 
nutrition scales, international classifications, look-up tables) for which intellectual 
property resides outside the research team?   
26. What about derived data created by your researchers in the course of their analyses – 
where does the copyright and intellectual property in these derived data resources lie? 
27. For this project, what is your Centre/Unit's ability to meet the demands of the MRC 
Good Clinical Practice Guidelines (20 years for data; 10 years for lab data)? 
GENERAL 
28. How are the case studies typical of the whole range of Unit datasets? 
29. What advantages could you see an MRC data archive/data dissemination service 
offering you as an active researcher?  PROBE: good practice, usability for successors. 
relevance of a dissemination service 
30. Are there any datasets out there not under your control that you would like to be able 
to access for your own research?   
31. How useful would you consider a national register of research instruments to be? 
32. Do you feel you would welcome assistance/advice on data preservation standards and 
practices?  Would you use an advisory service or published guidelines to enable you 
to preserve your own data? Would you use a service that actually preserved data for 
you? 
33. Are you aware of any international developments in the field of preservation/sharing 
of biomedical/health/social sciences data? 
 
 
MRC POPULATION DATA ARCHIVING AND ACCESS PROJECT CONSULTANTS’ REPORT       DRAFT 2.0 
DRAFT ONLY -- DO NOT QUOTE WITHOUT PRIOR PERMISSION FROM THE AUTHORS  96 
QUESTIONS FOR THE PROJECT MANAGER(S) 
QUALITATIVE INFORMATION – SCIENCE  
34. Study Title 
35. Acronym 
36. Summary of study aims 
37. Duration of study  
38. Start date [1st accrual of data] 
39. Methodology (we have a typology from the Phase 1). 
40. Study Location 
SAMPLE 
41. Study population: 
42. Sampling frame 
43. Number of cohorts  
44. Sample size of cohort  
45. Major topics covered 
46. Data sources utilised?  PROBE: medical records, school records, other ancillary or 
related information in addition to data directly created by research team 
HUMAN BIOLOGICAL SAMPLES 
47. Have you established/are you establishing a collection of human biological samples in 
this study? 
48. If yes, what are: a) the current numbers sampled? and b) the anticipated final 
numbers? 
49. Where is the collection held? 
50. What data are held on the samples? How are they held and maintained? (What 
information is known about the sample donors, including relevant personal and family 
data, or health or treatment information (including confirmation of diagnosis)?  
Include intellectual property - i.e. data you may have derived from your work with 
these samples. 
51. Can genetic information be derived from the samples? 
52. Where is this genetic information held? 
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53. Which organisation do you consider is the custodian of the collection? 
The custodian organisation has responsibility for safekeeping of samples and control of 
their use and eventual disposal in accordance with the terms of consent given by the 
donor.   
54. Is this organisation also considered to be the ‘owner’ of the data held on the samples? 
55. Have you had any applications to access the collection?  If so, how are these requests 
dealt with? 
 
RESOURCES 
56. Staff (FTEs) directly employed by the project in what kinds of capacities? PROBE: 
scientists, research assistants, IT people, data people.  If Unit has closed, how many 
staff were employed?  
57. How long have these people been involved with the project?  With the institution? If 
closed, how long were the staff involved with the project? 
58. Staff directly or indirectly supporting the work of the project in what kinds of 
capacities?  PROBE: computer services, IT consultants, University infrastructure, 
warehouses  
59. Any staff with formal experience or training in data preservation / archiving / records 
management? 
PHYSICAL STORAGE 
60. How are the data currently stored?  PROBE: Paper, electronic data; audio-visual 
materials 
61. Volume measure 
62. Rate of increase. 
63. Location and Contractors 
64. Cost measure, of storage and retrieval costs for data stored offsite pa? 
65. What security measures are in place for protecting the integrity of digital data? 
 PROBE: back-up media and procedures, version control, access control for 
multi-researcher teams, system security?  PROBE: Physical security : firesafes, 
climate control, offsite backups 
 
66. What security measures are in place for non-digital (e.g. paper and analogue image or 
sound) data  PROBE:  fireproof cabinetry, acid-free paper, climate control, locks 
and access control, etc? 
 
 
67. In terms of the current facilities you have for paper storage, how adequate do you 
think they are? PROBE: have you ever applied for specific funding for storage?  
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68. If data were originally collected in structured or unstructured paper-based formats, 
how often is recourse made to the paper/audio materials? For what purposes? 
 
69. How useful would you find it to have paper-based data held in electronic format? e.g. 
PDF  
 
70. How are interviewer manuals/training guides/rating notes stored and in what format? 
Are these used for training /promotional purposes beyond the scope of this project? 
Are they formally published at all? 
GENERAL 
71. What advantages could you see an MRC data archive/data dissemination service 
offering you as a project manager?   
72. Are there any datasets out there not under your control that you would like to be able 
to access for the project?   
73. How useful would you consider a national register of research instruments to be? 
74. Do you feel you would welcome assistance/advice on data preservation standards and 
practices?  Would you use an advisory service or published guidelines to enable you 
to preserve your own data? Would you use a service that actually preserved data for 
you? 
75. Are you aware of any international developments in the field of preservation/sharing 
of biomedical/health/social sciences data? 
 
 
QUESTIONS FOR DATA MANAGER(S) 
DATA ARCHIVING 
Data digitisation issues: 
76. If data were collected in structured paper-based formats, what proportion have been 
made digital (e.g. data entered into a computer file)?  What software was used to enter 
the data, and what formats/platforms/media are they stored in?  How often is recourse 
made to the paper/audio materials? For what purposes? 
 
77. If data were collected in unstructured paper-based formats, what proportion have been 
made digital and by what method (e.g. coded after the fact, verbatim copy-typing, 
scanning of papers)? What software was used to enter the data, and what 
formats/platforms/media are they stored in? How often is recourse made to the paper?  
For what purposes? 
 
78. If data are audio, visual, or moving images, what proportion have been made digital 
and by what method? What software was used to digitise the data, and what 
formats/platforms/media are they stored in? How often is recourse made to the 
original tape/images?  For what purposes? 
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79. If the data were collected in digital formats originally, what software was used to 
collect the data, and what formats/platforms/media are they stored in? 
 
80. What software formats and platforms are used to analyse the data in house? 
 
Version control issues: 
81. For open datasets, how are subsequent data accruals added to the existing (digital) 
dataset?   
 
82. For multi-researcher teams:  is there a single definitive digital version of the data, or 
do separate researchers on the teams have their own "massaged" versions?  Are these 
versions saved?  Are the relationships among the different versions documented? 
 
83. In the course of data analyses by the research team, are derived data created, and are 
these saved? Are the methods of their derivation recorded in a fashion useful to a 
secondary analyst?   
 
 
Metadata: information about data 
84. Is there a catalogue or register of the contents of paper files or analogue audio/image 
collections?  What form does this take and how is it maintained? 
85. Is there a catalogue or register of the contents of digital files?  What form does this 
take and how is it maintained?  PROBE: Are there formal ‘codebooks’ or ‘data 
dictionaries’ kept? 
86. Are study instruments (e.g. questionnaire pro-formas, interviewers guides/manuals, 
etc) kept for data, and if so in what form? Are coding frames described? 
87. Are protocols and methods for clinical or laboratory measurements recorded, and if so 
how? 
88. Are these publicly available, and if so in what form? 
89. Are there publications in the public domain based on the data?  What form do these 
take?    Is there a publicly available catalogue or register of these publications; how is 
it maintained and accessed? 
90. How accessible are your study instruments and data collections tools to the wider 
research communities?  PROBE:  published in manuals; widely circulated, well 
known; patented 
91. Would you see value in producing a web based register of study instruments? 
Personnel 
92. Who is responsible for maintaining the original (non digital) data?  Who is 
responsible for maintaining the digital data?  What is their experience or training, if 
any, in preservation / migration / archiving / records management? 
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QUANTITATIVE INFORMATION – INDIVIDUAL DATA-SET 
93. Numbers of variables? 
94. What proportion of the digital data are coded (labelled) variables (e.g. survey 
responses, etc)? 
95. What proportion of the digital data are real numbers / measurements? 
96. What proportion of the digital data is uncoded textual (free text)? 
97. Are there any date/time variables or physical measurements? 
 
GENERAL 
98. What advantages could you see an MRC data archive/data dissemination service 
offering you as a data manager?   
99. Do you feel you would welcome assistance/advice on data preservation standards and 
practices?  Would you use an advisory service or published guidelines to enable you 
to preserve your own data? Would you use a service that actually preserved data for 
you? 
100. How useful would you consider a national register of research instruments to 
be? 
101. Are you aware of any international developments in the field of 
preservation/sharing of biomedical/health/social sciences data? 
 
 
QUESTIONS FOR LAB MANAGER(S) 
 
HUMAN BIOLOGICAL SAMPLES 
102. Have you established/are you establishing a collection of human biological 
samples in this study? (e.g. DNA, Blood samples) 
103. If yes, what are: a) the current numbers sampled? and b) the anticipated final 
numbers? 
104. Cost measure, pa. 
105. In terms of the lab storage facilities, how adequate do you think they are?
 PROBE: have you ever applied for specific funding for storage?  
106. What data are held on the samples? How are they held and maintained? What 
information is known about the sample donors, including relevant personal and family 
data, or health or treatment information (including confirmation of diagnosis)?  
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Include intellectual property - i.e. data you may have derived from your work with 
these samples. Where is the linking information between the samples and data stored? 
107. Can genetic information be derived from the samples? Where is this genetic 
information held? 
108. What security measures are in place for data held on the samples? PROBE: 
access control etc? 
109. What security measures are in place for protecting the integrity of digital data? 
 PROBE: back-up media and procedures, version control, access control for 
multi-researcher teams, system security?  PROBE: Physical security : firesafes, 
climate control, offsite backups 
110. Which organisation do you consider is the custodian of the collection? (The 
custodian organisation has responsibility for safekeeping of samples and control of 
their use and eventual disposal in accordance with the terms of consent given by the 
donor).   
111. Is this organisation also considered to be the ‘owner’ of the data held on the 
samples? 
112. Have you had any applications to access the collection?  If so, how are these 
requests dealt with? 
113. Are you aware of any international developments in the field of 
preservation/sharing of biomedical/health/social sciences data? 
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APPENDIX 6: GOOD PRACTICE IN MANAGING DATA FOR SHARING AND 
PRESERVATION 
 
LIFECYCLE APPROACH TO DATASET MANAGEMENT 
Sharing and Preserving Datasets 
 
Access to the information contained in a digital dataset is dependent on a constantly shifting 
landscape of hardware and software. Datasets can only be used when appropriate hardware 
and software are available to read and present the data. Equally, datasets will only remain 
useful if the expertise and knowledge needed to interpret and manipulate the dataset is 
available. Thus it is important not to view sharing and preserving datasets as a purely 
technical challenge. 
 
To share or preserve a dataset, it must contain adequate documentation, be technically 
compatible, and have appropriate provisions for ensuring the authenticity of the data and 
managing access to the data. A comprehensive data management strategy must consider these 
issues at all stages in the lifecycle of a dataset (Figure 1), from its creation right through to its 
eventual long-term preservation and re-use, or destruction (for legitimate reasons). Choices 
made during the creation of a dataset are particularly important, as poor decisions made at 
this stage can limit the usefulness of a dataset throughout its life. 
 
 
creation
planning
data entry
data cleaning
initial use
analysis
derived data
collaboration
re-use
secondary
analysis
Destruction
preservation
storage
migration
 
 
Fig 1. Lifecycle of a Dataset 
 
Documentation 
Comprehensive documentation is vital if datasets are to be shared and preserved as useable 
resources, but many datasets are not properly documented. Publications arising from a dataset 
may not provide all the necessary documentation to fully understand a dataset. 
Documentation includes items such as field notes, codebooks, research reports, data entry 
instructions, notes on data manipulation (scaling, weighting, aggregation and other 
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operations), survey instructions, questionnaires, interview prompts and any other material 
which informs the use of the data. 
 
Documentation should be written as the dataset is created and developed. The departure of a 
key member of staff can mean the loss of vital knowledge about a dataset if the task of 
documenting is left until after the work is completed. Indeed, each time an individual or 
group ceases to be involved with a dataset, there is a danger that information critical to 
making informed use of the dataset may be lost. For example, information about problems 
with the wording of questions that may affect the trustworthiness of the answers may be lost 
if those conducting survey/interviews or collating information are not involved in later stages 
of the project. 
 
Technical compatibility 
Ensuring technical compatibility or, more pragmatically, minimising technical 
incompatibility should be given a particularly high priority during the creation of a dataset. 
Technical incompatibility is often caused by the unnecessary use of multiple data formats, or 
through the use of unusual software functionality. When more than one data format is used, 
the data must be frequently exported from one software package to another, an operation that 
often generates subtle changes/errors in the data. Similarly, the use of incompatible operating 
systems and hardware creates the need to constantly move data between different computer 
systems, which can also introduce errors into the data. 
  
More significant is the problem posed by complex datasets that make use of software - or 
possibly hardware - specific functionality.  These datasets can be difficult to share or preserve 
because they are dependent on a specific piece of software that may be expensive to 
purchase, require unusual expertise to operate, or will not run on all common operating 
systems.  
 
Authenticity and access 
The great ease with which digital data can be altered without trace lies behind the importance 
of implementing policies that can guarantee the authenticity of a dataset. A variety of 
technical procedures, such as digital signatures or recording unique file characteristics can be 
used to assist in demonstrating the authenticity of a dataset, but the basis for demonstrating 
authenticity is maintaining a clear record of how a dataset has been created and altered, who 
did the work and why. 
 
Digital preservation strategies 
Many issues involved in preserving data are similar to the issues involved in sharing data. 
However, the volatile nature of digital technologies generates additional problems for the 
long-term preservation of datasets. The conversion of digital data into meaningful 
information is dependent on the continuing availability of the digital technologies - the 
computer hardware, software, and the format specifications that hardware and software rely 
on - used to create the digital data. The rapid pace of change in computer technology means 
that these technologies can go from new to obsolete in a matter of years, quickly rendering 
datasets inaccessible.  
 
Any digital preservation strategy must therefore focus primarily on avoiding technological 
obsolescence. Two main approaches to avoiding technological obsolescence have been 
proposed: migration and emulation. 
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Migration is the process of converting information held in an obsolescent data format into a 
newer format. Data is preserved into the future by migrating it to a new data format with each 
new generation of software. Selecting open and well-used data formats should reduce the 
frequency of migration. 
 
Alternatively, instead of changing the data to fit the computer, it may be possible to change 
the computer to fit the data by emulating the original hardware environment on a modern 
computer. 
 
Migration is the most commonly adopted strategy for digital preservation at the moment. This 
is primarily because, unlike emulation, migration can be conducted without full access to the 
specifications of files, software and hardware, and it does not require the same level of 
software development work. The main danger of migration is that information may be lost 
during each migration exercise. Emulation has only been tested in very limited contexts. It 
relies on the creation of complex and accurate emulators. It is accepted as likely to be 
appropriate in some situations where data is especially dependent on specific hardware or 
software, but its wider feasibility is still a matter of debate. 
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RECOMMENDATIONS FOR TECHNICAL COMPATIBILITY 
 
Backup 
 
The media used to store digital data are fragile but easy to copy. To reduce the risk of damage 
or loss of data, all digital data should therefore be backed up. A good backup procedure will 
protect against a range of mishaps such as: accidental changes to data; accidental deletion of 
data; loss of data due to media or software faults; virus infections; hackers; catastrophic 
events (such as fire or flood). 
 
Frequency of backup 
The more frequently data are changed, the more frequently they should be backed up. Data 
that are changing significantly every day should be backed up every day. If frequent data 
backup is required, this process should be automated to reduce the burden on resources. 
 
Rolling backup copies 
Earlier backup copies should not be immediately discarded when a new backup is made. 
Backup copies made at several points of time, over a period of at least three months, should 
be kept as this will reduce the risk of incorporating recent, but as yet undetected, problems in 
all backup copies. 
 
Off-site backup copies 
At least one backup copy should be held off-site to ensure that a disaster, such as a fire in the 
office, will not destroy all copies of the data. Off-site is a relative term and the location of 
off-site copies should reflect the level of protection needed. Datasets of short-term, project-
specific significance might be stored in another building at the same institution. Backups of 
datasets of national and long-term significance should be stored elsewhere in the country 
 
It is also useful to keep a backup copy on-site. An on-site backup copy can be quickly 
retrieved and work recommenced if there is a minor mishap, such as the accidental deletion 
of an important file. 
 
Institutional backup policy 
When a project relies in part, or in whole on an institutional backup system, then project staff 
should ensure that the institution's policies will be appropriate to their needs: 
 
• institutions may maintain backups for a limited period; 
• institutions may, intentionally or unintentionally, not backup all data on their network; 
• institutions may not restore individual users’ files. 
 
Independent backups of critical data should always be maintained. 
  
Validate backup copies! 
A backup that does not actually work is of no use at all. Backup copies should be tested to 
ensure all data has been successfully saved and can be retrieved. 
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Recommended choice of backup media 
All copies of data should be held on new media. Do not continue to use media once they start 
to develop faults. The primary storage medium for the preservation of digital data is tape, but 
CD-R is often used for short-to-medium term backup and as an ease-of-use alternative to the 
primary storage media. Floppy disks should not be used for backup or preservation of data. 
DVD is not yet recommended for preservation, as its viable lifespan is still uncertain. 
 
For additional risk reduction, use media from different batches and write media using 
different drives in order to avoid replicating faults caused by a faulty production batch or 
drive. 
 
Refresh media 
Because the media used to store digital data are fragile and can degrade quickly it is good 
practice to ‘refresh’ data regularly by transferring it from old media to new media. 
 
Storage conditions for physical media 
Media should be stored according to the manufacturer’s recommendations for temperature, 
humidity, light levels and other factors, to ensure the recommended conditions are constantly 
maintained. 
 
Checksums 
Data backup and media refreshment both involve copying data. Checksums1 should be used 
to ensure that data have been copied successfully. When media are placed in storage, 
checksums should be stored with the data (as a separate file), and another copy of the 
checksums should be kept separately. 
 
Data Formats 
 
To make sharing and preserving data easier, data should, ideally, be stored in formats that are 
software independent, non-proprietary and widely supported. 
 
Use non-proprietary standards 
Data formats can be grouped into three broad categories relevant to the issues of sharing and 
preserving datasets. 
 
• Proprietary standards - formats such as Microsoft Word that are owned by a company 
and not made generally available. Data held in these formats can only be accessed 
through software that has been licensed to read the format. 
• Available standards - the specification of some proprietary standards, such as 
Microsoft Rich Text Format (RTF) and Adobe Portable Document Format (PDF) are 
made available to other software developers and the general public. Available 
standards are still proprietary and restrictions may be placed on their use in the future. 
• Open standards - standards created by a co-operative group that are then made freely 
available to anybody to use without restriction. 
 
                                                 
1 A checksum is a numerical calculation, based on the bits in a file, that is calculated before and after data is 
copied. A difference between the checksums indicates that an error has occurred. Checksums are a way of 
verifying that data has been copied successfully. 
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Open formats should be used whenever possible. Available formats, such as Microsoft RTF 
and Adobe PDF should be considered next. Proprietary formats should only be considered as 
a last resort. 
 
Use widely supported formats 
Preference should be given to widely supported data formats because these are more easily 
shared and less likely to become obsolete unexpectedly. 
 
Careful consideration should be given to the adoption of open standards, some of which may 
not be adequately supported by available software. 
 
Avoid specialist proprietary formats 
Reliance on specialist proprietary formats should be avoided as this commits a project to 
using one set of software products, even if better options emerge, or the software company 
ceases to support the software. 
 
Select software independent formats 
Select data formats that can be read by more than one software package, and preferably more 
than one type of software package (word processor, statistical package, spreadsheet, 
database). Simple plain text, delimited text and, increasingly, marked-up text formats often 
meet these requirements. For example, many different software packages can import and 
export delimited text, making it a useful format for storing and exchanging data. 
 
Record file format details 
Details of the version of software used to create or modify data should be recorded. It is also 
useful to record details of versions of software used to read files. 
 
Validate data export between formats 
Data may be exported for use in different software, to be shared with researchers using 
different hardware and software, or to store the data in more stable formats suitable for long-
term preservation (these are not necessarily the formats most convenient for analysis).  
 
Whenever data is exported from one format to another, checks should be made to verify that 
the export has not altered the information content of the dataset. Examples of potential 
problems to check are: 
 
• rounding of numeric values; 
• truncation of textual values; 
• numeric values that exceed allowable range; 
• mismatched colour palettes in images; 
• non-supported code pages or glyphs2 in text. 
 
Data should be exported by data managers or other project staff familiar with the data as they 
are best placed to spot any errors or inadvertent changes to the data that may occur in the 
export process. 
 
                                                 
2 A glyph is the symbol used to indicate a character in an alphabet. For example, the glyph for the character 
DOLLAR SIGN is “$” 
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Suggested data formats 
 
Data Type Suggested Preservation 
Format 
Suggested Format for 
Sharing 
tabular data tab delimited text text-based formats such as 
SPSS portable 
image data PNG or TIFF PNG or TIFF except for 
large images delivered 
online where JPEG is 
appropriate 
qualitative data XML marked-up text 
according to an 
appropriate DTD or 
schema 
software specific formats 
such as NUD*IST or plain 
text 
documentation plain text or XML marked-
up text according to an 
appropriate DTD or 
schema (e.g. XHMTL 1.0) 
RTF or PDF 
 
All text should be encoded as ASCII or UNICODE. When data may contain non-ASCII 
characters (generally, any non-Latin characters) it should always be encoded as UNICODE. 
Note that newer versions of software are likely to use UNICODE by default. Note that XML 
requires the use of UNICODE. 
 
Data Capture from Hardcopy 
 
When data is captured from hardcopy originals, such as survey forms, it is important to 
minimise the introduction of errors into the digital data due to the data capture process.  
 
Scanning 
Hardcopy documentation should be scanned at a resolution and colour depth that creates a 
legible image. Black and white (1 bit) page images at a resolution of 200dpi are adequate for 
plain typed documents. Higher resolution grey scale images are likely to be more suitable for 
handwritten material. Full colour (24 bit or higher) images at 600dpi should be considered for 
documents that include fine detail, such as photographs or diagrams. 
 
Optical Character Recognition 
Output from Optical Character Recognition (OCR) software of less than about 95% accuracy 
should not be accepted. Output should be proof-read against the hardcopy. 
 
Keyboard data entry 
Ideally, keyboard data entry should be double-keyed (all data entered by two individuals and 
then compared for differences). As a minimum, a random sample of data entry should be 
proof-read against the hardcopy. 
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RECOMMENDATIONS FOR AUTHENTICITY AND ACCESS 
 
Digital data can be copied, altered or deleted very easily, and this makes it very important to 
be able to demonstrate the authenticity of data, and to prevent unauthorised access to data for 
ethical, legal and quality reasons 
 
Master Files 
 
Assign responsibility for master files 
Responsibility for maintaining the master versions of all material (digital and hardcopy) 
should be clearly assigned to individual members of the project team. 
 
Restrict write access to master versions 
Because digital data is very easy to duplicate or alter, it is particularly important to ensure 
that access to the data is restricted to authorised individuals. Write access (i.e. the ability to 
alter the data) to the master files for a dataset should be restricted to the member(s) of the 
project team with responsibility for the master files. 
 
Formalise destroying master files 
A formal procedure should be drawn up to ensure that master files are not accidentally or 
prematurely deleted. The procedure should establish that the file is not in current use, has not 
been referred to in a published work, does not have potential for re-use, is not used to 
generate other files that are still in use and does not need to be maintained for administrative, 
ethical or legal reasons. 
 
Record changes to master files 
A log recording all changes to the master files should be maintained. The log should include, 
at a minimum, the time, date, and person responsible for all changes to master files. 
 
Maintain old master files 
To guard against accidental alteration or deletion of master files, old versions of master files 
should be maintained after they have been superseded, unless this is legally or ethically 
impossible. 
 
Version Control 
 
Uniquely identify files 
Each file within a dataset should be uniquely identified. A formal procedure should be 
written to govern the assignment of names to ensure that they remain unique. 
 
Files that are made available outside the project team (e.g. as references in publications, or as 
files sent to collaborators) should be identified using a persistent name, such as a URN 
(Uniform Resource Name), to ensure that the information can be found irrespective of its 
current or future location. 
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Record version and status 
The status (e.g. ‘draft’, ‘interim’, ‘final’, ‘internal’ etc.) and version, either as part of their 
unique name, or within their content, should be recorded. 
 
Record relationships between items 
In many cases the information contained in a single file is supported by information held in 
other files.  
 
• A delimited text data file may be used in conjunction with an SPSS setup file, 
specifying variable formats, labels etc., and may also be supported by a descriptive 
user guide which explains how variables were collected and collated. 
• The paper questionnaire that provided the raw data for each record in the dataset 
should be easily traceable from the data file. 
 
Whenever a change is made to a file (either its content or its file format), a check should be 
made to ensure no other files are affected. 
 
Track the location of all items 
If digital or hardcopy items are kept in more than one location then a list, index or other 
finding aid should be maintained to ensure that all relevant material can be easily located. 
 
 
Legal Rights and Responsibilities 
 
Rights of respondents 
Survey, interview, and other forms of information collected about individuals must be 
accompanied by clear documentation indicating the conditions under which respondents 
agreed to allow the data to be used. 
 
User licences 
Formal agreements should be made with any collaborators or other users outside the project 
team specifying the data they may use, the purposes they may use it for and the period they 
may keep the data for. 
 
Legal mandate 
At the extreme, there may be a need to ensure the legal admissibility and evidential weight of 
information stored digitally. The British Standards Institute has produced a code of good 
practice on these matters (Legal Admissibility and Evidential Weight of Information Stored 
Electronically, DISC PD 0009:1999). 
 
Computer Security 
 
Network security 
Access to project files should be restricted to approved individuals through the use of user 
accounts and passwords. Additional restrictions can be applied, if necessary, by assigning 
directory and file level access restrictions. 
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A member of the project staff should be responsible for ensuring that the list of individuals 
allowed access to the dataset remains up-to-date. 
 
MRC units that store data on networks managed by other organisations should be aware that 
many networks are insecure. Confidential data should not be stored on servers that host 
internet services (web or email). Especially sensitive material should be stored on computers 
that are not connected to a network. 
 
Upgrades and patches 
To prevent unauthorised access to data, it is important to apply all relevant security-related 
upgrades and patches to operating systems and applications as quickly as possible. 
 
A formal procedure should be adopted to ensure that new patches and updates are applied to 
all project computers. 
 
Viruses 
Project staff should be given training to recognise suspicious files and emails. 
 
All project computers should have regularly updated (preferably daily through a contract with 
an anti-virus software vendor) virus detection software. 
 
Email should not be received on computers storing data. 
 
Physical security of systems 
Prevention of unauthorised access to computer hardware and hardcopy material is very 
important. Sensible physical security precautions should be taken, such as locking rooms 
when staff are absent, limiting access to rooms where computers or media are held to a few 
individuals, logging computer media or hardcopy material that are removed from store 
rooms, recording who holds keys, etc. 
 
 
RECOMMENDATIONS FOR DOCUMENTATION 
 
Creating and Managing Documentation 
 
Documentation is an integral part of a research project. It should be written as the dataset is 
created and developed. The documentation should be comprehensive and provide all the 
necessary information to enable informed use of the dataset. 
 
Guidelines for documenting a dataset 
Guidelines should be developed to ensure that all project staff are aware of what information 
is needed to adequately document a dataset. 
 
Review documentation 
Documentation should be reviewed by members of the project (or other appropriate 
individuals outside the project) to ensure that it is comprehensive and understandable. 
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Indicate the relationship between documentation and data 
Clearly indicate in the documentation how it relates to the data (which file, which variable, 
which coding scheme). 
 
Hardcopy documents should be clearly marked with all the details needed to find other 
related hardcopy or digital material (see Version Control). 
 
A periodic check should be made to ensure that documentation for a dataset remains up-to-
date. 
  
Documentation in both hardcopy and digital forms 
When documentation is partially digitised a clear statement should be included with the 
digitised documentation explaining how it differs from the hardcopy original. 
 
When documentation exists in both digital and hardcopy form then one version should be 
clearly identified as the master version that should be used as the basis for any future revision 
of the documentation. 
 
Documentation Content 
 
The documentation for a dataset should provide all the information needed to make informed 
use of the data. Members of the project will be best placed to make detailed decisions on 
what and how to documented, although as a rule, it is better to be inclusive and record 
information that is not vital, rather than create sparse documentation that does not provide all 
necessary information. 
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Documentation checklist 
 
 
Provenance 
 
• History of the originating project  
o the purpose of the project  
o topic(s) of research  
o geographic and temporal limits  
o funders 
o principal investigators 
o information about methods  
• Methods used to create the dataset  
o consistency checks  
o error corrections  
o sampling strategies employed  
• Details of existing material used to create the dataset  
o existing sources of data used 
o procedures for updating, combining, or enhancing existing source data  
o coding and classification schemes used 
o description of any known copyrights held on existing source material 
 
Technical Details 
 
• Data characteristics 
data model (flat data file, relational database) and relevant details 
variable data types 
text encoding  
file formats 
• Ancillary information 
list of filenames and description of contents  
description of identification numbers assigned  
description of any known problems  
details of derived data 
details of codebooks and data dictionaries  
history of format changes to dataset 
• Software 
software used for creation (including specialized software such as OCR) 
software used for analysis 
software used for conversion, import and export of data 
operating system(s) and platforms that software ran on 
specialized hardware used (e.g. digital cameras and scanners)  
 
Access and Use 
 
• terms of consent 
• bibliographic references to any publications, or web sites, about the project  
• access conditions (free/restricted)  
• intellectual property rights statements 
• rights held by third parties in the dataset 
• history of how the dataset has been used 
• indication of how long archive is to be retained (indefinitely or fixed period) 
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GLOSSARY 
 
 
  
ADH Adult Dental Health Survey 
AHRB Arts and Humanities Research Board 
AIDS Acquired immune deficiency syndrome 
ALSPAC Avon Longitudinal Study of Parents and Children 
ASCII American Standard Code for Information Interchange 
BBSRC Biotechnology and Biological Sciences Research Council  
BHPS British Household Panel Survey  
BIOME BIOME is a collection of gateways which provide access to evaluated, 
quality Internet resources in the health and life sciences, aimed at 
students, researchers, academics and practitioners. 
BIOML BIOpolymer Mark-up Language  
BSI British Standards Institute 
BSML Bioinformatic Sequence Mark-up Language  
CCT Current Controlled Trials  
CDISC ODM Clinical Data Interchange Standards Consortium Operational Data 
Model  
CEN Comit é Européen de Normalisation European Committee for 
Standardization  
CERN European Organization for Nuclear Research  
CML Chemical Markup Language  
CODATA Committee on Data for Science and Technology 
CONCORDE MRC/INSERM trial of zidovudine in HIV infection 
CORBA Common Object Request Broker Architecture 
COREC Central Office for Research Ethics Committees 
CSA Cambridge Scientific Abstracts  
CSTP Committee for Scientific and Technological Policy 
CTU Clinical Trials Unit 
DAA MRC Data Archiving and Access Project  
DAIS Data and Information System  
DDBJ DNA Data Bank of Japan 
DDI Dataset Documentation Initiative 
DeCC Depression Case Control Study 
DNA deoxyribonucleic acid 
DoH Department of Health 
DSM-IV Diagnostic and Statistical Manual (Fourth edition) 
DTD Document Type Definition  
EAR  Division of Earth Sciences at the National Science Foundation (NSF) 
EBI European Bioinformatics Institute 
EDM  electronic document management  
EMBL European Molecular Biology Laboratory 
EPR Electronic Patient Record  
ESF European Science Foundation 
ESPRIT  Evaluation of Subcutaneous Proleukin® in a Randomised International 
Trial 
ESRC Economic and Social Research Council 
EUGLOSS Multilingual Glossary of technical and popular medical terms in nine 
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European Languages  
FOIA Freedom of Information Act  
Formaldehyde Study of the effect of formaldehyde on the mortality of workers in the 
UK chemical industry 
FTE Fixed-term employment 
GAME Genome Annotation Markup Elements  
GCP Good Clinical Practice 
GeneXML Gene Expression Mark-up Language  
GIS Geographic Information Systems  
GMC General Medical Council 
GP General Practitioner 
Graffiti Racist and Sectarian Graffiti in Glasgow – A Pilot Study 
HALS Health and Lifestyle Survey 
HEMS Health Education Monitoring Survey  
HGMP Human Genome Mapping Project 
HIDDEL Health Information Disclosure, Description and Evaluation Language  
HIV Human immunodeficiency virus 
HL7 Health Level Seven 
HMCA Health and Medical Care Archive  
HSC Health Service Circular 
HTML HyperText Mark-up Language 
IBM International Business Machines  
ICD-10 International Statistical Classification of Diseases and Related Health 
Problems (10th Revision)  
ICH International Conference on Harmonisation 
ICPSR Inter-University Consortium for Political and Social Research  
ICS International Collaborative Study 
ICSTI International Council for Scientific and Technical Information  
ICSU International Council for Science  
ICT Information and Communications Technology  
IEC Independent Ethics Committee 
INITIO An open randomised trial to evaluate different therapeutic strategies of 
combination therapy for HIV-1 infection 
INSERM L'Institut National de la Santè et de la Recherche Medicale/French 
National Institute for Health and Medical Research 
IoW Isle of Wight Studies 
IPR Intellectual Property Rights 
IRB Institutional Review Board  
ISO International Organization for Standardization 
ISRCTN an International Standard Randomised Controlled Trial Number  
JRF Joseph Rowntree Foundation  
KNAW Royal Netherlands Academy of Arts and Sciences  
LSOA Longitudinal Studies of Ageing 
MARC  MAchine Readable Catalogue Format  
Masculinity Masculinity and Health: The Social Factors Affecting Men’s Health 
MeSH Medical Subject  Headings 
Microsoft COM Microsoft Component Object Model 
MRC Medical Research Council 
mRCT metaRegister of Controlled Trials  
NARA National Archives and Records Administration 
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NATSAL National Survey of Sexual Attitudes and Lifestyles 
NCDS National Child Development Study  
NCHS National Center for Health Statistics 
NeLH National electronic Library for Health  
NERC Natural Environment Research Council 
NeSC National e-Science Centre  
NESSTAR Networked Social Science Tools and Resources 
NHANES National Health and Nutrition Examination Survey 
NHCS National Health Care Survey  
NHIS National Health Interview Survey 
NHS National Health Service 
NIAID National Institute of Allergy and Infectious Diseases 
NIH National Institute of Health  
NIS National Immunization Survey  
NIWI Netherlands Institute for Scientific Information Services 
NLM National Library of Medicine 
NRC National Research Council 
NSF National Science Foundation 
NSHD National Survey of Health and Development 
NTIS National Technical Information Service  
NVSS National Vital Statistics System 
NYS  New York State  
OECD Organisation for Economic Co-operation and Development 
OMNI Organising Medical Networked Information 
ONS Office for National Statistics 
OPCS Office of Population Censuses and Surveys 
PDF Portable document format 
PDGEN Parkinson's Disease DNA Bank 
PDMED Parkinson’s Disease Drugs Assessment Randomised Trial 
PDSURG Parkinson’s Disease Surgery Assessment Randomised Trial 
PI Principal investigator 
PSDML Protein Sequence Database Mark-up Language  
RAL Rutherford Appleton Laboratory 
RCP Royal College of Physicians 
RDN Resource Discovery Network  
REC Research Ethics Committee  
RNA ribonucleic acid 
SAMHSA Substance Abuse and Mental Health Services Administration  
SES Social and Economic Sciences  
SGDP MRC Centre for Social, Genetic and Developmental Psychiatry  
SGML Standard Generalized Mark-up Language 
SHARE SHARE: Does Teacher Led Sex Education Reduce Sexual Risk Taking? 
SILCAAT A Study of Interleukin-2 (IL-2) in People with Low CD4+ T-Cell 
Counts on Active Anti-HIV Therapy 
SNOMED Systematized Nomenclature of Medicine  
SOCCS MRC Scottish Colorectal Cancer Study 
SOP Standards Operations Procedures  
SQL (pronounced "ess-que-el") stands for Structured Query Language  
SWS Southampton Women's Survey 
TAPS Team for the Assessment of Psychiatric Services 
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TEDS Twins' Early Development Study 
Twenty-07 The West of Scotland Twenty-07 Study 
UCL University College London 
UKDA United Kingdom Data Archive 
UMLS Unified Medical Language System  
Wessex Fracture  Wessex Fracture Prevention Study 
WHO World Health Organization 
XML  eXtensible Mark-up Language 
Z39.50 The OSI client/server-based protocol established as a standard by the 
National Information Standards Organisation (NISO) which allows 
computer users to query a remote information retrieval system (server) 
using the software of a different system, and display results in the 
interface of the system used for input (client). 
 
 
